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Abstract 
Blastocystis is an obligate anaerobic, protistan parasite found in the intestinal tract of human 
and various other hosts. Blastocystis is placed within the stramenopiles. This diverse group 
also includes slime nets, water moulds and brown algae. The transmission of Blastocystis is 
believed to take place through the faecal-oral route. Waterborne transmission of Blastocystis 
through the use of untreated water or poor sanitary conditions has also been reported. 
Numerous epidemiological surveys have shown prevalence up to 10% of the population in 
developed countries and as much as 50-60% in developing countries. Differences in 
virulence among Blastocystis subtypes have been reported in a recent animal infection study. 
Blastocystis shows extensive genetic diversity and is divided into numerous genetic subtypes 
The parasite is commonly associated with gastrointestinal symptoms such as watery and 
mucous diarrhea, vomiting, and abdominal cramps and bloating. Epidemiological studies 
suggest an association between Blastocystis infection and irritable bowel syndrome. 
Irritable bowel syndrome (IBS) is identified as a functional bowel disorder in which 
abdominal pain or discomfort is associated with a defect or alteration in the consistency or 
frequency of stools. Diagnosis of IBS by physicians is carried out using symptom -based 
criteria known as the Rome criteria. To see whether there is any link between Blastocystis 
infection and irritable bowel syndrome (IBS), I have compared the frequency of subtypes of 
Blastocystis in IBS patients with those in the general population. 
In human population both UK and Libya showed similar distribution of Blastocystis subtypes 
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ST I, 2 and 3 are common in the two populations and ST3 has the highest frequency in UK 
while STI was the most common in Libya. 
Epidemiology studies on Blastocystis infection in animals have revealed high frequency of 
occurrence in cattle, pigs, primates and birds and it has often been suggested that Blastocystis 
infection is a zoonosis. In Libya, Blastocystis subtypes were detected from humans, birds and 
numerous mammals' hosts (camel, cow, sheep, goat, gazelle, Barbary sheep and gundi). Ten 
subtypes were detected (1, 2, 3, 5, 7,10,14, IS, 16, 17) and four new subtypes were found in 
cow, camel and gundi. Subtype I, 3, and 7 were in common between animal and human but 
subtypes 5, 10 and the four new subtypes were found only in animals. ST 2 was found in 
human only. 
Also I discovered four new hosts for Blastocystis from mouse deer, gundi, gazelle and 
barbary sheep. Both human and animal showed diversity in Blastocystis sUbtypes. 
Both human and animals become infected with same Blastocystis subtype and for this reason 
we need to find refined tool to differentiate between them, so I have developed MLST for 
Blastocystis subtype I based on mitochondrial DNA. Application ofMLST to 39 isolates 
from different host and different geographic place showed variation in the sequence of related 
isolates. Over all MLST proved to be a highly discriminatory and stable method for 
unambiguous characterization of Blastocystis. 
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1.1 History 
Blastocystis is an intestinal parasite of humans and various other hosts. In 1911, Alexeieff 
(Zierdt, 1991 a) was the first to describe the genus Blastocystis and proposed the name 
Blastocystis enterocola. Later, the organism was designated as a yeast by Brumpt, in 1912, 
who gave it the name Blastocystis hominis (Zierdt, 1991a). The name Blastocystis hominis is 
now firmly established and recognised worldwide. 
After being ignored for decades, this parasite has been recapturing the interest of 
parasitologists since the work of Zierdt et al. (1967). Even though a large number of studies 
have been performed, the possible pathogenicity of this parasite is still controversial (Haresh 
et al., 1999, Kuo et al., 2008, Upcroft et al., 1989, Vogelberg et al., 2010, Yakoob et al., 
2004). In this work, Blastocystis hominis will be referred to as Blastocystis sp. or simply by 
the genus name Blastocystis for reasons that will be made clear later. 
1.2 Taxonomy 
The taxonomic status of Blastocystis has been an enigma until recently and the history of the 
organism shows the difficulty in identifying its taxonomic position. Zierdt et al. (1967) were 
the first to provide an ultrastructural study of Blastocystis and showed that it was not a yeast 
or a fungus as suggested before by Alexeieff (1911), Brumpt (1912), Beaurepair Aragoao 
(1922), Knowles and Das Gupta (1924) and Lavier (1952), nor the cyst of another organism 
such as a Trichomonas sp., as proposed by Bensen (1909) and Bohne and Prowazek (1908). 
Others described it as vegetable material (cited in Zierdt et 01., 1967). Zierdf s conclusion that 
19 
it was a protozoan was supported by later ultrastructure studies done by different authors 
(Boreham and Stenzel, 1993, Dunn et al., 1989, Zierdt, 1991 a). 
The Blastocystis cell reveals protistan features of morphology as it lacks a cell wall but 
contains one or more nuclei, smooth and rough endoplasmic reticulum, a Golgi complex and 
mitochondrion-like organelles (Boreham and Stenzel, 1993, Dunn et aI., 1989, Tan et aI., 
1974, Zierdt, 1973, Zierdt, 1978, Zierdt, 1991a, Zierdt et aI., 1967, Zierdt and Tan, 1976a, 
Zierdt and Tan, 1976b). The organism has a number of morphologically distinct forms 
(Boreham and Stenzel, 1993, Dunn et aI., 1989, Tan et aI., 1974, Tan and Zierdt, 1973, 
Zierdt, 1991 a, Zierdt and Nagy, 1993, Zierdt et aI., 1967). Forms of Blastocystis, with the 
exception of cyst forms, are not bordered by a cell wal1 but are enclosed by a bilaminar 
membrane (Mehlhorn, 1988, Zaman et al., 1995b, Zierdt, 1991 a). Physiologically, 
Blastocystis spp. do not show any growth in fungal medium and growth is optimal at 37°C 
and neutral pH. Growth is not inhibited by antifungal agents such as amphotericin B (Dunn 
and Boreham, 1991, Zierdt, 1973, Zierdt, 1986, Zierdt et al., 1967, Zierdt and Williams, 
1974, Zierdt et al., 1995). These characteristics appear to link the organism more with 
protozoa than the fungi. 
On the basis of suggested means of multiplication and its morphological and culture 
characteristics, Blastocystis was classified by Zierdt (1978) in the subphylum Sporozoa, and a 
new class Blastocystea and new order Blastocystida were proposed. Later, Zierdt (1988) 
classified this organism to the subphylum Sarcodina (amoebas), in a separate suborder, 
Blastocystina, but data to support this reclassification were not been provided. 
Jiang and He (1993) later proposed a new subphylum Blastocysta which included the class 
Blastocystea, the order Blastocystida, the family Blastocystidae and genus Blastocystis. with 
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B.hominis as the type species. Although it was clear that Blastocystis did not fit well into the 
existing protozoa classification, there was not enough proof to raise a new classification for 
the organism (Boreham and Stenzel, 1993, Hollebeke and Mayberry, 1994). 
As the effect of the physiological state on the ultrastructural appearance of the organism 
became clear (see section 1.3), it was obvious more morphological and molecular data were 
needed (Zierdt, 1993). The taxonomy and phylogenetic affinities of Blastocystis have been 
analysed by comparison of the parasite's small subunit (SSU) rRNA gene sequence with 
those from different eukaryotes. By analysis of partial SSU rRNA sequence it was shown that 
Blastocystis is not monophyletic with yeast (Saccharomyces) or sarcodines (Johnson et al., 
1989). Based on these data, Johnston et al. concluded that Blastocystis should be placed as 
an outgroup of the clade that links ciliates and apicomplexa. 
In a subsequent study (Silberman et al., 1996) the complete Blastocystis SSU rRNA gene was 
sequenced and it showed that Blastocystis should be placed within the stramenopiles. This 
diverse group includes slime nets, water moulds and brown algae. This study also indicated 
that Blastocystis was, surprisingly, phylogenetically related to the flagellate Proteromonas 
(Silberman et al., 1996). Both these organisms share certain life-cycle traits. They are gut 
endosymbionts of vertebrates and encyst to an environmentally resistant form that appears to 
allow transmission between hosts. However, unlike Proteromo1las, Blastocystis does not have 
flagella and tubular hairs. Fig 1.1 showed the close phylogenetic position of Stramenopiles 
with the Alveolates (which include ciliates and apicomplexa) and Rhizaria (which include 
foraminifera and other free-living protozoa) groups. 
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Figure 1.1. The position of Blastocystis within Stramenopiles. Black dots represent values of 100% 
bootstrap support (BP) and Bayesian posterior probabilities (BiPP) of 1.0. Nodes without numbers 
correspond to supports weaker than 50% BP and 0.8 BiPP. Both maximum likelihood and Bayesian 
analysis were used based on concatenated sequences of 126 genes. This figure is taken from Burki et 
al., 2007 
In the revised classification of the six-kingdom system of life (Cavalier-Smith , 1998) 
Blastocystis is placed in a newly created super-group Chromalveolata, w ithin the subdi vis ion 
Stramenopiles, and subgroup Opalinata (Adl et al., 2005). Blastocystis is the firs t 
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stramenopile known to parasitise humans. One of the Pythium spp. which cause pythiosis, 
Pythium insidiosU111 , is the only other stramenopile which causes disease in mammals 
(Gaastra et aI., 2010). 
1.3 Morphology 
Blastocystis is a polymorphic organism. There are four generally recognised forms of 
Blastocystis, the vacuolar, granular, amoeboid and cyst forms (Tan et al., 2002). Reports of 
Blastocystis from human stool material and from host intestine have shown that other forms 
of the organism exist (Boreham and Stenzel, 1993, Mehlhorn, 1988, Zaman et al., 1995b, 
Zierdt, 1991 a, Zierdt, 1991 b, Zierdt and Tan, 1976b) but these forms have not yet been 
included in diagnostic texts. 
Light microscopy provides a quick method of identifying Blastocystis in samples but nearly 
all of the new information on cell biology and life cycle of this organism has been gained 
from transmission electron microscopy. Ultrastructural studies showed that a continuum of 
morphological forms of Blastocystis exists, with the appearance of the organism depending 
on the environmental conditions (Boreham and Stenzel, 1993, Dunn et al., 1989). Physical 
factors, such as osmotic changes, the presence of certain drugs, and metabolic status, may 
have an effect on the morphology of the organism both in vivo and in vitro (Stenzel and 
Boreham, 1996). 
1.3.1 Vacuolar form 
The vacuolar form, also called the vacuolated or central vacuole form, has been considered 
to be the typical Blastocystis cell form (Zierdt, 1991 a). It is generally spherical, and therefore 
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been supported by further studies. Other distinct but less frequent fOnTIS been described, 
such as avacuolar and multivacuolar cells, and cells having filament-like inclusions (Stenzel 
and Boreham, 1996). 
1.3.2 Granular form 
The granular form is commonly observed in old and non-axenized cultures (Tan, 2004). 
Granular forms usually are slightly larger than the average vacuolar forms, and diameters of 
15 to 25 I·lITI (Zierdt, 1973), 3 to 38 )lm (Tan et al., 1974), and 6.5 to 19.5 )lm (Dunn et at., 
1989) have been reported. 
Apart from the contents of the central vacuole, the granular form is similar in appearance to 
the vacuolar form. Granular forms also display a thin peripheral band of cytoplasm 
surrounding a large central vacuole. There is a difference in the morphology of the vacuolar 
contents. In the vacuolar form, the central vacuole usually contains finely granular material 
which is scattered throughout the vacuole (Dunn et al., 1989). In the granular form, the 
central vacuole may contain granules with many morphological types. 
Two granular types were proposed based on light microscopy studies. It was suggested that 
one granule type developed into daughter Blastocystis cells while the other had a role in 
metabolism (Zierdt et al., 1967). Later, with help of transmission electron microscopy, it was 
revealed that three types of granules, described as metabolic, lipid, and reproductive granules, 
were present in the cells (Tan and Zierdt, 1973). 
It was suggested that the metabolic granules were cytoplasmic, the lipid granules were found 
in central vacuole and cytoplasm, and the reproductive granules were present in the central 
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vacuole (Zierdt, 1973). These observations have not been confirmed and the study by Dunn et 
al. (1989) described myelin-like inclusions, crystalline granules, small vesicles and lipid 
droplets in the central vacuole of granular forms. 
Different conditions are known to induce granular form production from the vacuolar form, 
including (i) increased serum concentration in the culture medium (Dunn et al., 1989, Zierdt, 
1973), and (ii) transfer of cells to a different culture medium (Stenzel et al., 1991) or 
axenization of the culture (Tan et al., 1974). Vdovenko (2000) illustrated that the vacuolar 
form is an artifact of culture conditions and may not be part of the life cycle of this organism, 
which supports the view of Stenzel et al. (1991). Occasionally, the granular form has been 
observed in cultures without increased serum concentration (Dunn et al., ] 989). 
Although a number of mechanisms for division of vacuolar and granular forms have been 
described (Boreham and Stenzel, 1993, Jiang and He, 1993, Zierdt, 1991 a), the only 
confirmed mode of reproduction of these forms of Blastocystis is binary fission. 
1.3.3 Amoeboid form 
The amoeboid form of Blastocystis is present in culture and stools in small numbers (Fig.l .3) 
It is smaller than both vacuolar and granular forms, the cell size ranging from 2.6 )lm to 7.9 
)lm, and there are conflicting descriptions of its morphology, especially using electron 
microscopy (Dunn et al., 1989, Stenzel and Boreham, 1996, Tan et al., 2002). 
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Figure 1.3. Amoeboid form of Blastocystis occasionally seen in culture showing pseudopod-like 
cytoplasmic extensions (arrow) 
According to Zierdt (1973) this form appeared in small numbers in older cultures and those 
treated with antibiotics, and occasionally in faecal samples. The form has no central vacuole, 
the cells were reported to feed on bacteria, and one or two nuclei were seen at the centre of 
the cell. 
In contrast, in another report the amoeboid cells were said to contain a large central vacuole, 
and cultures with high serum content showed electron-lucent granules were present in the 
central vacuole of the organisms. In most specimens a distinct, permanent cell wall or 
membrane is not seen (Tan and Zierdt, 1973). Engulfed bacteria were seen in lysosome-like 
bodies within the cell (Dunn et al. , 1989). 
The way amoeboid cells multiply is unconfirmed. Some modes of division that have been 
suggested included budding (Zierdt, 1973) and plasmotomy (Zierdt, 1991 a). However, there 
is no conclusive evidence to support either of these reproductive modes. 
There has been a suggestion that the amoeboid form is an intermediate between the vacuolar 
and cyst forms of Blastocystis, but this has not been proven (Singh et al., 1995, Suresh el al., 
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1994). These reports also proposed that bacteria were ingested by the amoeboid form to 
supply nutrition for the encystation process. 
1.3.4 Cyst form 
Cyst-like forms of Blastocystis were first discovered in the fresh faeces of a patient with 
acquired immunodeficiency syndrome by Mehlhorn, (1988), but Stenzel and Boreham (1991) 
provided the first full morphological description of the cyst. The cyst forms were observed in 
faecal material, especially material that had been stored for many days before being fixed, 
and occasionally in laboratory cultures. The cyst appeared rounded or rarely ovoid by 
transmission electron microscopy (Stenzel and Boreham, 1991). 
Zaman et al. (199 5b) also have provided an ultrastructural description of the cyst form and 
have given a method for concentration of this form from faecal material by repeated washing 
in distilled water and centrifugation on Ficoll-Paque. The studies by Suresh (Suresh et al., 
1994, Suresh et al., 1993) were said to identify the cyst form, but the micrographs in these 
reports show organisms morphologically identical to the granular form described by other 
people (Boreham and Stenzel, 1993, Dunn et al., 1989, Tan and Zierdt, 1973). 
The cyst forms of Blastocystis are smaller than vacuolar and granular forms found in cultures. 
Their size is repOlied to be 5 to 10 f.UTI (Mehlhorn, 1988), 3.7 to 5 /lm (Stenzel and Boreham, 
1991), 3 to 6 /lm (Zaman et al., 1995a) and 2 to 5 /lm (Moe et al., 1996) in diameter. 
Multiple mitochondrion-like organelles have been distinguished in the cyst (Zaman et aI., 
1995a) and up to four nuclei per cyst have been described by Mehlhorn (1988), although 
Stenzel and Boreham (1991) discovered only one nucleus per cyst form from human faeces. 
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Blastocystis cysts isolated from animal faecal material show distinct morphological 
differences when compared with faecal cysts from humans. Large multinucleated cyst forms 
of Blastocystis were discovered in faecal material from Macaque monkeys. These cyst forms 
measured up to approximately 15 flm in diameter. Multiple individual cysts surrounded by a 
single fibrillar layer were detected from chicken faecal material (Stenzel et al., 1997) but 
other cyst forms with a bare cyst wall were also found. Individual cysts inside the multiple 
cyst form measured roughly 3-4 flm in diameter and were shown to be uninucleate. The 
authors proposed that the distinct morphologies of the cyst forms possibly reflected the 
presence of different Blastocystis species. 
Viability investigation of Blastocystis cysts showed that they do not lyse in water (Zaman et 
al., 1995a) and are capable of living at room temperature for up to 19 days (Suresh et al., 
1993) but are sensitive to excessive heat and cold and to common disinfectants (Moe et al., 
1996). In comparison to the cystic forms, the vacuolar and granular forms are susceptible to 
alteration in temperature and also hypertonic and hypotonic environments and exposure to air 
(Zierdt, 1991 a, Boreham and Stenzel, 1993, Matsumoto et al., 1987, Singh et al., 1995, 
Zierdt, 1973) and hence appear unlikely to provide a mode of transmission. Thus, the only 
transmission form of the parasite is the cystic stage (Yoshikawa et aI., 2004c, Tan et aI., 
2002). According to Yoshikawa et al. (2004c) the cyst form is considered as the only 
transmissible stage of this parasite. 
1.4 Life cycle and transmission 
The mode of transmission and life cycle of Blastocystis are little understood. Different life 
cycles have been suggested for Blastocystis by different authors (Boreham and Stenzel, 1993, 
Singh et al., 1995, Zierdt, 1973). Arguments about the methods of division of the parasite 
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have existed from the beginning. The first to propose a life cycle for Blastocystis was 
Alexeieff in 1911 (cited in Boreham and Stenzel , 1993a). He illustrated a complex life cycle 
which involved binary fission of a binucleate stage (plasmotomic division), and autogamy, a 
sexual phenomenon, to produce primary cysts. The cysts created spores by multiple budding. 
These spores were considered to be resistant forms . Another mode of reproduction described 
by Alexeieff is merogony. The accuracy of this life cycle was questioned by a number of 
authors (Lynch, 1917; Cifferi and Redaelli, 1938; Lavier, 1952) (cited in Boreham and 
Stenzel, 1993a) even though binary fission (also known as plasmotomic division) appears to 
have been readily accepted and observed in a number of studies (Dunn et al., 1989, Tan and 
Zierdt, 1973, Yamada et al., 1987, Zierdt, 1991 a, Zierdt et al., 1988, Zierdt and Swan, 1981). 
Figure 1.4 Cells of Blastocystis undergoing binary fission in culture (arrow). 
A new life cycle for Blastocystis was proposed by Zierdt in 1973 based on his microscopy 
observations. It shows that the vacuolar form develops into either the granular form, which 
later releases vacuolar daughter cells within the central vacuole, or to the amoeboid form, 
which produces vacuolar daughter cells by budding division. Boreham and Stenzel (J 993) 
have declared that there is no certainty on the role of the amoeboid form in the life cycle of 
Blastocystis. It is not even known whether the amoeboid form can divide by binary fission . 
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Uncertainty continued as a report by Zierdt et al. (1988) indicated that binary fission (Fig.1.4) 
and plasmotomy were two different forms of multiplication. 
At least four modes of multiplication were described by Zierdt (1991 a) for Blastocystis and 
all of them are asexual: binary fission, plasmotomy, endodyogeny and schizogony. However, 
the links between the modes of division were not demonstrated and little proof was presented 
for their existence. Sexual reproduction was not illustrated in Blastocystis in his paper. 
Another life cycle was proposed by Singh et al. (1995); these authors propose a life cycle of 
Blastocystis involving both thin and thick-walled cysts. They suggested that the thick-wall 
cysts are responsible for outside transmission through the faecal-oral route, whereas the thin 
walled cysts are autoinfectious leading to multiplication of the organism within the intestine. 
Progeny arise by schizogony within the precyst form, resulting in a thick-walled cyst, which 
in turn ruptures to liberate daughter vacuolar forms. In Singh's paper another cycle of 
autoinfection was also postulated, although this is not consistent with the description of 
autoinfection associated with other parasites, like Enterobius and Strongyloides spp. In this 
cycle, the vacuolar form differentiates into the thin-walled cyst form through the 
multivacuolar and precyst forms. They propose that schizogony is occurring within the thin-
walled cyst which later ruptures to release daughter vacuolar forms. 
Boreham and Stenzel (1993) suggested a simple life cycle of Blastocystis. The main form in 
the colon of humans is a small non-vacuolated cell without a surface coat. As this form 
passes through the colon, the small vesicles present in the cytoplasm coalesce to produce the 
multivacuolar stage found in faeces, which is encircled by a thick surface coat. The cyst wall 
seems to form underneath the surface coat which afterwards appears to slough off. The 
resulting cyst form is likely to be the infective stage of Blastocystis. Initial support for this 
31 
theory has been supplied by a study showing that the cyst form is infective to rats (Suresh et 
al., 1993). Little information exists on the origin of amoeboid forms since only a small 
number of amoeboid cells have been found in any samples. It is likely that the amoeboid 
form develops from the avacuolar form since there are morphological resemblances, as 
described by Dunn et al. (1989). Boreham and Stenzel (1993) proposed that the other forms 
are culture artefacts and not part of the life cycle in vivo. 
Additional experimental confirmation of this process of cyst formation and the ability of cyst 
stages to survive in external environmental conditions is essential. Infection of another host 
and excystation of the cell would complete the cycle. Since the cyst is more common in 
stored faecal material than in fresh stools, Stenzel and Boreham (1993) suggest that this form 
may develop in response to excretion from the host or to external environmental factors. Very 
little information is available. 
The mode of transmission of Blastocystis remains in question; although it is assumed that 
transmission may take place through the faecal-oral route, few studies have examined this 
point (Kain et al., 1987). Transmission of Blastocystis can be assisted by the contamination 
of environment, food, or water with excreted cysts from the hosts (LeeJayoova et al., 2008). 
Waterborne transmission of Blastocystis by the use of unboiled, untreated water or poor 
sanitary conditions has been rep0l1ed (Leelayoova et al., 2008, Nimri and Batchoun, 1994, 
Nimri, 1993). Doyle et al. (1990) suggested that the close association of humans and animals 
could be a source of transmission of Blastocystis. Also Rajah Salim et al. (1999) have found 
that people who come into close contact with animals have more chance of having a 
BlasLOcystis infection. In contrast, another study by Nilmi and Batchoun (1994) did not find 
any relationship between Blastocystis and presence of animals. Transmission of Blastocystis 
has been reported among family members in Italy (Guglielmetti et al., 1989), suggesting that 
other animals are not always involved. 
In reviewing the literature on Blastocystis none of the publications report anything about 
ploidy of Blastocystis during its life cycle and there is no convincing evidence for sexual 
reproduction (Tan et al., 2008). 
In summary, the Blastocystis mode of transmission is through the faecal-oral route, binary 
fission is the only accepted mode of cell division, and the cyst is the infective stage. 
1.5 Pathogenicity 
The most difficult question concerning Blastocystis today is whether this organism is truly 
pathogenic or a commensal, or is pathogenic only under specific conditions such as 
immunosuppression, poor nutrition or concurrent infections. Attempts to link pathogenicity to 
Blastocystis by epidemiological studies have been criticized due to the difficulty to exclude 
all other infectious and non-infectious causes, especially when it is considered that 25% of 
patients with diarrhea have no known etiology (Edmeades et at., 1978 cited in Boreham and 
Stenzel (1993). Although many authors have suggested that Blastocystis causes disease there 
are also a numbers of reports to contrary (Table 1.1 ) 
Table 1.1 Different survey and epidemiology studies suggesting pathogenic and non-pathogenic Blastocystis 
Reference Pathogen~onpathogeni 
Garcia et al, 1984 
Babcock et al, 1985 ~ 
Sheehanetal, 1986 ~ 
Babb alll Wagener, 1989 1 ~ 
Qadri et al., 1989 ~ 
Do)1e et al, 1990 ~ 
Zaki et aL, 1991 ~ 
Telalbasic et al, 1991 
Waghom and Hancock, 19911 ~ 
Nimri et al, 1994 ~ 
Jetinek et aL, 1997 
Tasova et al, 2000 ~ 
Kaya et al, 2007 ~ 
Vogellerg et al, 2010 
Ct"en et al, 2003 ~ 
Senayalll MacPt"erson, 1990 ~ 
ooennanetal,1994 
Markel alll Udkow, 1993 1 ~ 
Stmma et al, 1995 ~ 
Cluch et aL, 1992 ~ 
Miler and Minst"ew, 1988 1 ~ 
Horiki et ai, 1997 
® With & without Blastocystis 
o Blastocyttis with & without symptoms 
JBlastocyttis with & without diarrlloea 
~ Blastocystis alone & with other ~ogenic parosites 
Sample groups Size of the study Type of technique 
No of patien~o of sample 
Patients 2891196® I 485 I Formalin/e!M acetate concentration and tnchrome pennanent stained smear 
Out Patients 4oo{3600® I 4000 IFormalin{ethyi acetate concentration 
Patients 62/327® I 389 IUnstained wet mount smear 
Patients 76/2624® I 2700 ITnchrome staining technique 
Patients 647/2242® I 2889 IFormalin/ethyi acetate concentration and saline and iodine-stained wet mount smear 
Out Patients 124/190 I 143 IFormalinlethyi acetate concentration{ tnchrome stain and the modified acid-fast stain 
Patients (Children) 19120' I 39 IFormalin{ethyi acetate concentration and then wet faecal smear 
Patients 82{120 I 94 IUnstained wet mount 
Patients 51{15° I 6S IFormalin/ethyi acetate concentration and direct faecal smear using saline and 5% aqueous nigrosin (counterstain) 
School children 17S/28~ I 203 IWet mount preparation and formal-ether concentration 
Tourists ~'::':""-I~;";""-1795IDirect microscopy using iron-haematoxylin-stain and sodium acetate-acetic acid-formalin/ethylacetate-concentration technique 
Patients 2061200· I 406 IWet mount smear us~ saline and iodine IFormalin{ethyi acetate concentration and mchrome-stained smear 
Patients 46/6° 52 IWet mount smear us~line and iodine /Formalinlethyl acetate concentration method and mchrome and Kinyoun acid-fast stain 
Tourists 1° IDirect wet faecal smear 
Healthyaduls 99/193® 292 IMerthiolate-iodine formalin method 
Consecutiw patients 90130° I 120 IFormalin{ethyi acetate concentration, wetmount smear and iron-haematoxylin stain smear 
Patients 18{32' I SO IFormalin/ethyi acetate concentration and iodine wet mount 
Patients ~~"-::--+---I307IT richrome-stained technique 
Random patients 1189/112' 301 IDirect wet faecal smear and Formalin{ethyl acetate concentration 
Gay men with Hrv' and wi~4 49/9* I 58 
Consecutiw patients 11 ~ 11 
Random patients I 3016392® 6422 
o No Blastocystis with or without diarrhoea 
• Patients with & without hematological malignancy 
eBlastocystis patient with urticaria 
.Patients with Blastocystis & healthy control 
Haema~illand eosin, penodic acid Schiff-Alcian blue, acid-fas~ Warthin-Starry, mchrome and Giemsa stains 
Direct wet faecal smear and mchrome-stained smear 
Direct wet faecal smear 
GNo Blastocystis with or without symptoms 
*Gay men with & without HIV 
~Patients with symptoms of ententis and having Blastocystis 
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Type of study Country 
Retrospective chart review Los Al'geles, USA 
Reports~ Kathmandu, Nepal 
Reports~ NewYork,USA 
Report study Caifomia, USA 
Clinical report Riyadh, Saudi Arabia 
Prospective study Vancouver, Canada 
Clinical report Kuwait Kuwait 
Reportstu'!!y Sarajew, Bosnia 
Prevalence ~rt High ~mbe, UK 
Prevalence of intestinal parasites tbed, Jordan 
Case wntrol study Munchen, Gennany 
Non-randomized s~ Adana, Turkey 
~ liparta, Turkey 
Case I!E.Ort Dresden, Germany 
Case control s~ Taipei, Taiwan 
Prospective s~ Hamilton, Canada 
Prospective study Texas, USA 
Comparision between symptomatic & asymptomatic Oakland, USA 
P~ctive study control study B~kok, Thailand 
Pilot association stu<fy Aberta, Canada 
Association of Blastocystis with clinical disease Washil'9ton, USA 
Epidemio~c survey Tokyo, Japan 
Symptoms commonly linked to infection with Blastocystis are non-specific and include 
diarrhoea, abdominal pain, cramps or discomfort, and nausea (EI-Shazly et al., 2005, Graczyk 
et al., 2005, Kaya et al., 2007, Moghaddam et al., 2005, Stensvold et al., 2008, Gupta and 
Parsi, 2006, Motazedian et al., 2008, Nigro et al., 2003, Tasova et al., 2000). Profuse watery 
diarrhoea has been recorded in acute cases (Logar et al., 1994, Tan and Zierdt. 1973, Zaki et 
al., 1991). Other signs and symptoms sometimes reported include faecal leucocytes (Diaczok 
and Rival, 1987, Kaya et al., 2007), rectal bleeding (aI-Tawil et al., 1994, Bratt and 
Tikasingh, 1990) and eosinophilia (Katsarou-Katsari et al., 2008). Fever has been reported 
especially in acute cases (Gallagher and Venglarcik, 1985, Stensvold et al., 2008, Zaki et al., 
1991 ). 
Several studies have been carried out to evaluate the epidemiology of Blastocystis by 
detecting the presence or absence of the organism and linking this to pathogencity by 
dividing patients into symptomatic and asymptomatic groups. The analysis of the results 
from such studies is not straight forward as case definition varies, and the duration of 
Blastocystis carriage is not known nor is the incubation period. Therefore, if Blastocystis 
infections cause symptoms, we need to know whether these symptoms are acute, chronic or 
intermittent. Also in the evaluation of all studies in table 1.1, there was no consistent 
technique used to detect Blastocystis. Some stages may not be detected by direct microscopy 
or concentration techniques, and although culture is thought to be more sensitive this method 
is not always used. 
Some people have used individual case study results to make a judgment about the 
pathogenicity of Blastocystis. For example, Vogelberg et af. (2010) reported the possible link 
of a Blastocystis infection with the simultaneous occurrence of gastrointestinal illness. 
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Resolution of symptoms coincided with elimination of the parasite, suggesting it might be the 
cause of the problem. However, disappearance of symptoms may be due to elimination of 
unidentified pathogens rather than to the treatment of Blastocystis (Moghaddam et aI., 2005). 
Miller and Minshew (1988) assessed a small number of hospitalized patients (11 patients). 
Most of these patients had other diseases that could have explained the gastrointestinal tract 
problems or had recently received antibiotics or anti-protozoal drugs. The authors reached 
the conclusion that Blastocystis was not a pathogen. Chen et al. (2003) found that most of the 
individuals harbouring Blastocystis were asymptomatic, and that the occurrence of 
gastrointestinal symptoms was similar whether individuals were positive or negative for 
Blastocystis. Others (Markell and Udkow, 1993; Miller and Minshew, 1988; Shlima et al., 
1995) also concluded that Blastocystis is usually not a pathogen. 
Both endoscopy and biopsy results showed that Blastocystis does not invade the colonic 
mucosa in human patients (Diaczok and Rival, 1987, Doyle et aI., 1990, Garavelli et aI., 
1991, Stenzel and Boreham, 1996). Edema and inflammation of the intestinal mucosa has 
been repOlied to be present (Garavelli et a\., 1991, Kain et a\., 1987, Lee et aI., 1990, Russo et 
aI., 1988), but one case report (aI-Tawil et al., 1994) described colonic ulceration detected by 
colonoscopy and biopsy. Blastocystis was found in superficial ulcers and both inflammatory 
cells and eosinophila were present in the cecum, transverse colon, and rectum of the patient. 
Endoscopy of the upper gastrointestinal tract did not show any abnormal epithelia. This has 
excluded the possibility of other known bacteria, viral and pathogenic parasites as well as 
Clostridium difficile toxin being the cause. Non-infectious causes of the symptoms were not 
found, and the only parasite found in biopsy material linked with inflamed areas of the 
gastrointestinal tract was Blastocystis (aI-Tawil et al., 1994). 
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In contrast, another study (Chen et al., 2003) using upper gastrointestinal endoscopy and 
sigmoidoscopy showed that presence of the organism had no relationship with any intestinal 
lesions. Similarly, in a group of patients with Blastocystis infection, Zuckerman et al. (1994) 
did not find any evidence of significant intestinal inflammation by endoscopy. Intestinal 
permeability was assessed by excretion of a radioactive marker eICr-EDTA) and no increase 
was found. Based on this they concluded that Blastocystis did not cause significant intestinal 
Injury. 
The first report of a possible relationship between intestinal obstruction and concomitant 
Blastocystis infection was provided by Horiki et al. (1999). Intestinal blockage and 
accumulation of stool as well as haemorrhage from cancerous lesions may lead to more 
growth of Blastocystis. According to Tasova et al. (2000) Blastocystis is a common parasite 
in patients with haematological malignancy (HM) and it should be taken into account as a 
potential pathogen in patients with gastrointestinal symptoms and HM who are being treated 
with metronidazole. 
There seems to be no evidence for the role of protective immunity to Blastocystis at the 
community level (Ashford and Atkinson, ] 992). Ashford and Atkinson claimed that if the 
organism is pathogenic, only a small percentage of the community might be immune so that 
any individual immunity will not interfere with the overall community pattern. Other authors 
suggest that there is protective immunity in Blastocystis due to the self-limiting nature of the 
infection and spontaneous elimination of the parasite (Nimri, 1993). 
Most investigators agree that adults are more likely to be infected than children (Horiki et al., 
1997). However, several studies reported that older children and adults have a lower infection 
rate and fewer symptoms than younger children (N ilmi and Batchoun 1994); this may reflect 
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the stimulation of immunity by previous infection. However, this point remains controversial, 
as other studies have detected higher rat~s of infection in adults than in children (Ashford and 
Atkinson, 1992, Doyle et al., 1990, Logar et al., 1994, Martin-Sanchez et al., 1992, Qadri et 
al., 1989, Sanad et al., 1991, Suresh et ai., 2001). 
Protozoa can be significant enteric pathogens in patients with human immunodeficiency virus 
(HIV) infection. A wide variety of bacterial, viral, and parasitic pathogens can cause severe 
diarrhoea in patients with low CD4+ cell counts. Disagreement exists as to whether 
Blastocystis should also be included among the infectious agents capable of causing HIV-
related diarrhea. 
The prevalence and clinical significance of Blastocystis were determined by Albrecht et al. 
(I 995) in a cohort study of 262 patients with HIV infection carried out at a university hospital 
in northern Germany. Blastocystis was detected in faecal samples of 99 patients (38%) and 
detection rate was different between groups. Patients with acquired immunodeficiency 
syndrome (AIDS) were more likely to carry Blastocystis (46%) compared to patients in 
earlier stages of HIV infection (32%), P = 0.03. No association with clinical symptoms was 
confirmed and the presence of Blastocystis was frequently associated with concurrent 
isolation of other enteric pathogens and non-pathogens. Another study by Hailemariam et al. 
(2004) showed no significant difference between HIV/AIDS patients and a HIV seronegative 
control group in the presence of common intestinal parasites. However Blastocystis was more 
prevalent in HIV I AIDS patients than in controls (P < 0.05). A recent study in Jakm1a on 318 
HIV patients rep0l1ed parasitic intestinal infections in 84.3% of subjects with Blastocystis as 
the most frequent parasite found (72.4%) (Kurniawan et aI., 2009). 
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In a survey carried out in Dakar, Senegal by Gassama et al. (2001) among 594 patients from 
May 1997 to May 1999, 158 were HIV+ with diarrhoea (D+), 121 were HIV- 0+,160 were 
HIV+ without diarrhoea (D-), and 155 were HIV - 0-. The main causes of diarrhoea were 
different according to HIV serostatus of patients and Blastocystis was considered to be an 
opportunistic pathogen, since it was identified only in HIV infected patients, with higher 
prevalence in adults with diarrhoea (2.5% in HIV+D+ patients; 0.6% in HIV+D- patients) 
A study by Cegielski et al. (1993) investigated whether particular intestinal parasites are 
linked to HIV infection in Tanzanian children with chronic diarrhoea. All children were aged 
15 months to 5 years and admitted to hospital with chronic diarrhoea, and were compared to 
age-matched controls. Three groups were compared: HIV-infected and non-HIV-infected 
children with chronic diarrhoea and HIV negative controls without diarrhoea. Although 
intestinal parasites were detected in approximately 50% of children in all 3 groups, 40% of 
those with chronic diarrhea were HIV -seropositive and Blastocystis was more common in 
HIV -infected children (p=0.05) 
In contrast, Church et al. (1992) and Viriyavejakul et al. (2009) did not find any link between 
the presence of Blastocystis and diarrhoea symptoms in HIV infected patients. 
Blastocystis can be divided into different subtypes (STs; see section 1.11) and a number of 
authors have proposed that specific subtypes might be linked to pathogenicity. Hameed et al. 
(20 II) found Blastocystis ST3 in 61 % of urticarial patients and concluded it was a strong 
indicative pathogen for urticaria. The amoeboid form was detected in symptomatic patients 
with urticaria suggesting that this form was linked to pathogenicity. In addition, Katsarou-
Katsari et al. (2008) presented the case of a patient with acute urticarial lesions and minor 
gastrointestinal symptoms who had Blastocystis ST3 that produced amoeboid forms 
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throughout cultivation. Meanwhile, Stensvold et al. (2010) reported a case of Blastocystis 
ST2 infection probably connected with repeated gastrointestinal and urticarial symptoms. In 
contrast, Dogruman-AI et al. (2008) suggested that Blastocystis ST2 is non-pathogenic. 
Some authors reached the conclusion that Blastocystis is pathogenic, because treatment led 
to a reduction of symptoms and elimination of parasite in patients with acute diarrhoea, 
including some who had been treated with prednisone for rheumatoid arthritis (Lee et al., 
1990) and in others taking only the drug against the parasite (Ertug et al., 2009, Kaya et al., 
2007, Moghaddam et al., 2005, Rossignol et al., 2005). 
Several pUblications and diagnostic texts suggest that the abundance of Blastocystis in stool 
samples is related to signs and symptoms of the infection and that the numbers of organisms 
seen in faecal smears should be recorded in pathological reports (Lee, 1991, Pikula, 1987, 
Sheehan et al., 1986, Zafar, 1988, Zierdt, 1991 b, Zierdt, 1993). Some investigators, I ike 
Garcia et al. (1984), Sheehan et al. (1986), and Kay et al. (2007), recognize Blastocystis as a 
pathogen when no other cause of intestinal disease is identified, especially if the parasite is 
found in large numbers on the faecal smear. Senay and MacPherson (1990) found that 
symptoms due to the parasite were not related to the quantity of the Blastocystis present in the 
stool sample. In contrast, Doyle et al. (1990) and Sheehan et al. (1986) proposed that 
Blastocystis is more likely to cause symptoms when present in large numbers, defined as > 5 
organisms per oil field. 
Other papers have found no correlation between the number of Blastocystis in stool samples 
and the presence or intensity of symptoms (Doyle et al., 1990, Horiki et al., 1999). A 
decrease in the number of Blastocystis or eradication of the organisms has been significantly 
correlated with clinical recovery (Kain and Noble, 1989) but Miller and Minshew (1988) 
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suggested that there is no correlation between resolution of symptoms and either 
anti protozoal treatment or disappearance of Blastocystis from faecal samples. Until there is 
confirmation that Blastocystis can be a pathogen and that the number of organisms is 
connected to virulence, numbers of Blastocystis cells should still be recorded and not 
interpreted as insignificant. (Church et al., 1992, Doyle et al., 1990, Logar et af., 1994, 
Rolston et al., 1989, Zaki et al., 1991). 
Blastocystis is a group of genetically diverse organisms, some of which may cause chronic or 
acute infection in some immunocompetent humans. The way Blastocystis behave in humans 
is similar to Giardia and Entameba histolytica-expression of symptoms depends on parasite 
genotype, host genotype, host immunity, and age. Parasite genotype may vary geographically 
along with other factors. Despite increasing reports that Blastocystis has pathogenic potential, 
the true nature of its virulence is currently unconfirmed due to the limited numbers of studies. 
In conclusion, considering that there are no reports clearly prOVIng that Blastocystis is 
nonpathogenic and since there are several studies concluding the opposite, it should be 
considered as a possible pathogen when all other possible infectious or noninfectious causes 
ofthe symptoms present have been excluded. 
1.6 Blastocystis and Irritable bowel syndrome 
Irritable bowel syndrome (IBS) is "a functional disorder of the gastrointestinal tract 
characterized by regular occurrence of abdominal pain or discomfort along with alteration in 
frequency or consistency of the stool in the absence of organic etiology" (Agrawal et al., 
2008, Sorouri et al., 2010, Yale et al., 2008). It is a very common disorder with a worldwide 
prevalence of 10-20% (Longstreth et al., 2006). 
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Young adult patients are more frequently diagnosed with IBS than people over the age of 50 
years (Drossman et al., 2002) and most studies find a female predominance (Nam et al., 
2010, Park et al., 2010) although only a few people see their family doctor. The disease 
results in a reduced quality of life and is a multi-billion pound health-care problem (Talley 
and Spiller, 2002). In the UK, only 50% of IBS cases are thought to be diagnosed (Spiller et 
al.,2007). 
The symptoms of IBS differ from one person to another and may include irregular bowel 
movements, abdominal pain or discomfort, flatulence, and diarrhoea or constipation (Salonen 
et al., 2010). Stress worsens IBS rather than being causative in any way (Agrawal et al., 
2008). 
According to the widely used Roma II criteria (Table 1.2) IBS sufferers can be clustered into 
three symptom groups based on the stool appearance, stool frequency and defecatory 
symptoms: diarrhoea predominant (IBS-D), constipation predominant (IBS-C), and mixed 
type (IBS-M) with alternating occurrence of both diarrhoea and constipation (Longstreth et 
al., 2006, Sorouri et al., 2010, Khan and Chang, 2010). 
Table 1.2 Roma II Criteria (Li et al., 2003) 
At least 12 weeks or more, which need not be consecutive, in the 
previous 12 months of abdominal pain or discomfort that has 2 of 3 
features: 
Relief with defecation 
Onset associated with a change in the frequency of stool 
Onset associated with a change in the form (appearance) of stool 
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More recently, the Roma III criteria (Table 1.3), which concentrate on the symptom 
frequency over persistence, have been issued (Longstreth et al., 2006). 
Table 1.3 Roma III Criteria (Dong et al., 20 I 0) 
Recurrent abdominal pain or discomfort at least 3 days per month 
in the last 3 months associated with 2 or more of the following 
Improvement with defecation 
Onset associated with a change in frequency of stool 
Onset associated with a change in form ( appearance) of stool 
The cause and pathophysiology of IBS are complicated and not well explained, and the main 
significant abnormalities include visceral hypersensitivity, irregular. gut motility and 
autonomous nervous system dysfunction (Salonen et al., 2010). Barbara et al. (2009) 
demonstrated that there is reliable evidence showing that IBS may be the adverse result of an 
acute episode of infectious gastroenteritis, the so-called postinfectious (PI) IBS, and the 
infectious agents involved in the development of IBS include pathogenic bacteria, parasites, 
and viruses. Studies have illustrated that genetic factors, chronic stress and enteric infections 
can predispose persons to developing IBS (Khan and Chang, 2010). Most drug therapies to 
date are unable to make a major impact on the quality of life for sufferers (Khan and Chang, 
20 10). Hence, an imp0l1ant problem is to understand what lies behind the development of 
symptoms in IBS (Thompson, 2005) . 
An understanding of the role of Blastocystis in IBS is restricted by the ambiguity surrounding 
its pathogenicity (Stark et al., 2007). Nevertheless, symptoms that have been attributed to 
infection with Blastocystis are non-specific, IBS-like and include diarrhoea, abdominal pain, 
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cramps or discomfort, and nausea (Doyle et al., 1990, Zaki et al., 1991). Furthermore, 
chronic excretion of Blastocystis with persistent symptoms has been reported (Zaki et al., 
1991 ). 
Hussain et al. (1997) showed that IgG antibody levels to Blastocystis in patients with IBS 
were significantly higher compared with asymptomatic controls, demonstrating immune 
activation, and suggesting some association between Blastocystis and IBS. In a study by 
Yakoob et al. (2004) Blastocystis was more frequently demonstrated in the faecal samples of 
IBS patients (46 %) than the control group (7%). Giacometti et al. (1999) evaluated a 
possible link between Blastocystis infection and IBS and their findings support a link 
between the two. In contrast, Tungtrongch et al. (2004) found no relationship between 
presence of Blastocystis in faeces and IBS diagnosis. In chapter 4 this study will be discuss in 
more detail. 
Some authors have suggested that an intestinal tract that is abnormal for any reason may 
provide conditions suitable for proliferation of Blastocystis (Udkow and Markell, 1993, Neal 
et aI., 1997). It is possible that Blastocystis infection is an indicator of intestinal dysfunction 
or resident intestinal flora disorders rather than a cause of IBS. Whenever Blastocystis is 
detected in stool samples of patients with IBS it does not necessary mean that the symptoms 
are due to this organism and other infective and non-infectious causes should be investigated 
(Stark et al., 2007). 
]n summary, accumulating reports suggest an association between Blastocystis infection and 
IBS. However, it is unclear whether Blastocystis is a primary etiological agent in IBS, and it 
has been suggested that an abnormal intestinal situation like IBS may give an environment in 
which parasite numbers can increase (Udkow and Markell, 1993). 
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1.7 Treatment of Blastocystis 
The necessity for treatment of Blastocystis infections remams controversial (Stenzel and 
Boreham, 1996). In the absence of certain proof of pathogenicity of the organism, treatment 
with possibly unsafe drugs and the failure to examine the true cause of symptoms in patients 
are of concern to many physicians (Markell and Udkow, 1986). 
Most data on the treatment of Blastocystis are case control studies to investigate and evaluate 
both the clinical findings and the effect of drugs like metronidazole, trimethoprim-
sulfamethoxazole (TMP-SMX), nitazoxanide and paromomycin in patients with Blastocystis. 
The main problem in evaluation of these studies is the diagnostic methods used to detect the 
organism. Stool microscopy is the most common technique and culture was used in one 
study only, by Stensvold et al. (2008). 
There are a number of papers discussing the treatment of Blastocystis but only two papers 
described a controlled treatment trial; these studies were carried out in Egypt and Italy. 
One of the control treatment trials described by Nigro et al. (2003) between April 1999 and 
October 2000, consisted of 616 subjects with diarrhoea referred to an outpatient clinic of the 
University of Catania. Five hundred were referred by a primary care physician; 116 arrived 
from other sections of the unit. Three fresh stool specimens were collected from each of the 
616 subjects. All stool specimens were examined by direct wet mounted smear, trichrome 
staining, flotation and formol-ether concentration techniques. 
A total of 76 patients had Blastocystis infection as the only potential cause of diarrhoea. Of 
the 76 enrolled subjects, 40 were randomly assigned to group A (treatment), and 36 to group 
B (placebo). 
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Table 1.4 Faecal results and Symptoms of Metronidazole-treated (n=40) and Placebo-treated (n=36) 
Subjects at 1 and 6 Months post-treatment 
1 Month post-treatment 6 Months Post-treatment 
Metronidazole Placebo Metronidazole Placebo 
Blastocystis positive 
Symptomatic 5(13%) 31(86%) 10(25%) 24(67%) 
Asymptomatic 3(7%) 4(11%) 11(28%) 7(19%) 
Blastocystis negative 
Asymptomatic 32( 80"10) 1(3%) 19(48%) 5(14%) 
Metronidazole treatment was a single 1.S-gram dose (as six 2S0-mg pills) orally per day for 
10 consecutive days. This trial resulted in the resolution of symptoms in 87.5 % of treated 
subjects one month after treatment compared to 14% in the placebo group. Blastocystis was 
eradicated from the stool in 80% of individuals who received metronidazole vs. only 3% in 
the placebo group. Seventy five percent of subjects in the treatment group were asymptomatic 
at the end of 6 months compared to 33% in placebo group (Nigro et al., 2003). This study 
compared the efficiency of metronidazole with a placebo in the treatment of diarrhoea in 
which Blastocystis was the only organism found. Metronidazole was observed both to reduce 
diarrhoea and achieve a higher rate of parasitic clearance. The extension of follow-up to 6 
months resulted in an increase of parasitic relapses in the metronidazole-treated group both 
symptomatic and asymptomatic. It is not known whether the recurrence of Blastocystis IS 
related to recrudescence or to reinfection. 
A second clinical trial evaluated the efficiency of Nitazoxanide for the treatment of diarrhoea 
and enteritis associated with Blastocystis. This is a Randomised, double-blind, placebo-
controlled study was carried-out in Egypt (Rossignol et at., 2005) 
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Different formulae of Nitazoxanide were used in this study, including 500mg orally for 
patients 12 years or older and 200 mg or 1 OOmg twice daily for three days orally for children 
between 4-11 and 1-3 years, respectively. 
Four days after completion of therapy, 36 (86%) of the 42 patients who received 
Nitazoxanide showed resolution of symptoms compared with 16 (38%) of 42 patients who 
received a placebo (P< 0.0001). Thirty-six (86%) of 42 patients receiving Nitazoxanide were 
also clear of Blastocystis organisms in the post treatment stool samples compared with only 5 
(12%) of 42 patients who received the placebo « 0.0001). There was no difference In 
response rate between patients who received the drug as tablets or as a suspension. 
These studies suggest that Blastocystis is pathogenic in some patients and can be treated 
successfully with nitazoxanide or metronidazole. It is unclear whether the effect on 
Blastocystis is direct or indirect through its effect on the bacterial flora. The high rate of 
recurrence after 6 months in the study by Nigro et al. (2003) suggests that Blastocystis may 
be suppressed rather than eliminated by metronidazole treatment, although reinfection cannot 
be ruled out. 
1.8 Epidemiology and prevalence 
The epidemiology of Blastocystis remains incompletely known. Blastocystis is often the most 
frequent parasite reported in human faecal samples, both from symptomatic patients (Pikula, 
1987, Vickerman, 1994, Zierdt et al., 1995) and from healthy individuals (Ashford and 
Atkinson, 1992). 
47 
Table 1.5 Prevalence of Biastocystis infections in different countries 
Prevalence (%) Country Reference 
0.5 Japan (Horiki et ai., 1997) 
2.1 Turkey (Koksal et ai., 2010) 
3.2 Canada (Doyle et ai., 1990) 
3.7 China (Wang et ai., 2002) 
7 Mexico (Diaz et ai., 2003) 
8 Canada (Senay and MacPherson, 1990) 
11.3 Germany (Jelinek et ai., 1997) 
13.5 Thailand (Yaicharoen et ai., 2006) 
13.6 Italy (Cirioni et ai., 1999) 
14.1 Taiwan (Cheng et ai., 2003) 
14.2 Turkey (Ostan et ai., 2007) 
14.7 India (Rayan et ai., 2010) 
14.9 Malaysia (Suresh et ai., 2001) 
15 Germany (Paschke et at., 2010) 
16.3 Egypt (Sanad et ai., 1991) 
20 USA (Amin, 2002) 
22.9 Argentina (MinvieIIe et ai., 2004) 
25 Jordan (Nimri, 1993) 
26.5 Brazil (Nascimento and Moitinho Mda, 2005) 
26.6 Libya (Alfellani et at., 2007) 
30 Thailand (Shlim et at., 1995) 
......... Egypt (Rayan et at., 2007) .J.J • .J 
36.4 Colombia (Londono et ai., 2009) 
40.7 Philippines (Baldo et ai., 2004) 
40.9 Brazil (Aguiar et ai., 2007) 
52.3 Malaysia (Noor Azian et at., 2007) 
61.8 Chile (Torres et ai., 1992) 
The incidence of infection with Blastocystis in a range of communities has been investigated 
(Table 1.5) but the results must be treated with caution since most studies were based on 
samples submitted to parasitology laboratories and therefore are mostly related with 
symptomatic patients (Boreham and Stenzel, 1993) and the methods used vary. Due to the 
variation of Biastocystis prevalence between studies within the same country I have 
compared different studies in Turkey and Malaysia to see why these differences may occur. 
Table 1.6 compares two studies carried out by different authors in different areas of Turkey. 
Koksal et al. (2010) collected faecal samples from an outpatient group in Istanbul whereas 
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Ostan et al. (2007) obtained faecal samples from random students at a primary school In 
Manisa. 
Table 1.6 Comparison of Blastocystis prevalence in two studies in Turkey 
Authon; Koksal et al. (2010) Ostan et al. (2007) 
Type of patient Out patients suspected of having intestinal parasites Children in primary school 
Age group 19-40 years (young aduh) 9-12 (children) 
Location Istanbul city Manisa city 
No of sample stool samples 27664 294 
Prevalence of intestinal parasites 1114(4%) 91 (31%) 
Prevalence of Blastoc),stis only 604 (2.1 %) 42 (142%) 
Technique used for diagnos is Abnost same teclmique > stool microscopy and fonnalin-ethyl acetate concentration 
Both the prevalence of all intestinal parasites and of Blastocystis is higher in samples 
collected from Manisa city than Istanbul. Istanbul is the capital of Turkey and is considered 
as an urban area. In contrast Manisa is a smaller city, not on the scale of Istanbul and half of 
the students came from a shanty area and the other half from a wealthy district with an 
improved infrastructure. In Manisa, students who lived in good conditions also had a lower 
Blastocystis and intestinal parasite prevalence compared with students who lived in a shanty 
area. In both studies the techniques used are almost the same and the difference in the 
prevalence of intestinal parasites between the studies is primarily affected by the location or 
infrastructure of these cities although the comparison of children vs adults could also be 
important. 
In Malaysia, two studies were carried out by Noor Azian et af. (2007) and Suresh et af. 
(2001) and showed differences in prevalence of Blastocystis. 
49 
Table 1.7 Comparison of Blastocystis prevalence in two studies in Malaysia 
Authors Noor Azian et al.(2007) Suresh et al.(2001) 
Type of patient An aborigine community Peoples Iivin~ in flats 
Age group 0-70 years 0-80 vears 
Location Pahang city Kuala Lumpur city 
No of samples 130 187 
Prevalence of intestinal parasites 72.30% 27.90% 
Prevalence of Blastocystis onlv 52.30% 14.90% 
Direct microscopy using Trichrome, formalin-ether 
Technique used for diagnosis Trichrome staining was carried out concentration and modified trichrome, stools were 
also cultured for Blastacystis 
In the study by Noor Azian et al. (2007), 130 faecal samples were collected from 7 villages in 
Pos Senderut, an aborigine settlement in Pahang. 68 samples were positive for Blastocystis 
(52.3%) and 94 of the samples showed intestinal parasites (72.3%). In the other study carried 
out by Suresh et al. (2001), the intestinal parasite prevalence was 27.9% whereas Blastocystis 
was found in only 14.9%. I think it is clear the difference in Blastocystis prevalence is 
affected by the type of patient and the enviroment of these people. The first study was carried 
out in an aboriginal population who lived in houses built on stilts, with bamboo roofs and no 
electricity, running water or toilets inside their dwellings. In contrast the other groups of 
people living in blocks of flats have a good hygiene standard. We can see that both the 
prevalence of intestinal parasites and Blastocystis is higher in the aborigine group. 
The variation of Blastocystis prevalence within these studies was due to various different 
reasons, including poor socioeconomic conditions, overcrowding, lack of education, and low 
standard of sanitation and hygiene. These all contribute to a high prevalence of intestinal 
parasite infections (Rajeswari, 1994). 
Blastocystis was originally reported as being associated with diarrhoea in the tropics and 
sUbtropics (Jelinek et al., 1997). Numerous of studies have pointed out that travel to the 
50 
tropics is an important risk factor for infection with Blastocystis (Ashford and Atkinson, 
1991, Babb and Wagener, 1989, Hahn and Fleischer, 1985). In contrast, Horiki et al. (1997) 
reported that the possibility of travel as a risk factor for infection was still in question. Recent 
reports have shown that Blastocystis infection is common in residents of tropical, subtropical 
and developing countries (Ashford and Atkinson, 1990; Babcock et al., 1985; (Cegielski et 
aI., 1993); Elmasry et al., 1990; Nimri, 1993; Nimri and Batchoun, 1994; Reinthaler 1988; 
Torres et al., 1992; Zafar, 1988; Zaki et al., 1991). Refugees, immigrants, and adopted 
children from developing countries emerge as having a higher prevalence of Blastocystis 
infection than other adults and children who were raised from birth in the same communities 
(Guglielmetti et al., 1991, Lee, 1991). This conclusion is based on small numbers and it is 
unclear whether these people had been infected before arrival. It would also be important to 
know which countries they came from as some countries have higher prevalence of 
Blastocystis than others. Also foreign workers, such as the Peace Corps volunteers, are also at 
risk of getting the infection when functioning in areas where this parasite is endemic 
(Herwaldt et ai., 2001). On the other hand, Cirioni et al. (1999) found that the prevalence of 
Blastocystis was lowest in groups of travellers returning to Italy from developing tropical 
countries. 
It has been reported that Blastocystis has a higher prevalence in developing countries 
(approximately 30 to 50 %: Ashford and Atkinson, 1990, Torres et al., 1992) compared with 
developed countries (approximately 1.5 to 10 %: Doyle et al., 1990, Logar et al., 1994, Senay 
and Macpherson, 1990, Sun et al., 1989, Vickerman, 1994), although exceptions do occur 
(Reinthaler et al., 1988). Within communities, lower socioeconomic groups or those with 
lower standards of hygiene may show a higher prevalence than the remainder of the 
community (Libanore et aI., 1991), Nimri 1993, Torres 1992). Rayan et al. (2010) illustrated 
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that intestinal parasites are more frequent among rural children compared with urban 
children, including Blastocystis. 
Increased risk of infection may also be linked with the workplace. A recent survey in 
Malaysia by Raja Salim et al. (1999) illustrated that people working intimately with animals 
were at higher risk of getting Blastocystis infection. The authors suggested that the animal 
handlers most likely gained the infection from the animals through the faecal-oral route. 
Prevalence of Blastocystis does not show large differences between genders (Kain et al., 
1987, Garcia et al., 1984, Sun et al., 1989, Torres et al., 1992) although some papers report 
that the incidence in female adults is slightly higher (Doyle et al., 1990, Kain et al., 1987, 
Sanad et al., 1991, Senay and Macpherson, 1990, Wang et ai, 2002, Nascimento and 
Moitinho, 2005). Studies of Blastocystis infections among children showed that the ratio of 
male to female is 2:1 (Nimri, 1993; Nimri and Batchoun, 1994) but the significance of this 
has not been determined. 
The occurrence of Blastocystis infection has been linked to weather conditions, with the 
proposal that infections are more common during hot weather (el Masry et al., 1990, 
Knowles and Gupta, 1924). I n contrast, other studies by Cegielski et al. (1993), Stenzel and 
Boreham (1996) and Senay and Macpherson, (1990) did not find any difference in the 
number of infections at different times of the year. Seasonal studies of human parasite 
infections in the USA by Amin (2002) showed that the prevalence of Blastocystis is highest 
between July and October then decreases in December. These dates do not contradict a 
possible summer infection peak. Exposure, experience of symptoms, seeking medical advice, 
and testing could explain this. The result of Suresh and Smith (2004) was not much different 
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from Amin (2002) where they found infection more common in summer (July-September) 
than in winter/spring. 
In summer people do go out for pICniCS and barbecues and there are more eating raw 
vegetables like salad, cucumber and tomato which could be contaminated with parasites like 
Blastocystis. Also people tend to travel more in summer especially to tropical countries where 
the hygiene level considered as low and they could get exposure to contaminated food or 
water either by eating, drinking or even swimming in rivers. In summer people may also go 
out to farms and petting zoos where they may get exposure to animals known to carry 
Blastocystis like sheep, cow or even birds. 
1.9 Diagnosis 
1.9.1 Smear microscopy 
Diagnosis of Blastocystis in laboratories worldwide is achieved mainly by usmg light 
microscopy of wet mounts of either fresh stools or concentrates. Permanent faecal smears 
using the Trichrome staining technique have been recommended for routine use in the 
diagnosis of Blastocystis (Garcia et al., 1984, LeBar et al., 1985, Lee, 1991, Markell and 
Udkow, 1990), although other stains can be used successfully, like iron haematoxylin (Senay 
and MacPherson, 1990), Gram (Miller and Minshew, 1988), Giemsa (Ricci et al., 1984) and 
Wright's stains (Vannatta et al., 1985). However, Zierdt (1991) mentioned that the smears of 
clinical material stained with Gram stain are not usually successful as Blastocystis cells lyse. 
Many diagnostic laboratories consider the vacuolar form of 5-8 11m to be the standard 
morphology, however, due to the recent observation of the forms in vivo, it is necessary to 
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search for the smaller multivacuolar forms in fresh faecal samples otherwise infected patients 
will be misdiagnosed (Stenzel et aI., 1991). 
1.9.2 Concentration technique 
Another way to detect Blastocystis is through concentration methods used to detect other 
protozoa and faecal parasites. Some have reported that centrifugation causes disruption of 
vacuolar, multivacuolar, and granular forms of the parasite (Millar and Minshew, 1988). 
Conversely, other authors have described concentration methods to be successful for 
Blastocystis (Aldeen and Hale, 1992, Garcia et al., 1984, LeBar et al., 1985, Qadri et al., 
1989, Zierdt, 1991 a). Examination of multiple stool specimens is recommended to improve 
the discovery of low numbers of Blastocystis and other intestinal parasites. The organism 
must be differentiated from leukocytes (Zierdt, 1991 a), Cryptosporidium spp. and the cysts of 
other protozoa, particularly those of Entamoeba histolytica, Entamoeba hartmanni and 
Endolimax nan a (Gallagher and Venglarcik, 1985). Comparing the efficiency of microscopy 
and culture in the identification of infected stools, Kukoscke et al. (1990) found that culture 
had no benefits over microscopy. On the other hand, a study by Leelayoova et al. (2002) 
illustrated that xenic in vitro culture (XIVC) was significantly more sensitive for the 
detection of Blastocystis than the formol ethyl acetate concentration technique (FECT) and 
direct smear. Suresh and Smith (2004) were able to detect Blastocystis in faecal samples by 
XIVC when there was no parasite detected by FECT. A number of reports have shown that 
the FECT results in very poor sensitivity for parasite detection (Stensvold et al., 2007a). 
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1.9.3 Culture technique 
Culture of clinical specimens is not recommended as a routine procedure but is beneficial 
when microscopic diagnosis is uncertain. Although Kukoschke et af. (I 990) found that using 
culture for detecting of Blastocystis has no ad:,antages compared to wet mount examination, 
Zaman and Khan (1994) showed that cultures are better than direct microscopy in term of 
sensitivity. However, Zierdt (1991a) reported that culture of Blastocystis cells from stool 
samples was not successful unless large numbers of parasites were present. 
1.9.4 Serological test 
Serology has been employed in an effort to recognize patients with Bfastocystis infections, 
but with very limited success (Stenzel and Boreham, 1996). A lack of humoral immune 
response was described by Chen et af. (1987). 
1.9.5 PCR 
Detection of Bfastocystis in stool samples by microscopy can be insensitive (Leelayoova et 
al., 2002). This has led to the development of techniques for the isolation of Blastocystis and 
extraction of the DNA necessary for PCR (Leelayoova et af., 2004). Parkar et af. (2007) 
revealed that PCR-based methods were more sensitive than in vitro culture for detection of 
Blastocystis but their published work found that favoured growth of a particular subtype 
could occur in vitro when the host is infected with more than one subtype. In contrast, 
Stensvold et af. (2007) stated that XIVC has very little or no impact on subtype distribution 
or variation within a given specimen. 
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The benefit of PCR for identification of Blastocystis is well-known. It can be achieved on a 
stool that is not totally fresh, and PCR is possible where FECT or culture is not practical 
because of inadequate material. PCR is almost as fast as FECT and much faster than culture 
techniques. PCR is recommended for screening for Blastocystis infection and for use in 
prevalence determination (Stensvold et al., 2006). Recently a commercial PCR kit has been 
available for the detection of Blastocystis in the laboratory (Clongen Laboratories, LLC). 
In summary, in view of current data, trichrome staining of a direct smear together with stool 
culture is the best non-molecular approach for diagnosis of Blastocystis and PCR 
amplification of Blastocystis DNA from fresh stool or stool culture is a more sensitive 
alternative to microscopy. The advantage of PCR is that it requires less time (approximately 
three hours) instead of the 3-4 days required for culture. Although PCR is the most sensitive 
technique it is not always feasible due to cost, equipment and the need for special training 
compared to trichrome stain and culture. Combinations of diagnostic tests are going to give 
more accuracy than one diagnostic test. 
1.10 Genetic diversity of Blastocystis 
Both human and animal Blastocystis isolates are morphologically similar and have most of 
the forms described (vacuolar, granular and cyst). No work has been carried out to check if 
there are any tiny morphological variations. The designation of Blastocystis species and the 
ways in which these species may be recognized have not been settled. Initial data indicated 
that multiple morphological types of Blastocystis can be distinguished in human hosts and 
this suggested that more than one species of Blastocystis infects human (Stenzel and 
Boreham, 1996). 
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Blastocystis has been detected in a range of vertebrate hosts, including rodents, pigs, cows, 
birds, reptiles and frogs, and some of these have been considered as zoonotic strains through 
evidence of genotypic homology to the human isolates (Yoshikawa et al., 1996; Clark, 1997). 
Blastocystis infections are common in a large variety of mammals and is likely that many 
undescribed species of Blastocystis exist (Clark, 1997). Noel et al. (2005) suggested based 
on DNA sequences that more than one species of Blastocystis could infect humans. 
Furthermore, their findings highlighted the low host specificity of this organism and showed 
that several types of human Blastocystis infection might be of zoonotic origin. Based on 
limited evidence animal handlers appear to have a significantly higher rate of infection with 
Blastocystis than individuals who do not come in contact with animals (Rajah Salim et al., 
1999), However, further investigation of different groups with animals exposure is needed 
before it can be concluded that some Blastocystis infections are zoonotic. Hence, it is 
valuable to screen for genotypes among Blastocystis isolates from animals when evaluating 
the zoonotic potential for human infection (Abe et al., 2003c). 
Even though Blastocystis is considered to be pleomorphic in morphology, new species names 
have been designated for isolates from birds based on morphological features alone (Belova 
and Kostenko, 1990, cited in Abe et al., 2003a). Other new Blastocystis species names have 
been based on dissimilarity in optimal growth temperature and lor electrophoretic karyotype 
(Chen et al., 1997b, Noel et al., 2005). Karyotypic diversity between human Blastocystis 
isolates is quite extensive (Carbajal et al., 1997, Ho et al., 1994, Upcroft et al., 1989). 
Because ofthis, karyotypic variation among Blastocystis isolates from human and non-human 
hosts is not enough to identify new species (Abe et al., 2003c). 
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Many researchers have reported that Blastocystis shows evidence of great genetic and 
antigenic heterogeneity. These studies have shown that differences can be detected among 
isolates from the same host, whereas similarities may exist between isolates from different 
hosts (Tan, 2004). Studying the relative proportion of different genotypes in different hosts 
might reveal important epidemiological features, e.g. reservoir hosts and pattems of 
transmission (Hunter et al., 2004). It is expected that different parasite genotypes may have 
different reservoirs (Hunter et al., 2004). Direct transmission of Blastocystis among humans 
has been reported (Yoshikawa et al., 2000), but most of the Blastocystis infections in humans 
are believed by some to be potentially of zoonotic origin (Iguchi et al., 2007). 
The genetic diversity of Blastocystis isolates might be linked to the uncertainty in the role of 
Blastocystis in disease (Clark, 1997, Arisue et al., 2002). For example it is possible that only 
Blastocystis belonging to one subgroup are able to cause disease in humans (Clark, 1997). 
Since there is no suitable animal model existing for Blastocystis infection, the pathogenicity 
of Blastocystis cannot be demonstrated experimentally (Tan et al., 2002). Hence, comparing 
human Blastocystis isolates from clinically symptomatic and asymptomatic patients may 
show a possible association between certain genotypes and the pathogenic potential of this 
parasite (Yoshikawa et al., 2004b). However, whether specific genotype(s) of Blastocystis 
can cause symptomatic infections in humans remains is a point of energetic debate (Yan et 
al., 2007). 
1.11 Blastocystis subtypes 
Blastocystis shows extensive genetic heterogeneity. At present there are 13 subtypes (STI-
13) that have been identified on the basis of sma)) subunit rRNA gene analysis from 
mammalian and avian hosts (Noel et al., 2005, Noel et al., 2003, Parkar et al., 2007, 
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Stensvold et al., 2009, Yoshikawa et al., 2004a). Many Blastocystis STs show a broad host 
range, even though they may not all be of zoonotic significance based on previous studies 
(Abe, 2004, Parkar et al., 2007, Stensvold et al., 2009, Yan et al., 2007, Yoshikawa et al., 
2003). 
Subtype 
I 
I I 1 
l I 
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I 
I 5 
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Fig 1.5 Phylogenetic tree showing the relationships among the first nine Blastocystis STs 
This figure is adapted from Stensvold et al. (2007). The original analysis was by Noel et al., (2005) 
using complete SSU rRNA gene sequences with maximum-likelihood analysis; all of the nodes were 
supported by 100% in bootstrap analysis. 
ST3 has been reported to be the most prevalent subype in the human population followed by 
STI (Bohm-Gloning et al., 1997, Eroglu and Koltas, 2010, Li et al., 2007, Souppart et al., 
2009, Stensvold et al., 2009, Yoshikawa et al., 2004b). STs 1,2, and 4 have been linked by 
some to gastrointestinal symptoms (Dominguez-Marquez et at., 2009, Kaneda et at., 2001, 
Katsarou-Katsari et at., 2008). Others found only STI in a group of symptomatic patients 
(Yan et at., 2006), and Hussein et at. (2008) agreed with this hypothesis, proposing that STI 
was linked with increased pathogenicity. In contrast, results from Tan el al. (2008) show that 
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ST3 is linked with disease. Various other studies, however, have indicated there is no 
correlation between specific subtypes and the pathogenic potential of Blastocystis (Bohm-
Gloning et al., 1997, Ozyurt et al., 2008, Yoshikawa et al., 2004b) 
]n non-human hosts, STI was the major ST in pigs with a few cases of ST2 (Navarro et al., 
2008). According to Yoshikawa et al. (2009), ST2 was the higher prevalence subtype in 
monkeys as well as human. Few cases of ST3 were detected in primate, pigs and cattle by 
different authors (Abe et al., 2003c, Parkar et al., 2010, Yoshikawa et al., 2004a). To date, 
ST4 is the only ST found among rodents. This ST has only occasionally been isolated from 
non-human primates and has not so far been detected in other mammals except an opossum 
and humans. Overall, in humans ST4 makes up 5% of the isolates (Abe et al., 2003c, Parkar 
et al., 2010, Stensvold et al., 2009, Yoshikawa et al., 2004a). 
A previous survey of Blastocystis STs in synanthropic and zoo animals by Stensvold et al. 
(2009) observed that birds usually harbour ST6 and 7 but these are hardly ever found in 
mammals and have been detected from humans only occasionally. The same authors showed 
that ST8 was common in non-human primates, especially in woolly monkeys, and it was very 
rare in humans. ST9 presently consists of only two isolates and these are of human origin 
(Noel et al., 2005). 
ST5 and STI 0 have a wide host range, containing isolates from primates, pigs (ST5 only) and 
other livestock (Noel et al., 2005, Stensvold et al., 2009). Studies of the incidence of 
Blastocystis subtypes in pigs fall in two groups: those that find mainly STI (Navarro et al., 
2008, Thathaisong et at., 2003) and those that find mainly ST5 (Yan et al., 2007, Yoshikawa 
et al., 2003, 2004, Stensvold et at., 2009) 
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Recently three novel sUbtypes were detected by Parkar et al. (2010) from elephant (ST 1 I), 
giraffe and western grey kangaroo (ST12), and quokka (STI3), a marsupial. They have not 
yet been reported in other hosts. As many types of animals have not yet been screened for 
Blastocystis subtypes it seems likely that more new STs will be found and wider host ranges 
will be identified. 
The method by which subtyping was performed in Noel et al. (2005) paper was using almost 
full length of SSU rRNA gene sequences of 90 Blastocystis isolates from human, rats, birds 
and reptiles in a large phylogenetic analysis, including some new and some sequences 
available in databases (Noel et al., 2005). Tree construction was performed using the 
stramenopile Proteromonas lacerate, a commensal flagellate of reptiles and amphibians, as 
the out-group in view of its position closely related to Blastocystis in previous phylogenetic 
studies. 
The data set included 1,563 unambiguously aligned positions, which were analyzed by the 
maximum-likelihood method using the programme MrBA YES. The rooted tree identified 
seven clades, each highly supported by Bayesian posterior probabilities (BP) of 100% plus 
several discrete lineages. Some of these discrete lineages were later called new subtypes by 
Sciculuna et al. (2006) and given the names ST8 and ST9 by Stensvold et al. (2007). Many 
different methods naming subtypes were published by different groups but a consensus 
naming scheme was produced by Stensvold et al. (2007) and this is now used by everyone 
working on Blastocystis. 
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1.12 Multilocus Sequence Typing (MLST) 
Blastocystis has been divided into numerous subtypes, but the genetic distance between 
subtypes is significant (up to 7% between SSU rRNA genes) and so they could each be 
considered distinct species. In other parasites genetic variation within species can sometimes 
determine virulence and methods to detect variation within species have been developed. The 
ability to identify precisely the strains of infectious agents that cause disease is a major aim 
for epidemiological surveillance and public health judgments; however, there are no 
completely satisfactory methods of achieving this (Maiden et al., 1998) 
The most commonly used molecular typing methods, for instance microsatellite typing, 
pulsed-field gel electrophoresis (PFGE) and arbitrarily primed PCR (AP-PCR), depend on 
comparison of DNA fragment patterns on gels (Enright and Spratt, 1999). Another typing 
method is multilocus enzyme electrophoresis (MLEE), which uses protein variation that 
accumulates very slowly in the population (Maiden et al., 1998). MLEE was the main 
method for characterising bacterial isolates for epidemiology studies for many years and has 
given many insights into popUlation structures of bacterial pathogens (Musser et aI., 1986). 
MLEE uses the variation in the electrophoretic mobilities of house-keeping enzyme rather 
than in the corresponding genes (Spratt, 1999). MLEE has many attractive features and 
provides data that are useful for population genetic analysis. Although this technique has 
been used mostly for bacteria it has also been used for Giardia lamblia (Meloni et al., 1995), 
Trypanosoma cruzi (Diosque et al., 2003) and Plasmodium Jalciparum (Abderrazak et al., 
1999). However, because it relies on cultures it is laborious and generates results that are 
difficult to compare between laboratories (Spratt, 1999). 
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More recently, a modification of this method (Multi-locus sequence typing; MLST) has been 
developed (Spratt, 1999). This has the advantage of the speed and simplicity of DNA 
sequencing. It is similar to MLEE by studying variation present in multiple housekeeping 
genes, but with MLST the variation is detected by sequencing gene fragments (Urwin and 
Maiden, 2003). 
Althought molecular methods have been used to distinguish between Blastocystis subtypes 
genetically (Stensvold et al., 2008), none exist to detect variation within SUbtypes. To 
understand more about transmission, host specificity and pathogenicity of this parasite we 
need a tool which helps to differentiate between strains of the same subtype and MLST is one 
of the best methods to carry out this work with the infonnation currently available. 
1.13 Summary of background information 
Blastocystis is a prevalent enteric protist that infects a variety of animals and is classified 
taxonomically within the heterogeneous group, the Stramenopiles, which includes water 
moulds, slime nets and brown algae. Blastocystis was the first Stramenopile known to 
parasitise humans. Morphologically, Blastocystis is polymorphic and there are few main 
stages that have been described. There are different conflicting life cycles that have been 
proposed and this inconsistency is due largely to the belief that Blastocystis demonstrates 
multiple reproductive processes. Until confirmed otherwise, binary fission is the only 
accepted mode of reproduction. Transmission of the parasite is by a cyst stage, considered as 
the only infective stage, and it is widely accepted that Blastocystis is transmitted by the 
faecal-oral route like other gastrointestinal protozoa. Waterborne transmission of Blastocystis 
through untreated water or poorly sanitary conditions has also been indicated, and person to 
person transmission among family members, among mentally deficient persons in institutions 
and in communities without sufficient sanitary facilities is likely occurring also. 
It is unclear whether Blastocystis is a true pathogenic organism or a commensal, or possibly 
is capable of being a pathogen under specific conditions. Many reports suggest that 
Blastocystis causes disease. However, there also have been a similar number of reports to the 
contrary. Elimination of all other infectious and non-infectious possible causes of symptoms 
is a major problem, especially when the pathogenicity of many other associated organisms is 
also uncertain. Many studies that investigate the pathogenicity of Blastocystis have not 
eradicated all known viral, bacterial, or other protozoal infections as possible causes of 
symptoms while others have not considered non-infectious causes. Some authors have 
concluded that Blastocystis is pathogenic because chemotherapy has resulted in a reduction of 
symptoms and elimination of organisms. Other authors indicate that Blastocystis may cause 
symptoms when present in large numbers as severity of symptoms has been reported to 
correlate with the numbers of Blastocystis found in faecal samples. At present, the inability to 
fulfil Koch's postulates, mainly due to a lack of experimental animal models, and difficulty in 
excluding all other sources of symptoms means the role of Blastocystis as a causative agent 
of human disease remains unclear. 
Irritable bowel syndrome (IBS) is a complicated, multifaceted heterogeneous disorder, rather 
than a single disease. Blastocystis has been linked to IBS but the role of Blastocystis in IBS is 
again unclear due to the uncertainty surrounding its pathogenicity. However, symptoms that 
have been linked to infection with Blastocystis are similar to those present in IBS and include 
diarrhoea, abdominal pain, cramps or discomfort, and nausea. The prevalence of Blastocystis 
in IBS patients has been repOlied to be higher than in the general population. 
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The need for treatment of Blastocystis infections is controversial in the absence of conclusive 
evidence of pathogenicity of this organism. There are a few studies investigating the effect of 
drugs on Blastocystis in vitro, with the most effective drugs reported to be metronidazole, 
trimethoprim sulfamethoxazole, paromomycin, rifaximin and Nitazoxanide. Metronidazole is 
the most frequently prescribed antibiotic, used alone or in combination with another, such as 
paromomycin or cotrimoxazole (TMP-SMX). 
Blastocystis is the most frequently isolated parasite In epidemiological surveys and its 
prevalence varies widely from one country to another and among communities of the same 
country. In general, developing countries have higher prevalence of the parasite than 
developed countries and this has been linked to poor hygiene, exposure to animals and 
consumption of contaminated food or water. 
Blastocystis most often has been diagnosed by light microscopic examination of faecal 
material using wet mounts, either unstained or stained with iodine. Culture from faecal 
material is reported to have no advantages over light mIcroscopy for the detection of 
Blastocystis. PCR amplification of Blastocystis DNA from fresh stools or stool cultures is a 
more sensitive alternative to microscopy, and genotyping should be included in the analysis 
where possible. 
Blastocystis has been isolated from a wide range of hosts including primates, livestock, 
rodents, birds, reptiles, amphibians and insects. Blastocystis demonstrates evidence of great 
genetic heterogeneity, and differences can be detected among isolates from the same host, 
whereas similarities may exist between isolates from different hosts. At this time 13 subtypes 
have been recognized based on small subunit rRNA gene analysis from mammalian and 
avian hosts. 
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The genetic distance between subtypes is significant (up to 7%) and they could be considered 
distinct species. In some parasites, genetic variation within species can determine virulence 
and methods to detect variation within species have been developed. None have been applied 
to Blastocystis so far. The method Multi-locus sequence typing (MLST) has been reported to 
have the advantage of speed and simplicity of DNA sequencing, and seems the best choice 
for studying Blastocystis variation within subtypes. 
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AIMS AND OBJECTIVES 
1.13.1 Aims 
The aim of this study is to understand the significance of genetic diversity in Blastocystis. 
1.13.2 Objectives 
The objectives of this study are 
Objective No 1 
To compare the Blastocystis subtype distribution between the UK and Libya 
Objective No 2 
To investigate Blastocystis subtypes in IBS patients 
Objective No 3 
To investigate associations between Blastocystis subtypes and specific hosts 
Objective No 4 
To investigate the possibility that Blastocystis infection is a zoonosis 
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Objective No 5 
To develop a MLST method that distinguishes strains within Blastocystis subtypes 
Not all the objectives were completely achieved in this study, and each separate objective 
will be considered in detail in each results chapter. 
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CHAPTER 2 
Materials and methods 
2.1 Blastocystis samples 
Most of the UK samples from both humans and animals were provided as culture Iysates by 
the Diagnostic Parasitology Laboratory of the London School of Hygiene and Tropical 
Medicine. The origin of these samples came from IBS clinics, patients referred by a physician 
for ova and parasite analysis, and different zoo locations. The London School of Hygiene and 
Tropical Medicine ethics committee approved this study under Reference number 5026. 
Libyan patients supplied their stool samples to Sebha Central Medical Laboratory for a 
variety of reasons, for example, gastrointestinal symptoms, applying for a job in the food 
industry, routine screening prior to army enlistment. The ethics committee of Sebha 
University in Libya said no approval was needed to carry out this additional work (date of the 
letter 10/9/2008). 
Both Libyan and UK faecal samples were examined by direct microscopy using normal 
saline solution and Lugol's iodine stain. Approximately 50 mg of faecal sample was 
inoculated into Robinson's medium (Clark and Diamond, 2002) and incubated at 37°C. Also 
a modification of Jones' medium (Leelayoova et al., 2002) using a Luria agar slant and 
supplemented with 10% human serum was used to culture Blastocystis from some human and 
animal faecal samples in Libya. 
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The screenmg for Blastocystis in 3-4 day-old cultures was done with standard light 
microscopy and subculturing was carried out every 2-3 days. Blastocystis growing in medium 
was harvested by centrifugation at 13,000 xg for 10 seconds. Supernatant was discarded 
carefully and the tube vortexed vigorously to resuspend the cells in the residual supernatant. 
For larger preparations, Blastocystis cells were transferred into L YSGM medium with 5% 
adult bovine serum (Stechmann et al., 2008) and then subcultured every 3-4 days until the 
parasite established in the medium. The whole culture volume (10 ml) was then transferred to 
a tissue culture flask of L YSGM (50ml) and incubated in order to obtain more material for 
DNA preparation. 
2.2 DNA extraction from cultured cells 
2.1.1 Cell lysis 
300 III of cell lysis solution was added to the resuspended cells (ca.50 Ill) to lyse the 
Blastocystis. This lysis solution contains 0.25% sodium dodecyl sulfate (SDS), a detergent 
that helps to break down the cell membrane. 0.1 M Ethylenediamine tetraacetic acid (EDTA) 
pH8 is present to inhibit nucleases by complexing with the divalent cations needed by these 
enzymes. 
2.1.2 Purification of DNA 
Puregene core kit A (Qiagen, Crawley, UK) was used for DNA purification according to the 
manufacturer's protocol. The protocol is presented briefly below. 
70 
2.1.3 Protein removal 
1.5 ~l of Proteinase K (20 mg/ml) was added to the 300 ~l lysate and the mixture was 
vortexed for 5 seconds at medium speed, followed by incubation at 55 DC for 30 minutes to 
degrade the proteins. 
2.1.4 Removal of RNA 
4 ~l of RNase A (4 mg/ml) was added to the lysate to degrade RNA and incubated at 37 DC 
for 5 minutes. Then the tube was cooled to room temperature by placing in ice for 1 minute. 
2.1.5 Protein precipitation 
Protein and other contaminants were precipitated from the cell lysate usmg a high 
concentration of salt. 1 00 ~l of ammonium acetate (the concentration of ammonium acetate is 
not given by the manufacturer) was added to the tube, vortexed at high speed for 20 seconds, 
and centrifuged at 13,000 xg for 1 minute. A tight pellet is formed. 
2.1.6 DNA precipitation 
The supernatant having the DNA was removed into a fresh 1.5 ml microcentrifuge tube 
containing 300 ~l of 100% isopropanol. The sample was inverted gently 50 times to mix and 
precipitate the DNA, then centrifuged at 13,000 xg for 1 minute. DNA becomes visible as a 
small white pellet. 
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The supernatant was discarded and 300/11 of 70% ethanol was added, the tube inverted 
several times to wash the DNA pellet and centrifuged at 13,000 xg for 1 minute. After the 
supernatant was removed carefully, the tube was left with open lid for 15 minutes to help 
evaporation of ethanol. 50/11 of DNA hydration solution (a low salt buffer) was added and 
vortexed for 5 seconds at medium speed to break the pellet. The tube was incubated for 5 
minutes at 65°C to accelerate hydration then vortexed for 5 seconds at medium speed to mix 
the sample. DNA was stored at 4°C, or -20°C for long storage. 
2.3 DNA extraction directly from faecal samples 
Some DNA was extracted directly from Libyan cow faecal samples using a QIAamp DNA 
Stool Mini Kit (Qiagen, Crawley, UK) according to the manufacturer's protocol. 
2.4 Polymerase chain reaction 
2.4.1 Barcoding region of SSU rRNA gene 
'DNA barcoding' is the term used to describe a method proposed for producing a unique 
identifier for all living species (Hebert et al., 2003). This system is expected to be very 
beneficial for understanding the diversity of uncultured protozoan lineages that do not have 
enough morphological details for species separation (Tautz et a!., 2002). Herbert et al. (2003) 
suggested that a DNA bar coding system for animals could be based on sequence diversity in 
a 650 bp fragment of the mitochondrial cytochrome C oxidase subunit I (cox 1) gene. 
Although this gene was confirmed to be helpful for the identification of animal species, and 
also some protists (Chantangsi et at., 2007), this gene is not usable for all groups of 
eukaryotes (ScicJuna et aI., 2006). For example, anaerobic eukaryotes do not normally have a 
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mitochondrial genome and therefore the gene (cox 1) is not present, and many other groups of 
eukaryotes are yet to be studied at the level of the mitochondrial genome. In addition, a few 
groups of eukaryotes, such as ciliates, have different sized insertions within the cox 1 gene 
that produces difficulties in the PCR amplification of the barcode sequences (Norman and 
Gray, 1997). 
SSU rRNA genes also contain regIOns of sequence variation that are useful for DNA 
barcoding; for instance, Scicluna et al. (2006) established the usefulness of a 600 bp segment 
of SSU rDNA for identifying subtypes of Blastocystis. Although it is unusual for an 
anaerobic organism to have one, the mitochondrial genome present in Blastocystis does not 
have a coxl gene and so barcoding in Blastocystis has focussed on the SSU rONA method 
developed by Scicluna et al. (2006). This gene is also present in numerous copies within the 
genome of most eukaryotes, which makes it easy to amply, and contains highly conserved 
regions that allow the design of universal primers for PCR amplification (Sogin et al., 1986). 
PCR amplification of Blastocystis SSU rDNA for 'Barcoding' was performed In a 40J-l1 
volume per reaction using the two primers BhRDr and RD5 (Table 2.1) at 2 ~M 
concentration to amplify a 600 bp region (ScicIuna et al., 2006), DNA template, Biomix 
(Bioline, London, UK) and deionized water. The following amplification profile was used: 30 
cycles of denaturation at 94 DC for 30 seconds, annealing at 59 DC for 30 seconds and 
extension at 72 DC for 30 seconds. 
Amplification was performed using a G-storm GS 1 thermal cycler (Gene Technologies Corp. 
Surrey, UK). PCR products were separated by electrophoresis using 1.2% (w/v) agarose gels 
in Tris-Boric Acid-EDTA buffer. The gel was stained with ethidium bromide and the bands 
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observed under ultraviolet light and photographed. Specific bands were cut out when 
required. 
2.4.2 Complete SSU rRNA gene 
The whole SSU rRNA gene was amplified using the protocol of Clark (1997) which uses the 
primers RD5 and RD3 (Table 2.1). PCR amplification was performed as above with the 
following amplification profile: a denaturation step of 94°C for 4 min then 30 cycles of 
amplification of 1 minute at 94 °c , 90 seconds at 65°C, and 2 minutes at 72 0c. 
2.4.3 PCR product purification 
Two methods for product purification were used. In the first, PCR products were extracted 
from gel pieces using the QIAquick gel extraction kit according to the manufacturer's 
protocol (Qiagen, Crawley, UK). Sodium iodide is used to solubilise the gel for 10 minutes at 
50°C until the gel dissolves completely. 100% isopropanol (0.3 ml) is added to the sample 
and mixed. The solution is then transferred into the spin column, centrifuged for 1 minute, the 
flow-through discarded and 0.5 ml of Sodium iodide solution added to wash the column. 
After centrifugation, 0.75 ml of wash buffer PE is added to the column. The purpose of this 
step is to get rid of all Sodium iodide, and PE contains ethanol to keep DNA bound to the 
column. After standing for 2-5 minutes, the column is centrifuged for 1 minute then changed 
to a clean 1.5 ml microcentrifuge tube and 20 III of sterile deionized water added. The 
column is allowed to stand for 1-2 minutes to allow the DNA to release from the column then 
centrifuged for 1 minute at 13,000 xg. The DNA is then ready to be used for sequencing 
reactions. 
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GeneJET PCR Purification Kit was also used, according to the manufacturer's protocol 
(Fermentas, York, UK). A binding buffer is added to the PCR mixture, then transferred to the 
column and centrifuged for 30-60 seconds at 13,000 xg. The flow through is discarded and 
the column washed with 700 III wash buffer, centrifuged for 30-60 seconds, the flow through 
discarded, and the column transferred to clean 1.5 )11 microcentrifuge tube. 20 )11 of deionized 
water is added, the column allowed to stand for 2 minutes then centrifuged for 1 minute at 
13,000 xg. Then the DNA is ready to be used. 
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2.4.4 Barcoding sequence 
The sequencing primer used is identical to the internal primer (BhrDr) of the peR reaction. 
Either BhrDr or RDS primer can be used to sequence barcoding region but BhrDr tends to 
give better quality sequence compared with RDS. 
During my work I have tried both RDS and BhrDR primers and I found that BhrDR primer is 
given better sequence than RDS. Also Sciculuna et al. (2006) reported this difference 
between these primers where the peaks were higher and background was lower with BhrDR 
when traces for the two stands were compared for the same sample and they recommended 
BhrDR for Blastocystis DNA barcoding. Therefore, in this study we used BhrDr. 2 III of peR 
product was used for sequencing, along. with 1 III (0.2 IlM final concentration) of 1: 100 
diluted primer, 0.5 III of Big Dye v.3.1 reaction mix (Applied Biosystems, Warrington, UK), 
2 III Sx sequencing buffer and finally 4.5 III of sterile deionized water. The total volume is 10 
Ill. The following reaction profile was used as recommended by Applied Biosystems: 25 
cycles of 
Step one: denaturation at 94°C for 15 seconds. 
Step two: annealing at 50 °e for 15 seconds. 
Step three: extension at 60°C for 4 minutes. 
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2.4.5 Complete SSU rRNA gene sequence 
The same protocol for bar-coding sequence was used except that we used several internal 
primers (Figure 2.1) (as well as RD3 and RDS) to cover the whole region. Primers were 
diluted 1: I 00, at 0.2 11M final concentration. All primers used to sequence the SSU rRNA 
gene are listed in Table 2.1 
. Table 2.1 Primers used for sequencing of complete SSU rRNA genes 
Primer Sequence 
RD3 S' TGATCCTICCGCAGGTICACCTAC 3' 
RD5 5' ATCTGGTIGATCCTGCCAGTA 3' 
BhrDr 5' GAGC I I I I I AACTGCAACAACG 3' 
528 R 5' GAGCTGGAATIACCGC 3' 
528 F 5' GCGGTAATICCAGCTC 3' 
1055 R 5' ACGGCCATGCACCAC 3' 
1055 F 5' GTGGTGCATGGCCGT 3' 
1200 F 5' CAGGTCTGTGATGCCC 3' 
AEMH5 F 5' TCCAAGGAAGGCAGCAGGC 3' 
AEMH3 R 5' AAGGGCATCACGGACCTGTI 3' 
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528 R 
• 
BhRDr 
• 
RD5 
~ 
AEMH5 F 
~ 
AEMH3 R 
• 
1055 R 
• 
528 F 
~ 
SSU rRNA gene 
~ 1800 Bp 
1200 F 
RD3 
• 
1055 F 
~ 
Fig 2.1 Location of the 10 primers used to sequence complete SSU rRNA genes . Red = forward 
primer, black = reverse primer 
2.4.6 Precipitation of sequencing products 
~ 
After the sequencing reaction was completed, 40 III of 75% isopropanol (-20°C) was added 
to precipitate the sequence products, vortexed for a few seconds and incubated at room 
temperature for 15 minutes, then centrifuged at 13,000 xg for 20 minutes. The supernatant 
was discarded with care leaving the DNA at the bottom, followed by adding 180 III of 75% 
isopropanol (-20°C) to wash the pellet, vortexing for 20 seconds and centrifuging at 13,000 
xg for 8 minutes. The purpose of using isopropanol is to precipitate the DNA and to get rid of 
unused dye-labelled nucleotides. Pellets were dried in a heating block at 94°C for 4 minutes. 
The sample is now ready for sequence reading. 
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2.5 Sequence reading 
The reactions were analyzed on a DNA sequencer ABI PRISM 3730 (Applied Biosystems) 
by the LSHTM core facility and the output was examined for accuracy using Chromas 
software (Technelysium Pty Ltd, Australia). 
2.6 Interpretation of sequence result 
Each sequence was edited manually using Chromas software vl.61. The sequence was copied 
as a fasta file into the BLAST search programme (http://blast.ncbi.nlm.nih.goviBlast.cgi). 
Blast search parameters were selected with the option to search for similarity to Blastocystis 
sequences in GenBank. The results were presented with different percentage identity and 
similarity. The sequence in GenBank with the highest percentage identity, which is usually 
approximately 98-100%, was considered to identify the subtype of the query sequence. If the 
top hits observed in the BLAST search were shown to have 97% identity or less, this was 
considered to perhaps be the result of identifying a new subtype and further investigation to 
compare it with closely related subtype sequences was performed using Multalin (Corpet, 
1988) and phylogenetic analysis to confirm whether it represented a new subtype. 
2.7 Phylogenetic analysis 
Phylogenetic trees were constructed using sequence data from complete gene sequences of 
the SSU rONA. Sequences of genes obtained in the present study were aligned with 
previously published sequences of Blastocystis (STI-STI3) obtained from GenBank using 
the program BioEdit version 7.0.9.0, and then manually adjusted where necessary. 
Phylogenetic analysis was performed using MEGA 5.0 (Tamura et aI., 2011). Trees were 
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constructed usmg both neighbour-joining and maxImum likelihood methods. For the 
neighbour-joining tree bootstrap values were calculated by the analysis of 1000 replicates. 
The options for the analysis were pairwise deletion for gaps and maximum composite 
likelihood, heterogeneous pattern among lineages and different rate among site as the model. 
The gamma parameter is 0.3. In maximum likelihood bootstraps values were calculated 
using 100 replicates. The mode used was General Time Reversible with gamma distribution 
and Invariant sites, and all sites were used. This model was chosen as best by Model Test in 
MEGA 5. 
Proteromonas lacertae was used as the outgroup because it is the closest known relative to 
Blastocystis. The two methods used will be described briefly: 
2.7.1 Neighbour-joining (NJ) 
Neighbour-joining (NJ) is a tree-building process that uses the distance approach where the 
distance between each pair of sequences is used to estimate the best tree. This method also 
does not always produce the tree that best fits the data, but computer simulations have shown 
that is quite efficient in obtaining the correct tree. It can be used with any type of distance 
data (Saitou and Nei, 1987) and one of the advantages of the neighbour-joining method is that 
it is quite easy and quick to perform, largely because the multiple alignment has been reduced 
to a simple form- a table of pairwise distances between sequences. 
2.7.2 Maximum likelihood (ML) 
Maximum likelihood (ML) evaluation has been widely accepted as one of the most accurate 
techniques for reconstructing phylogenies. 
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Felsenstein (1981) first applied this method to nucleotide-based phylogenetic analyses. 
Numerous computer studies (Huelsenbeck, 1995, Kuhner and Felsenstein, 1994, Rosenberg 
and Kumar, 2001, Ranwez and Gascuel, 2002) have shown that ML programmes can recover 
the correct tree from artificial data sets more often than other methods. The maximum 
likelihood method estimates the correct tree by finding the tree with the highest probability of 
occurring, this depends on using estimates of the mutation rate and other parameters that are 
either obtained from other studies or estimated from the data. 
The advantage of maximum likelihood is that the evolutionary model used can include other 
variables thought to be biologically important. However, the more complex the evolutionary 
model is the more computer intensive and time-consuming the phylogenetic analysis 
becomes. 
Other types of methods like maXImum parSImony and UPGMA are not widely used 
compared to ML and NJ. 
2.7.3 Bootstrap analysis 
Bootstrapping is a common approach used to make statistical conclusions about phylogenetic 
trees. The term "bootstrapping" was defined by Efron (1979) as "to obtain estimates of 
error in nonstandard situations by resampling the data set many times to provide a 
distribution against which hypotheses can be tested". Very soon after the introduction of the 
bootstrap Felsenstein (1985) proposed using bootstrapping as a method for obtaining 
confidence limits on molecular phylogenies. For sequence data, positions in the multiple 
alignment are resampled and a new best tree calculated. This is repeated many times. 
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The proportion of samples in which a clade is recovered is indicated as a percentage and 
referred to variably as the bootstrap value or bootstrap percentage (BP). 
The percentage is usually indicated on the tree figure next to the relevant clade. The higher 
the value obtained, the greater the confidence we have in the grouping indicated by that node 
in the tree. Because each re-sampling involves calculating the best tree from that data set, 
bootstrapping adds a lot of time to a phy logenetic analysis so the number of re-sampled data 
sets used is sometimes determined by the time and computing power available. 
2.8 Development of MuItilocus sequence typing (MLST) 
Specific details involved in the development of the MLST method will be given in chapter 5. 
2.9 Statistical analysis 
Statistical analysis was performed using a statistical web site: 
http://t~lcult'l/. vassar.edu!lowfv /VassarStats .html 
Chi-square test was used to assess the significance of relationships between Blastocystis 
subtypes and hosts. Probability values of less than 0.05 were considered statistically 
signi ficant. 
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Chapter 3 
Distribution of Blastocystis subtypes in UK and 
Libya populations 
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3.1 Introduction 
Blastocystis is a ubiquitous parasite with a worldwide distribution (Jelinek et al., 1997, Tan, 
2004). It is common for it to be the most frequently isolated parasite in epidemiological 
surveys (Amin, 2002, Baldo et al., 2006, Taamasri et al., 2000). Incidence varies from 
country to country and within various communities of the same country. Generally, 
developing countries have a higher frequency of the. parasite than developed countries and 
this has been related to poor hygiene, exposure to animals and consumption of contaminated 
food or water (Tan, 2008). 
DNA- based methods are able to identify genetic variation between Blastocystis organisms 
which seem to be morphologically similar. In spite of these recent methodological advances, 
few studies have investigated the molecular epidemiology of Blastocystis infections. Such 
studies have mostly focused on the difference in incidence of Blastocystis subtypes between 
asymptomatic and symptomatic individuals (Bohm-Gloming et aI., 1997, Kaneda et al., 
2001; Yoshikawa et ai., 2004; Yan et al., 2006; Souppart et al., 2009). Recent surveys have 
included subtype information obtained by peR of Blastocystis DNA directly from faeces or 
stool culture, and such studies are starting to provide more information on the distributions of 
subtypes among human populations (Tan, 2008). 
Several studies of Blastocystis subtypes in humans were carried out in temperate countries 
like UK, France, Germany, Italy and USA. The Libyan climate is different from these 
countries especially in the south where there is dry hot weather most of the year. We decided 
to investigate whether there is any difference in the distribution of Blastocystis subtypes 
between temperate and hot climate countries, and to expand the number of samples in UK to 
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compare it with other studies. In addition, we wanted to compare Libyan Blastocystis 
subtypes with those in Egypt, which has long border with Libya, as a report showed a high 
prevalence of unusual subtypes like ST6 and ST7 (Hussein et al., 2008) which are considered 
as rare subtypes in humans worldwide. 
In Libya, Blastocystis subtypes have not been investigated previously and the present study 
aimed to characterize Blastocystis isolates from un selected Libyan people in order to compare 
the Libyan subtype distribution with the UK population and that seen in other countries. 
3.2 Materials and Methods 
3.2.1 Source of specimens 
A total of 147 stool samples were used in this study from both the UK and Libyan unselected 
populations. In the UK, the GP asks for ova and parasite examination usually because 
patients are symptomatic but the cause is unknown. In Libya, samples are sent by physician 
for ova and parasite examination in order for the patient to get a health certificate, to join the 
army or for a student to join the university. 
3.2.1.1 UK sample 
Culture lysates for one hundred and nine faecal specimens from GP submissions between 
2004-2010 for ova and parasite diagnosis were obtained from the Diagnostic Parasitology 
Laboratory in the London School of Hygiene and Tropical Medicine. 
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3.2.1.2 Libyan samples 
Both the Mediterranean Sea and the desert affect Libya's climate. In the winter. the weather is 
cool with some rain on the coast and in the drier desert the temperature can drop to sub-
freezing at night. 
The Sahara is basically very dry and hot in the summer and cool and dry in the winter. 
Temperatures in the summer can reach 50°C during the day but more commonly are around 
40°C. Summer night temperatures can vary from 30 to 40°C. 
Sebha is a city in southwestern Libya (Fig 3.1) at Latitude 27.0333 Longitude 14.4333 with a 
population of 130,000. It was historically the capital of the Fezzan region and is now capital 
of the Sebha District. The weather is hot and dry in summer and cold and dry in winter. 
Thirty-eight faecal samples were collected from unselected Libyan patients attending Sebha 
Central Medical Laboratory for ova and parasite examination. 
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Fig 3.1 Map of Libya showing the location of sample collection from both humans and 
animal hosts 
3.2.2 Sample processing 
For isolation of Blastocystis parasites, DNA extraction, peR and sequencing see chapter 2 
sections 2.1-2.7 for details 
3.3 Results 
All of the samples included in this study represented single subtype infections and even 
subtypes have been identified by barcoding. One hundred forty seven isolates were 
investigated in total, as summarized in Table 3.1. 
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ST3 was the most common subtype in UK population (45%) followed by ST4 (23%), STl 
(17%) and ST2 (10%). Subtypes 5, 7 and 8 were detected in a low percentage of samples in 
this population. Only four STs were identified within the Libyan population. STI was the 
dominant subtype with 50% followed by ST3 (40%). ST2 (8%) and ST7 (2.6%) were the 
only others detected. 
Table 3.1 Numbers of each subtype in UK and Libya random groups 
Country 5ubtype 
5T1 5T2 5T3 5T4 5T5 5T6 517 5T8 Total 
UK 19 (17%) 11 (10%) 49 (45%) 25 (23%) 2 (2%) - 2 (2%) 1 (1%) 109 
Libya 19 (50%) 3 (8%) 15 (40%) - - - 1 (3%) - 38 
Total 38 (26%) 14(6%) 64 (44%) 25 (17%) 2 (1.4%) - 3 (2%) 1 (0.7%) 147 
Statistical analysis of the data was performed for all pairs except that the numbers for STs 5-8 
were combined. The Chi-square test gave a P value of 0.0003 so the difference between UK 
and Libya subtype distribution is highly significant. It is clear that the major differences 
between the populations are the absence of ST4 and the much higher prevalence of STI In 
Libya. The other subtypes show similar frequencies. 
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3.4 Discussion 
To date there are only nme Blastocystis subtypes that have been detected in humans 
worldwide (Stensvold et al., 2009). All previous studies except Motazedian et al. (2008) 
reported that a big majority of human Blastocystis infections were attributable to ST3 
isolates. The proportions of other subtypes vary between places. STI was the third most 
common variant in the UK, Malaysia and Denmark, while ST2 is the fourth subtype in 
Germany, UK, Japan, Malaysia and Denmark. ST4 is the second most common subtype in 
Denmark, Malaysia and commonly found in the UK (Table 3.2). The subtype distribution in 
the UK population in the present study was quite similar to that found in Europe and N0I1h 
America (Table 3.2) but the Libyan popUlation shows most similarity with the Iranian study 
as both show STI as the most common subtype found (Table 3.2). 
Although Libya has a long border with Egypt and people frequently migrate between the two 
countries still they can show different Blastocystis subtype distributions. 
Two studies were carried out in Egypt, one by Hussein et al. (2008) and the other by 
Souppart et al. (2010). Comparing my data from Libya with Hussein et al. (2008) using the 
chi square test, the P value was 0.0 I 54 which shows a significant difference between the 
groups. ST3 was the most common ST in Egypt patients whereas STI was the most common 
ST in Libyan patients. ST6 was detected in only in Egyptian patients whereas ST7 was 
detected in both popUlations; however in Egypt ST7 was three times more common than in 
Libyan patients. ST2 was found only in Libyan patients. 
Comparing my data with Souppart et al. (20 10) study revealed that there is a range of 
subtypes in both populations (Table 3.2) except that ST7 was detected in Libyan patients 
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only. Comparing the two populations USIng Chi square, the P value was 0.0293 which 
showed that there is a significant difference between the populations. This difference is due 
to the higher STI in Libyan patients compared to Egyptian and a higher frequency of ST3 in 
Egyptian patients. In this study, the Libyan population shows the highest prevalence of STI 
reported worldwide (50%) (Table 3.1) but ST3 prevalence was quite similar to that found in 
other countries (40%). 
The study by Hussein et al. (2008) used STS (sequence-tagged sites) for identifying SUbtypes 
compared to sequencing in the study by Souppart et al. (2010) and in my study. ST5 relies on 
a panel of subtype-specific primers for PCR to identify subtypes. It is not clear whether this 
has affected the results in any way, but] think sequencing should be used to identify 
Blastocystis STs in epidemiological studies. The sample number has to be greater than the 
one used in these three studies, with identification of both age and gender of the patients 
presented as this might give some clues about the epidemiology of Blastocystis STs in 
different countries. 
Because data are limited in number and geography we do not know whether these findings in 
Sebha are representative of the whole of Libya as the two studies from Egypt showed that 
they have different results in different parts of the country. 
Concerning ST1, it has been suggested by some authors that it might be linked to zoonotic 
transmission from farm animals (Noel et al., 2005; Tan 2008). The finding that this ST was 
very common in our Libyan population suggested that contamination from mammals might 
be significant source of transmission. Many people in Libya keep animals at home, like goat 
and sheep, or in a family farm, like cow, and camel, and they use them for food and milk. 
There is more likely to be exposure to animals in Libya than into UK but due to the low 
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prevalence of STI in animals in Libya (see chapter 5) it is unlikely they are the source of 
infection for humans. In Libya most people have contact with sheep on Scarify Day where 
Muslim people slaughter hundreds of thousands of sheep every year. People are in contact 
with sheep during the slaughter or cleaning of the sheep intestines and abdomen for eating. If 
STI is of zoonotic origin the sheep will be the most likely source of transmission but 
unfOJ1unately we were unable to survey sheep in our study due to availability of time. 
None of the previous studies have detected ST8 in humans except Scicluna et al. (2006) and 
Stensvold et al. (2009) and they reported 5% (including zoo keepers) and I % prevalence 
respectively; in this study ST8 was found only once in the UK (0.7%) (Table 3.1). 
ST5 was originally considered to be specific to pigs and cattle (Noel et al., 2005), however 
recently Parkar et al. (2007) and Yan et al. (2007) reported occasional ST5 in human isolates. 
In this study, ST5 was identified only in the UK population and was rare (2%) compared with 
other subtypes in the same population. Because ST5, ST7 and ST8 are more commonly 
associated with non-human hosts (see chapter 5) it is possible that these infections originate 
from contact with livestock, birds and non-human primates, respectively. Information on 
animal contact by these individuals is not available but in the design of a future study then 
information about subject occupation has to be obtained; for example, veterinary practitioner, 
zookeeper, working in animal slaughterhouse, working in an animal market, or any other 
contact with animals. In addition, the type of house may be important: are they living in a 
house, flat or shanty house, or in a farm that has animals living there as well. All this 
information is essential to know ifthere is likely to be any contact with animals or not. 
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On the other hand ST5 was not detected in any Libyan human samples but is common in both 
camels and cows (Chapter 5), therefore, ST5 in humans is not always correlated with 
prevalence in domestic mammals. 
Both Libya and the UK populations carry several subtypes and there were four subtypes in 
common (STl, ST2, ST3 and ST7); STl shows the high frequency in Libyan samples while 
ST3 is the most common subtype in UK. ST4, ST5 and ST8 were detected only in the UK 
samples. ST3 is the second dominant ST in Libya whereas ST4 is the second most common 
ST in UK. ST6 was not detected in any populations while ST2, ST3 and ST7 showed similar 
percentages in both groups. 
We can observe from Table 3.2 that ST4 is more limited to temperate countries in Europe and 
North America with the exception of Japan, Malaysia and China. In other countries where 
ST4 was not detected, STl can be considered as high or moderate in prevalence. It is not 
clear why ST4 is absent from countries like Libya, Egypt, Iran, Nepal and Turkey. It could be 
due to climate as most temperate countries have ST4 with a few exceptions. Also culture 
might be playing some role as Libya, Egypt, Iran and some parts of China are considered to 
be Muslim. These need further investigation. 
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Table 3.2 Subtype classification of human Blastocystis sp. Isolates from different countries 
-
Reference Country No of samples STl ST2 ST3 ST4 ·ST5 ST6 ST7 5T8 5T9 Mix5T Unknown ST 
Bohm-Gloning et al. 1997 Germany 78 18 (23 %) 1 (1.3 %) 51 (6504 %) 5 (604 %) - - - - - - 3 (3.8 %) 
Clark 1997 UK 29 2_(6.9 %t 1 (304 %) 22l75.9 %1 4{13.8%) - - - - - - -
Yoshikawa et al. 2000 Japan 32 1 (3.1 %) - 30 (93.8 %) - - 1 (3.1 %) - - - - -
Kaneda et al. 2001 Japan 55 11 (20 %) 12~21.S %t 24 (46.6 %1 6 {10.9 %) - 2 (3.6 %) - - - - -
Thathaisong et al. 2003 Thailand 153 7 (4.6%) 
-
138 (90.2%) 
- -
2 (1.3%) 
- - -
6(3.9%) -
Japan 50 4(8%) - 26 (52%) 2(4%) - 11 (22%) 5 (10%) - 2(4%) -
I Bangladesh 26 2 (7.7%) - 24 (920/<>1. - - - - - - - -
Yoshikawa et al. 2004 Pakistan 10 2 (20%) - 7(70%) - - 1 (10%) - - - - -
Germany 12 3 (25%) 2 (16.7%) 5 (41.7%) 2 (16.7%) - - - - - - -
Thailand 4 1 (25%) - 1 (25%) - - 1 (25%) - - - 1 (25%) -
Stensvold et al. 2006 Denmark 29 1 (304 %) 6 (20.7 %) 15 (51.7 %) 7 (24.1 %) - - - - - - -
Scicluna et al. 2006# UK 49 2. (40/01 8~16.3 %) 20 {40.S 0/01 16(32.7%) - - 1 (20/<>1. 1120/<>1. - 1 (2 %) -
Yan et al. 2006 China 35 13 (37.1 %) - 14 (40 %) - - - 2 (5.7%) - - 6 (17.1 %) -
Stensvold et al. 2007 Denmark 28 5_L17.9 %} 9132.1 %} 13 (4604 %) 1_(3.6 %} - - - - - - -
Menounos et al. 2007 Greece 45 9 (20 %) 6 (13.3 %) 27 (60 %) 1 (2.2%) - 1 (2.2%) 1 (2.2%) - - - -
li et al. 2007 China 192 47 (24.5 %) 9 (4.7 %) 116 (6004 %) 1 (0.5 %) - 1 (0.5 %) - - - 10 (5.2 %) 8 (4.1%) 
Hussein et al. 2008 Egypt 44 8 (18.2 %) - 24 (54.5 %) - - S (lS.2 %) 4(9.1%) - - - -
Motazedian et al. 2008 Iran 45 20 (4404 %) 4 (S.9 %) 16 (35.6 %) - - 2 (4.4%) 3 (6.7 %) - - - -
bzyurt et al. 2008 Turkey 87 8 (9.2 %) 12 (13.8 %) 66 (75.9 %) 1 (1.2 %) - - - - - - -
Rivera. 2008 Philippines 12 4 (33.3 %) 2 (16.7 %) 5 (41.7 %) - - 1 (S.3 %) - - - - -
Wong et al. 2008 Singapore 14 2 (14.3 %) - 7 (50%) 1 (7%) - - 4 (2S.6%) - - - -
Tan et al. 2008 Malaysia 20 9 (45%) 1 (5%) 10 (50%) 
- - - - - - - -
Dogruman-AI et al. 2008 Turkey 92 17 (18.5%) 20 (21.7%) 51 (5504%) - - - - - - 4 (4.3%) -
SolJPpart et al. 2009 France 40 8 (20%) 4 (10 %) 20 (50 %) 4 (10 %) - - 1 (2.5 %) - - 3 (7.5 %) -
Yoshikawa et al. 2009 Nepal 20 4 (20%) 4 (20%) 12 (60 %) - - - - - - - -
Tan et al. 2009 Malaysia 40 5 (12.5 %) - 20 (50 %) - - 111.27.5%J 2_(5%) - - - 2 (5%) 
Dogruman-AI et al. 2009 Turkey 35 1 (2.9 %) 10 (28.6 %) 21 (60 %) - - - - - - 3 (8.6 %) -
5tensvold et al. 2009 Denmark 24 2 (8.3%) 3112.5%) 6(250/<>1. 9 (37.5%) - - - - 1.14.2%1 3 (12.5%J -
Rene et al. 2009 Denmark 99 20 (20.2 %) 15 (15.2 %) 39 (3904 %) 16 (16.1 %) - 1 (1 %) - 1 (1%) - 7 (7 %) -
Souppart et al. 2010 Egypt 20 3(15%) 4-<20 %) 12~60 %.1 - - - - - - 1 i5 %.1 -
Eroglu and Koltas 2010 Turkey 25 9 (36 %) 6 (24%) 10 (40 %) - - - - - - - -
Santin et al. 2011 USA 14 4 (28.6 %) 117.1 %} 3~21.4 %) 2 (14.3 %) - - - - - 4 (28.6 %) -
Stensvold et al. 2011 Denmark 22 9 (41%) 11 (50%) 2 (9%) 
Meloni et al. 2011 Ital.y 30 216.7 %1 5 (16.7) 13 (43.3 %) 6 (20%) 4 (13.3) 
Present study UK 109 19 (17.4 %) 11 (10.1 %) 49 (45 %) 25 (22.9%1 2l1.8 %) - 2~1.8 %) 1(0.9%) - - -
Present study Libya 38 19 (50 %) 3 (7.9 %) 15 (39.5 %) - - - 1 (2.6 %) - - - -
Total All countries 1657 302(18.2%) 170 (11.3%) 933 (56.3~) 109lZ-...2%) 2 (0.13%) 43(2.6%) 26 (1.-7%) ~0.2~ 3 {0.2%) 54(3.3%) 13 (0.8%) 
·Parkar et al. (2007) also detected one case of ST5 in a human from Thailand, but as the number of samples was small (5) we did not include that study in this table 
# 7 samples from zoo keepers were not included in this table from Scicluna et al. (2006) 
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The objective 
To compare the Blastocystis subtypes distribution between the UK and Libya 
The geography of the UK and Libya is very different. One is located in Europe and the other 
in North Africa, with completely different weather, life style and even diet. Hence 
investigation of whether there are any differences in distribution of Blastocystis subtypes 
between these countries could give insight into the importance of environment at factors. 
Samples were collected from random individuals in Sebha city, which is located in the South 
West of Libya and where the weather almost always dry hot in summer and dry and cold in 
winter whereas in London the weather is considered as temperate. The results showed that 
there is a difference in Blastocystis ST distribution between the UK and Libya. ST 3 was the 
most common in the UK while STI was the most frequent ST found in Libya. ST4 was the 
second most common ST detected in the UK whereas in Libya no ST4 was identified. Libya 
showed a similarity in Blastocystis distribution with Iran except that no ST6 was found in 
Libya but was present in Iran (4.4%). The paper by Santin et al. (2011) included a small 
member of human samples collected from Colombia and when compared to Libya and Iran 
the subtypes showed a similar distribution, with only of Blastocystis STI, ST2 and ST3. 
Whether there is any a common factor linking these countries is not clear. In contrast the STs 
detected in the UK showed a similar distribution to other Europe countries, including 
Denmark and Italy. 
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Caveats to data interpretations 
The number of samples from the Libyan population is small compared with the UK 
population. If the numbers were equal then there might be more subtypes detected in the 
Libyan population like ST4, ST5 or even ST8. Also samples collected from Sebha city may 
not reflect the whole population of Libya and the same applies to the UK samples. For 
example more samples should be collected from Tripoli (North West of Libya) and from 
Benghazi (North East of Libya) and compared with Sebha samples (South West of Libya), 
and similarly in the UK where samples could be collected from different regions. This could 
show more STs or a different ST distribution in region of each country and the ST prevalence 
presented in Table 3.1 could be quite different. In addition, we do not know whether people 
in either country had been exposed to animals, and this could influence the interpretation. 
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Chapter 4 
Blastocystis subtypes in IBS patients and 
unselected hosts 
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4.1 Introduction 
The pathogenic role of Blastocystis in the human intestine is questionable because the 
organism has been found in both symptomatic and asymptomatic persons (Yakoob et al., 
2004). Although several reports have suggested that B lastocystis causes gastrointestinal 
disorders, the specific pathogenicity of this organism has not yet been defined. The parasite is 
commonly associated with gastrointestinal symptoms such as watery and mucous diarrhea, 
vomiting, abdominal cramps and bloating (Kaya et al. 2007). Epidemiological studies also 
suggest a role in irritable bowel syndrome (Stark et al., 2007, Ustun and Turgay, 2006). 
Irritable bowel syndrome (lBS) is a bowel disorder in which symptoms are associated with 
alteration in the consistency or frequency of stools. Diagnosis of IBS by physicians is carried 
out using symptom -based criteria known as the Rome criteria. Because Blastocystis 
infection is more common in IBS patients and because symptoms linked to Blastocystis 
resemble IBS, the potential role of Blastocystis in IBS needs to be investigated. To see 
whether there is any link between Blastocystis subtypes and irritable bowel syndrome (lBS), I 
have compared the frequency of subtypes of Blastocystis in patients samples submitted from 
IBS clinics with those patients from GP clinics. 
4.2 Material and Method 
4.2.1 Source of specimens 
A total of225 Blastocystis isolates were used in this study. 
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4.2.1.1 IBS samples 
One hundred and sixteen Blastocystis -positive samples submitted for routine ova and 
parasite analysis came from IBS clinics in England. 
4.2.1.2 U nselected samples 
109 Blastocystis-positive samples submitted by doctors for individual patients were used as 
the non-IBS control. This is the same group of samples described and analysed in Chapter 3 
Both sample groups were received through the Diagnostic Parasitology Laboratory of the 
London School of Hygiene and Tropical Medicine. The final diagnosis is not known for these 
patients so it is possible that some unselected individuals were later diagnosed with IBS, and 
some IBS clinic patients were later diagnosed with other causes of their symptoms. 
4.2.2 Culture, DNA extraction, PCR and Sequence reaction 
These methods were as described previously. See Chapter 2, section 2.1-2.7 for details. 
4.3 Results 
Samples were received from 225 individuals, 116 samples from IBS clinic submission 
unselected group and ST6 only in IBS but ST7 and ST8 were found in both IBS and 
unselected groups with low frequency (Table 4.1). Although ST3 has the highest frequency in 
the IBS group (40%), comparing both groups shows that ST4 in IBS is much higher than in 
unselected. ST1 and ST2 showed similar prevalence in both groups.and 109 samples from GP 
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submission (Table 4.1). DNA was extracted and sUbtypes were identified by 'barcoding'. 
Eight subtypes were detected in this work and ST3 shows the highest frequency over all. In 
the IBS samples, ST4 shows the second highest percentage (38%), nearly twice as high as in 
the' control' group (23 %). ST5 was detected only in the 
Table 4.1 Numbers of each sequence type obtained from each group 
Host 
Subtype Total 
STl ST2 SB ST4 STS ST6 sn ST8 
IBS 13 (11 %) 8 (7%) 46 (40%) 44 (38%) - 1 (1 %) 1 (1 %) 3 (3 %) 116 
Unselected 19 (17 %) 11 (10%) 49 (45%) 2S (23%) 2 (2 %) - 2 (2 %) 1 ( 1 %) 109 
Total 32 (14 %) 19 (8.4%) 95(42%) 69 (30.7%) 2 (0.9%) 1 (0.4%) 3 (1.3%) 4(1.8%) 225 
The result of chi square test showed the P value is 0.136. The difference in subtype 
distribution between IBS and unselected samples is not significant. 
4.4 Discussion 
I would like to start by discussing the evidence for Blastocystis being associated with IBS. In 
a study reported by Yakoob et al. (2004) at the Aga Khan University Hospital in Karachi, 
Pakistan, 95 patients with symptoms diagnosed as IBS according to Roma II criteria who 
attended the gastroenterology clinic from January 2002 to June 2003 were studied. Single 
stool samples were used and wet mount smears prepared using physiologic saline and 
Lugol's iodine. For culturing Blastocystis, Jones medium was used without adding starch and 
the cultures were incubated at 37°C and examined after 24,48, 72 and 96 hours. 
The authors compared their IBS group with a control group. Age groups were almost the 
same between IBS and control, being a little higher in the control group, whereas gender 
showed more males in IBS and more females in the control group. The bowel habit of the 
control group was described as diarrhoea with loose consistency of stools, which I think is 
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not good control group as some may have had IBS and they should have used a control group 
without any diarrhoea symptoms. 
The authors compared diagnostic data from both the IBS and control groups using stool 
microscopy and culture but the data were combined in one table (Table 4.2), which made it 
unclear for the reader. It would have been clear to separate the data into two comparisons as 
follows (Table 4.2 & 4.3). 
Table 4.2 Comparison of stool microscopy between IBS and control group 
IBS Control Total 
Positive 30 4 34 
Negative 65 51 116 
Total 95· 55 150 
P=0.005 
Table 4.3 Comparison of stool culture between IBS and control group 
IBS Control Total 
Positive 44 4 48 
Negative Sl Sl 102 
Total 95 SS lS0 
P= < 0.001 
From the tables we can observe that both methods show a higher prevalence of Blastocystis 
in IBS patients with high significance. I believe the author's conclusion that stool culture is 
more sensitive than stool microscopy but comparing the IBS patients with this control group I 
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think it is not a good comparison, as this control group is suffering from symptoms I ike 
diarrhoea which may bias the result. 
In Italy, Giacometti et al. (1999) compared the prevalence of Blastocystis in patients affected 
by non IBS gastrointestinal disorders and patients affected by IBS. Over a 2-year period from 
March 1996 till April 1998, 388 successive individuals with gastrointestinal symptoms were 
referred to the institute (Table 4.4).212 individuals were male and 176 were female. Patient 
ages varied from 18 to 84 years with an average of 44.2 years. 
The patients were classified into two groups according to the Roma diagnostic criteria; 
individuals affected with the functional gastrointestinal disorder IBS (R+) and individuals 
with gastrointestinal disorders other than IBS (R-). Three samples were collected from each 
patient and all samples were examined by a direct smear microscopy using Lugol's iodine, 
then stools were concentrated by a formalin-ethylacetate technique. More than one slide was 
prepared for detection of ova and parasites. 
The authors decided to use the criterion of 5 organisms or more per field to consider someone 
as positive for Blastocystis. 
The p value was 0.006 and showed that Blastocystis is more common in IBS with high 
significance (Table 4.5). However, when they compared prevalence of < 5 organisms per 
field in both groups the p value was 0.085 which is not significant. 
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Table 4.4 Prevalence and concentration of Blastocystis hominis organisms in the stool of patients 
with or without irritable bowel syndrome (Taken from Giacometti et al. 1999) 
Presence of B.hominis No. (%) 
(per x 40 field) R-patients a R . b + patients 
(n= 307) (n= 81) 
No organism present 284 (92.5) 66 (81.5) 
Any organism present 23 (7.5) 15 (18.5) 
< 5 organism per field 
B.hominis only 13(4.2) 8(9.9) 
B.hominis plus other nonpathogens 4(1.3) 1 (1.2) 
~ 5 organisms per field 6(2.0) 6(7.4) 
a Patients affected by gastrointestinal disorders other than irritable bowel syndrome 
P value 
0.006 
0.085 
0.613 
0.031 
b Patients defined as affected by irritable bowel syndrome according to Rome diagnosis criteria 
81 IBS patients were described for their first comparisons. 72 patients reported for follow up 
at 6 months and out of these 72 patients 53 were no longer considered to be patients affected 
by IBS and only 19 patients as affected by IBS (Fig 4.1). It is well known that IBS is chronic 
disease so it seems that some IBS patients may have been misdiagnosed initially and were 
considered to be IBS patients when in fact they were not. This makes the results not suitable 
for comparison and I think this can be considered to bias the result in this paper. 
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Total Samples 388 
/~ 
Non IBS IBS 
307 81 Time zero 
72 Time 6 months 
/\ 
Non IBS IBS 
53 19 
Fig 4.1 Breakdown of patient numbers and diagnosis from Giacometti et af (1999) 
The choice of using the criterion of 5 organisms per field to identify positive patients is not 
justified. Microscopy is not so accurate and what if some people had 4 organisms per field, 
for example, should they be considered in this study or not? is this significantly different 
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from 5 or 6 ? It seems very arbitrary as a cut-off point and there is no justification given for 
its use- it is only random number. 
Some people may have had more than 5 organisms per field on average but have been missed 
in diagnosis due to the sample of stool examined or it may be that Blastocystis was not the 
typical shape, for example only cysts or amoeboid stages. Both Udkow et al. (1993) and Zaki 
et al. (1991) reported that patients who do not show any symptoms may present with large 
numbers of Blastocystis cells in their faeces. This makes the choice of measuring cell density 
strange. In addition, stool culture was not used in this study despite showing I~ore sensitivity 
than stool microscopy in a number of studies. 
Tungtrongchitr et al. (2004) performed one study with a cohort of 59 IBS patients (27 male; 
32 female) that were diagnosed by physical and biochemical laboratory examinations for the 
inclusion criteria of Roma Criteria II, and with 25 normal individuals used as control (Table 
4.5). These individuals attended the Out-patient Department-General Practice sections of 
Siriraj Hospital and Ramathibodi Hospital, Bangkok. All patients provided one stool sample 
for analysis. Wet mount smears were prepared and evaluated under the microscope using 
saline and iodine solution for the presence of parasites. Trichrome, modified Trichrome and 
acid fast staining were also used. Blastocystis culture was carried out using monophasic 
medium. 
The authors showed that there is no statistical difference between Blastocystis in IBS and 
control patients (P= 0.87). 
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Table 4.5 Prevalence of parasitic infections in irritable bowel syndrome (l8S) and control subjects 
(From Tungtrongchitr et al. 2004) 
Parasite IBS (N=59) Control (N=25) P-value 
B.hominis (vacuolated form) 13.6% {8/59} 12.0 % {3/25} 0.87 
Non-pathogenic protozoa (Endolimax nana cyst) 5.1 % (3/59) 
Strongyloides stercoralis Rhabditiform larva 1.7 % (1/59) 
Hookworm egg 8.0% (2/25) 
Giardia lamblia cyst 1.7% {1/59} 
The authors claimed that their results were the same as those of Giacometti et al. (1999) but 
in fact they were not similar. In Giacometti's paper the difference was very significant when 
they compared prevalence of Blastocystis in two patients groups (P=0.006) which supported 
an association between Blastocystis and IBS. The result compared in Tungtrongchitr et al. 
(2004) with the Giacometti et al. (1999) paper is only the prevalence of < 5 organisms per 
field in patients without symptoms and patients with IBS. Also the authors reported that the 
culture method was found to be more sensitive than other methods without using any 
statistical analysis test. 
In another study Hussain et ai. (1997) measured the IgG antibodies levels in patients with 
IBS and Blastocystis at the Aga Khan Hospital (n=22) and the Jinnah Hospital (n=34) in 
Karachi during a six month period, also 36 healthy volunteers considered as endemic controls 
that did not give any history of IBS and were negative for all intestinal parasites including 
Blastocystis were recruited from the staff at the Aga Khan Hospital (Table 4.6). Patients were 
diagnosed with IBS on the basis of Roma II Criteria. Although stool microscopic examination 
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with saline and iodine was used to detect other intestinal parasites, the presence of 
Blastocystis in the stools was detected by culturing the organisms in Jones' medium. 
The distribution of age and gender was similar in all groups. Patients with IBS showed 
increased levels of IgG antibodies irrespective of the presence or absence of Blastocystis in 
their stools. Hussain et al. (1997) also mentioned that in some patients the stool samples may 
have been negative for Blastocystis as they had received previous treatment with 
metronidazole. 
Table 4.6 Percentage seroposivity in patients with irritable bowel syndrome (lBS) (From Hussain 
et al. 1997) 
Group IgG IgGl IgG2 IgG3 IgG4 
IBS (BH+) 
(n=23) 65 8.7 47.8 0 0 
IBS (BH-) 
(n=32) 55 0 46.8 12.5 0 
Control 
(n=36) 45 0 20 0 0 
In this article four antibodies levels were measured: total IgG and IgG subclasses IgG 1, IgG2 
and IgG3. They observed a low level of IgG 1 in IBS patients only when the stool was 
positive for Blastocystis (Table 4.7), whereas no IgG3 was seen in IBS patients with 
Blastocystis. However the level of IgG2 was similar in IBS patients with and without 
Blastocystis. Also the authors mentioned that patients with IBS showed increased levels of 
overall IgG antibodies irrespective ofthe presence or absence of Blastocystis. 
In the paper title the authors state that IgG2 antibody level to Blastocystis. increased 
significantly in patients with IBS but this is not what is stated in the result section: IgG2 
antibody was similar in patients with or without Blastocystis. The link is between IBS and 
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control patients where the authors showed that IgG2 increased in IBS compared with healthy 
control group. I think the conclusion in the title is misleading. 
In general there are some criticisms for each of these four papers. 
For Yakoob's paper: the control group may not be a good control as it showed a higher 
percentage of diarrhoea than the IBS group. No description of the diarrhoea was gIven 
whether it was loose, watery, semi-soft or mucus diarrhoea. This may be significant. 
For Giacometti's paper: many of the non-IBS patients as classified at 6 months follow-up 
were previously considered as IBS and had been used in comparisons between IBS and non-
IBS at recruitment. Since IBS is a chronic disease this suggests a lot of the initial diagnosis 
may have been incorrect. Using the criterion of < or > 5 organisms per field to identify 
infected and uninfected patients is not appropriate when investigating whether there is a link 
between Blastocystis and IBS. It is arbitrary. 
For Hussain's paper: They detected increased level of IgG antibodies in presence or absence 
of Blastocystis organism in patients with IBS. The significance is unclear. Also they claimed 
that stool negativity in these patients may be due to previous treatment with metronidazole 
before presenting at the hospital. I believe this could bias the results by using patients who 
already received treatment. 
For Tungtrongchitr's paper: the author collected only one stool sample from each patient and 
this could be a bias in the result, as other authors like Vennila et al. (1999) have mentioned 
that the shedding pattern of Blastocystis in infected persons is irregular. 
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The number of IBS samples is more than twice that of the control group and this could affect 
the result. The authors revealed that IBS patients who had Blastocystis were given 
metronidazole (l,200mg for 7 days), but they could not be fully cured using this standard 
treatment. It is possible that this resistance of Blastocystis could be linked to SUbtypes. 
In summary, none of the four papers show any strong evidence of whether there is a link or 
not of Blastocystis to IBS. More research needs to be carried out to prove or disprove this 
link. 
Table 4.7 Different studies ofIBS and control groups in several countries 
Country Reference Method Frequency of detection in IBS patients Frequency of detection in control 
Italy Giacometti et aI., 1999 Stool microscopy 19% 115/81) 8% 123/307) 
Pakistan Yakoob et aI., 2010a Stool culture 60% 195/158) 24% 138/157) 
Stool microscopy 55% 187/158) 20% 132/157) 
Pakistan Yakoob et al., 2010b Stool culture 53% 190/171) 16% 125/159) 
Stool microscopy 48% 183/171) 17% 127/159) 
Pakistan Yakoob et aI., 2004 Stool culture 46% 144/95) 7.3% 14/55) 
Stool microscopy 32% 130/95) 7.3% 14/55) 
Turkey Dogruman·AI et aI., 2010 Stool microscopy 38% 18/21) 12% 15/43) 
Mexico Ramirez·Miranda et aI., 2010 Stool microscopy 16% /18/115) 12% 125/209) 
United Kingdom Windsor et aI., 2001 Stool microscopy 38% 1>800 samples) 7% 164) 
Thailand Tungtrongchitr et aI., 2004 
Stool culture 14% 18/59) 12% 13/25) 
Stool microscopy 8.5% IS/59) 8% 12/25 
Thailand Surangsrirat et aI., 2010 Stool culture 17% 111/66) 10% 16/60) 
Currently, few studies have been performed to investigate any association of Blastocystis 
subtypes and IBS. Two studies have investigated this link, one by Droguman-AI et al. (2009) 
and the other by Yakoob et al. (2010a). In Droguman-AI et al. (2009) the number of samples 
was only 21 (5 from IBS and 16 from control). Three subtypes were detected (ST1, ST2 and 
ST3, including mixed infections). ST3 was the most frequent in controls whereas ST2 was 
higher in IBS compared to controls and STI was detected only in controls. Two mixed 
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infections were detected in the control group. Due to the number of samples in Droguman-AI 
et al. (2009) the study of Yakoob et al. (201 Oa) is more useful as the num ber of samples is 
high (Table 4.7). 
Table 4.8 Distributions of Blastocystis subtypes from IBS and the unselected control group 
samples 
Reference Country Patient group Samples numbers ST1 5T2 5T3 ST4 STS ST6 5T7 ST8 MIXST Unknown ST 
Yakoob et aI., 2010a Mistan 
185 123 75 (61 %) 6 (5 %) 23 (19 %) 6 (5 %) 3 (2.4 %) 3 (2.4 %) 5 (4 %) - - 2 (2 %) 
Unselected 56 12 (21.4 %) 4 (7 %) 26 (46.2 %) 2 (4 %) 4 (7%) 3 (5.4 %) 5 (9 %) - - -
185 116 13 (11 %) 8 (7%) 46 (40 %) 44 (38 %) - 1 (1 %) 1 (1 %) 3 (3 %) - -
Present study UK 
Unselected 109 19 (17 %) 11 (10 %) 49 (45 %) 25 (23 %) 2 (2 %) - 2 (2 %) 1 (1 %) - -
In my UK study eight subtypes were detected while in Yakoob et al. (201 Oa) only seven 
subtypes were identified, plus two unidentified samples. Blastocystis STI and ST3 were the 
major subtypes in Pakistan group whereas ST 3 and ST4 were in UK. In the Yakoob study, 
STI, 2, 3, 4, 5, 6 and 7 infection were present in both IBS and control. In our study all eight 
subtypes were detected in both groups except ST5 in IBS and ST6 in the control group. ST3 
showed a similar percentage in both countries and groups except in the IBS group from 
Pakistan where the prevalence was low (19%). The frequency of STI in IBS from Pakistan 
was very high (61 %) and was five times higher compared to IBS in UK. The distribution of 
STI from both control groups and IBS samples from UK showed not much difference. ST4 
was highest in the IBS group in UK (38%) while in IBS samples from Pakistan it showed a 
very low percentage (5%). 
ST5 6 7 and 8 were detected as sporadic cases within both studies. ST8 was identified in , , 
UK with low percentage in both groups but none were detected from Pakistan. Worldwide 
only Scicluna et al. (2006) and Stensvold et al. (2009) have detected ST8 in humans. In ST2 
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179 
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there was not much variation between the two groups in both countries, while ST6 and ST7 
showed a higher percentage in Pakistan compared to the UK. 
Statistical analysis showed that there was no significant difference between Blastocystis 
subtypes and patient groups in UK (P=0.082). In Pakistan, the P value is less than 0.001 
which means that there is a highly significance difference between IBS and control group 
subtypes due to the high prevalence of STI in IBS (Table 4.9). 
Both the control and IBS samples that we received came from different IBS clinics and non-
IBS patient sources. We do not know whether some patients in the control group in fact have 
IBS. Similarly samples received from IBS clinics also could actually be from individual 
eventually diagnosed with other conditions. For this reasons our study groups are not very 
well defined and this could affect our results. For example if ST4 in the control group was 
lower after excluding patients with symptoms consistent with IBS then this may alter the 
significance of the P value. To design a better study we need to identifY patients with a 
definite diagnosis of IBS for the IBS group and if possible only asymptomatic individuals in 
the control group. The IBS patients will be easier to identifY than a source of asymptomatic 
individuals infected with Blastocystis as only people with illness usually submit stool samples 
for analysis. 
There is an indication that ST4 is associated with IBS in the UK although it is not 
statistically significant. However, this association is not seen in Pakistan where STI is more 
common in IBS patients and ST3 is less common. If both results are real it suggest that other 
factors are influencing the association of subtype with IBS, perhaps strains within STs. 
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The objective 
To investigate Blastocystis subtypes in IBS patients 
Subtypes in IBS patients were investigated but no significant association was found. 
However, these are problems with the samples used. 
In order to investigate any link between Blastocystis STs and IBS we need to get faecal 
samples from both IBS patients and a control group. In order to do this we have to get true 
IBS patients. This can be done through contact with IBS clinics in order to have complete 
medical information about each IBS patient and the final diagnosis in order to ensure that 
they are real IBS patients. The same thing applies to the control group. It is important to be 
sure that they do not meet the Roma criteria and so do not have IBS. It is also important that 
they match the IBS group as closely as possible except for the diagnosis. This sort of study 
was not possible in my case due to various reasons, including time and labour but also 
because IBS and control samples were received through the Diagnostic Laboratory at 
LSHTM and we do not get access to imp0l1ant information about each patient like clinical 
history, history of contact with animals, their occupation and where they are living. 
Once we have samples with all this information, it will be possible to investigate Blastocystis 
STs in each group, and see whether there is any significant difference between the ST 
distributions. With the sample group that was available there are too many factors that are 
unknown. 
III 
Chapter 5 
Blastocystis subtypes in domestic and zoo 
animals 
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5.1 Introduction 
Blastocystis infects humans, amphibians, reptiles, cockroaches and a wide range of mammals 
and birds (Tan, 2004, Abe, 2004; Yoshikawa et al., 2007; Yoshikawa et al., 2004; Teow et al 
1991). Blastocystis has been reported in many parasite surveys of animals in zoological 
gardens, especially in non-human primate species (Abe, 2002), while studies of Blastocystis 
in domestic animals have also revealed high frequency of occurrence in cattle, pigs and birds 
(Yamada et al., 1987, Abe et al., 2002). 
Subtype studies of Blastocystis infection in humans have shown that some Blastocystis 
isolates from mammals and birds have the same subtypes seen in humans and so seem to 
have zoonotic potential (Clark 1997; Salim et al., 1999). Therefore it has been proposed by 
many authors that human infections may result from zoonotic transmission of the parasite, 
but this remains to be established. 
At the beginning of this study nine STs had been described in mammals and birds (Fig 1.5). 
In 2009, STI0 was reported in cattle and non-human primates (Stensvold et al., 2009) and in 
2010 STs 11-13 were reported by Parkar et al. (2010) in a variety of zoo animals. The aim of 
this study was to determine the STs of Blastocystis in zoo and domestic animals from two 
different countries, the UK and Libya, and to investigate the degree of host specificity among 
these STs. In order to investigate the hypothesis (animals are the source of Blastocystis in 
humans) we need to know the host range and STs of Blastocystis in a variety of animals 
In Libya there is frequent human exposure to animals but no information whereas in the UK 
there is a limited human exposure, but only data on zookeepers who works with monkeys. In 
the UK, in general people may get exposure or contact with animals like dogs, cats, ducks or 
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squirrels but not to monkey, cow, sheep or goat. There are limited people who have frequent 
exposure to animals in UK like zookeepers. For this study I did have samples from 
zookeepers, however the numbers are very small and this is a limitation to my study. In 
Libya, people get exposure to different animals like sheep, cow, goat, camel, chicken and 
even rodent. We do have samples from these animals but from animal handlers we tried hard 
to get samples from them but they refused. I consider this as another limitation to my work 
and I think data questionnaire for Libyan human samples from clinics may help to gather 
some information about animal exposure and Blastocystis infection in Libya in future. Even 
so, the information on Blastocystis subtypes in different animal hosts is an important part of 
that future study and the results will be reported here. 
5.2 Materials and methods 
5.2.1 Source of specimens UK 
5.2.1.1 UK animal samples 
105 faecal samples from non-human primates and two mouse deer were received for routine 
parasitological investigation by the Diagnostic Parasitology Laboratory in the London School 
of Hygiene and Tropical Medicine from various animal facilities and collections (Table 5.1). 
Samples were processed as indicated in chapter 2. We were dependent on zoos submitting 
samples, so the number and range of samples was limited. Most samples were from 
individual monkeys and received over a period of several years but some were samples from 
groups of animals living in the same enclosure so the individual animal providing the sample 
could not be identified. Most hosts were represented by only a small number of samples and 
so the range of subtypes found in those species is likely to be incomplete. 
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Table 5.1 List of animal hosts and zoo location in UK 
Host Animal zoo location 
Monkey World Paignton Twycross Monkey Sanctuary Colchester Chessington Wobum 
Total 
Unknown 
Chimpanzee 11 1 - - - 2 14 
Gorilla - 3 - - - 2 5 
Woolly Monkey 14 - 5 1 - 20 
Macaque 2 4 - 2 - 8 
Orangutan 7 4 - - - - 11 
Gibbon 6 4 - - 1 - 11 
Diana Monkey - 4 - - - - 4 
Baboon - 2 - - - - 2 
Lemur - 2 - - 2 
Allen Swamp Monkey 1 2 - - - 3 
Colobus - 1 - - - - 2 3 
Pat as Monkey - - - 2 2 - 4 
Siamang 3 - - - - - - - 3 
Langur - - 3 - - - - - 3 
Marmoset 1 - - - - - 1 
Mandrill - 3 - - - - 3 
Black Howler Monkey - - 2 - - - - - 2 
Unknown monkeys 1 1 - - - - - 2 4 
Mouse deer - 2 - - - - - - 2 
Total 46 33 10 5 3 2 2 4 105 
5.2.1.2 UK human samples 
34 faecal samples were submitted by zoo keepers who work closely with non-human 
primates in zoos in the UK (Table 5.7). These samples were submitted for routine ova and 
parasite screening to the Diagnostic Parasitology Laboratory. 
5.2.1.3 Libyan animal samples 
A total of 309 faecal samples were collected from various animal hosts in Libya during July 
2008- August 2010 to determine the range of Blastocystis parasites present in this country. 
Samples were collected from different animals from different parts of Libya including camel, 
cattle, goat, donkey, horse, gazelle, Barbary sheep and gundi. In the city ofSebha, 248 faecal 
samples were collected and analysed. One faecal sample per animal was taken at each 
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collection time from each farm. A total of 33 faecal samples from Zawia were investigated 
and 13 and 15 samples were collected from Garaboli and Zahira respectively. 
Camel samples were collected from six farms in Sebha. The distance between farms varied 
between 5 and 40 KM and the number of camels in each farm varied from 30 to 1000 head. 
Goat and cattle samples were collected from three farms in Sebha plus 13 samples from cattle 
were collected from Garaboli as well. Samples from gundi, gazelle and Barbary sheep were 
collected at a tourist camp in Sebha 
Two donkey samples were collected from Sebha and the rest from Zahra; horse samples were 
collected from Zahra only. 
For all animals, faecal samples were collected directly after defecation by the animal so 
collection was dependent on observing defecation. This was so that the faeces was as fresh as 
possible. For the gundi, the people who look after them helped me to collect the samples by 
holding the animals until the samples could be collected. Gloves were worn at all times while 
collecting samples from the animals. 
Obtaining a stool sample from most animals was easy and it was not necessary to catch the 
animal, but it could be picked up where it lay. Most animals defecate after meals, so by 
watching the animal after feeding the animal soon passed faeces and I collected it. To prevent 
contamination I could not just scoop it up off the ground but had to be very careful not to take 
any soil or plant matter. I used a very clean disposable implement, such as a tongue depressor 
or cotton swab, to scoop a faecal sample into a container, and] avoided cross- contamination 
by using gloves and washing my hands after collection. 
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After samples had been collected from an animal I labelled the faecal container according to 
animal type and gave it a serial number, location of the farm, date and time of collection. To 
investigate the presence of Blastocystis, in the laboratory all samples were examined using 
direct smear microscopy and culture was performed using modified Robinson's culture. This 
occurred as soon as possible after collection, within 6 hours. 
In Sebha, samples were collected from several animal hosts but the most samples were 
collected from camels. Six farms in Sebha were studied for Blastocystis. 
Table 5.2 Animal host samples and farm locations in Libya 
Animal host 
Total location Farm 
camel cattle goat Barbary sheep gazelle gundi donkey horse chicken 
1 30 30 
2 19 19 
3 59 59 
4 34 34 
5 15 15 
6 6 6 
7 6 10 16 
Sebha 8 7 7 248 
9 8 2 10 
10 2 2 
11 12 1 13 
12 11 11 
13 5 5 
14 5 9 4 18 
15 3 3 
Garaboli 16 13 13 13 
Zahra 17 13 13 15 
18 2 2 
Zawia 19 33 33 33 
Total 196 36 38 5 9 4 16 2 3 309 
An additional 33 samples were collected from one camel farm from Zawia. Goats provided 
the second largest number of samples and all were collected from Sebha. 
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Cattle samples were collected from both Sebha and Garaboli. Samples were handled as 
described in chapter 2. 
5.2.2 Sample analysis 
Blastocystis isolation, DNA extraction, PCR and Sequencing were performed as in chapter 2, 
sections 2.1-2.6. The only exception is 13 samples from cow where DNA was extracted 
directly from faeces (Table 5.4). 
5.3 Results 
414 faecal samples were examined from animal hosts in both the UK and Libya. In addition 
34 faecal samples from zoo keepers from the UK were analysed. 29 primate keepers from 
Monkey World were compared with the non-human primates from the same zoo to 
investigate whether there was any evidence of transmission of Blastocystis between them. 
13 STs were recognized by barcoding including four new subtypes (STI4, STI5, STl6 and 
STI7) that are described below. 
5.3.1 Libyan animal samples 
From the total number of 309 Libyan animal samples examined using culture for Blastocystis, 
141 (47.6 %) gave positive results. The incidence of Blastocystis in these animals is 
illustrated in Table 5.3. 
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Table 5.3 The incidence of infected animals with Blastocystis in Libya. 
Host Positive by culture Negative by culture Total 
Camel 111 (57%) 85(43%) 196 
Cow 2 (9%) 21 (91%) 23 
Goat 17 (45%) 21 (55%) 38 
Gundi 4 (100%) 
- 4 
Gazelle 4 (44%) 5 (56%) 9 
Barbary sheep 2 (40%) 3 (60%) 5 
Donkey - 16 (100%) 16 
Horse - 2 (100%) 2 
Chicken 1 (33.3%) 2 (66.7%) 3 
Total 141 (47.6%) 155 (52.4%) 296 
141 samples were positive by culture, and PCR were performed on all these samples but only 
70 gave positive PCR (Table 5.4). In addition 13 samples extracted directly from cow faeces 
were positive. This percentage could be due to different reasons; either presence of inhibitors 
within samples, low DNA degradation, or during the preparation of the samples the DNA 
may have been lost. It is also possible that the organisms in the negative PCRs were divergent 
in the region of the BhRDr primer and so the amplification did not work, however the primer 
is conserved in all known Blastocystis to date. 
Table 5.4 PCR results of animals infected with Blastocystis in Libya. 
Host Positive by PCR Negative by PCR Total 
Camel 47 (42.3%) 64 (57.7%) 111 
Cow *15 (100%) - 15 
Goat 4 (24%) 13 (76%) 17 
Gundi 1 (25%) 3 (75%) 4 
Gazelle 1 (25%) 3(75%) 4 
Barbary sheep 1 (50%) 1 (50%) 2 
Chicken 1(100%) - 1 
Total 70 (45.5%) 84 (54.5%) 154 
*Includes 13 samples of Blastocystis DNA extracted directly from cow faeces. 
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There were nine subtypes detected in Libyan animals with four considered to be new 
subtypes, collected from camel (Camelus dromedarius), cow and gundi (Ctenodactylus 
gundi) (Table 5.5). Identification of the four new subtypes was based on sequence of the bar-
coding region compared with sequence of other sUbtypes from GenBank. They showed more 
than 3% nucleotide divergence from the known sUbtypes. Comparison of the whole gene 
sequence of SSU rDNA with complete sequence of other subtypes also confirmed that they 
were distinct. 
Table 5.5 Distribution of Blastocystis subtypes in Libyan mammals and birds 
Host sub~pe ST1 ST2 ST3 ST4 ST5 ST6 ST7 ST8 ST9 STto ST11 ST12 sm ST14 ST15 ST16 ST17 MixST Total 
Camel 5(11%) - 5(11%) - 20(43%) - - - - 6(13%) - - - - 2(4%) 1(2'k) 1(2%) 7(15%) 47 
Cow - - - - 2(13%) - - - - 6(40%) - - - - - 2(13%) - 5(33'~) 15 
Goat - - 1(25%) - - - 1(25%) - - 1(25%) - - - - - - - 1 (25'k) 4 
Gundi - - - - - - - - - - - - - 1(100%) - - - - 1 
Barbary sheep - - - - - - - - - 1(100%) - - - - - - - - 1 
Gazelle - - - - - - - - - - - - - - - - - 1(100'k) 1 
Chicken - - - - - - 1(100%) - - - - - - - - - - - 1 
Total 5(7%) - 6(9%) - 22(31%) - 2(3%) - - 14(20%) - - - 1(1.4'10) 2(2.8'10) 3(4.3'10) 1(1.4%) 14(20'k) 70 
Overall, ST5 shows the highest frequency (31 %) with STlO is in the second position with 
20%. Out of all the animals, camels have more STs but also represent the most samples, The 
number of STs in cow and goat were low possibly because the numbers of samples were low 
as well. ST5 is more common in camels (41 %) than other animals, while ST1, ST3 and STI 0 
all occur in camel with similar prevalence (11-13%). Both camel and cow showed more 
mixed infections than other animals. Chicken, barbary sheep (Ammotragus lervia) and gundi 
demonstrated only one subtype each, carrying ST7, STI 0 and ST14 respectively. In the 
gazelle (Gazella leptoceros) no subtype could be assigned because it showed only a mixed 
infection. 
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ST10 was the subtype with the widest host range and was detected in four animals, camel, 
cow, goat and barbary sheep, whereas ST3, ST5, ST7 and ST16 were each detected from two 
different hosts. Some subtypes were detected only in one specific animal: STL ST15 and 
ST17 were found only in camels while STl4 was detected only in gundi (Table 5.5). 
In cows, three subtypes were detected (ST5, STI 0, and STI6) and among these subtypes 
STlO had the highest frequency (40%) .. The two ST5 samples from cow show some 
divergence from other ST5 sequences. Complete gene sequences will be necessary to decide 
whether these need to be assigned to a new SUbtype. In goats three subtypes were seen as 
well, ST3, ST7 and STI 0, with equal frequency. Donkeys and horses did show any 
Blastocystis in their faeces, either by direct smear or by culture. 
5.3.2 UK animal samples 
In the UK, 105 samples were collected from non-human primates (NHP) and two samples. 
from mouse deer. Nine subtypes were identified, with one new subtype (STI7) detected from 
various hosts including chimpanzee, gibbon, lemur and an unidentified monkey. This subtype 
was also detected in a Libyan camel (see above). A few samples showed mixed subtype 
infections (Table 5.6). 
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Table 5.6 Blastocystis subtype distribution identified in non-human primates and other 
mammals from the UK (n=105) 
Host STl ST2 ST3 ST4 ST5 ST6 m ST8 ST9 STlO STll STl2 ST13 ST14 STlS STl6 ST17 MIX ST/Bad seq PCR(-) 
Chimpanzee - 4 3 - 3 - - 1 - - - - - - - 1 1 1 
Gorilla - 1 1 - 1 - - - - - - - - - 2 
Woolly monkey - 1 3 - - - - 14 - - - - - - - - - 2 
Macaque 1 - 7 - - - - - - - - - - - - - -
Orangutan 2 4 2 - 2 - - - - - - - - - - - - - 1 
Gibbon - 2 1 - 1 - - 3 - - - - - - - - 1 2 1 
Diana Monkey 2 - 2 - - - - - - - - - - - - - - - -
Baboon - - 2 - - - - - - - - - - - - - - -
lemur - - - - - - - - - - - - - - - - 1 - 1 
Allen Swamp Monkey - - 3 - - - - - - - - - - - - - - - -
Colobus - - 2 - - - 1 - - - - - - - - - - - -
Patas Monkey 1 - 3 - - - - - - - - - - - - - - - -
Siamang 2 - - - - - - 1 - - - - - - - - - - -
langur - - 2 - - - - 1 - - - - - - - - - - -
Marmoset - - 1 - - - - - - - - - - - - - - - -
Mandrill 3 - - - - - - - - - - - - - - - - - -
Black Howler Monkey - - - - - - - 2 - - - - - - - - - - -
Unknown monkeys 1 - 1 - - - - - - - - - - - - - 1 1 -
Mouse deer - - - - - - - - - - - - 2 - - - - -
Total 12 12 33 - 7 - 1 22 - - - - 2 - - - 4 4 8 
ST3 is the dominant subtype in NHPs with a high frequency seen among macaques in 
particular (Table 5.6). This is also the most common ST in humans. However, ST8 is the 
Total 
14 
5 
20 
8 
11 
11 
4 
2 
2 
3 
3 
4 
3 
3 
1 
3 
2 
4 
2 
IDS 
second most common in NHPs and was most common in woolly monkeys. ST8 is very rare 
in humans, except for zoo keepers (Sciciuna et al., 2006). 
In Table 5.7 we compare STs in non-human primates with STs in zoo keepers from the same 
zoo. ST8 was the highest ST in NHP from monkey world and found in more than 13 % of 
zoo keepers. ST3 is the most common ST in zoo keepers. ST4 was not detected from any 
NHP but shows 10.3% in zoo keepers. Most woolly monkey samples have ST8 but we do 
not know how many zookeepers with ST8 were working with woolly monkeys because they 
rotate among primate groups .. 
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Table 5.7 Blastocystis subtype distribution in zoo keepers and non-human primates in 
Monkey world zoo in UK. 
Host 
Subtype 
STl ST2 5T3 ST4 ST5 5T6 sn ST8 
Non-human primates 4(10%) 10 (25%) 8(20%) - 2 (5%) - - 16 (40%) 
Zoo keepers* 7 (24.1%) 5 (17.2%) 9 (31%) 3 (10.3%) - - 1 (3.4%) 4 (13.8%) 
Total 11 (15.7%) 15 (21.4%) 17 (24.3%) 3 (4.3%) 2(2.9%) - 1 (1.4%) 20 (28.6%) 
*In addition, there were three with negative peR and one with bad sequence 
Total 
40 
29 
70 
ST6 was not detected in any NHP host whereas ST7 was identified only in one sample from a 
colobus monkey (Table 5.6) and one zookeeper (Table 5.7) 
Mouse deer can be considered a new host for Blastocystis and was infected with STl3 which 
was recently reported in a quokka by Parkar et al. (2010). This means that ST13 is not 
confined to marsupials. No infections with ST6, ST9, ST11 or ST12 were detected in this 
study, in either UK or Libyan animal samples. 
5.3.3 Phylogenetic analysis 
There were four new subtypes detected in this study. However this conclusion was based 
initially only on the barcode region. To confirm this result and to investigate how the new 
STs are related to the others, the complete gene sequence was obtained. 
5.3.4 peR amplification 
The amplification of the SSU rRNA coding regions of 5 Blastocystis isolates from gundi, 
camels, cows, monkeys and mouse deer analyzed in this study was carried out as described in 
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Chapter 2 using primers RD5 and RD3 to produce a DNA fragment of the expected size (_ 
1.8 kb in length) as determined by gel electrophoresis. STI0 was originally identified based 
on small regions only (Stensvold et al., 2009) and so a gene for this subtype was sequenced 
completely in this study in addition to the new sUbtypes. Sequences obtained from the five 
Blastocystis isolates in the present study were aligned with the SSU rRNA sequences of 12 
Blastocystis sequences collected from GenBank representing different subtypes for 
phylogenetic analysis (Table 5.8). These 12 isolates have been sequenced previously along 
the entire or partial (Parkar et al., 2010) length of the SSU rDNA. Since the nucleotide 
sequences of SSU rDNA for STl1, ST12 and STl3 were incomplete, as reported by Parkar et 
al. (2010), we decided to use the same region (1100 bp) from each ST to construct the 
phylogenetic tree (Fig 5.1). Two isolates from camel, one from Sebha and the other from 
Zawia, showed similar sequences to an unpublished one found in a mouflon in the barcoding 
region and since the whole gene of SSU rRNA of the mouflon sample already been 
sequenced (Taner-Mulla, 2010) we decided to use that sequence to construct the phylogenetic 
tree instead of sequencing ST 15 again. 
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Table 5.8 Reference sequences for each Blastocystis subtype included in this work with 
their GenBank accession number, host, location and reference 
ST Host location GenBank Reference 
ST-l Primate Japan ABI07968 Abe (2004) 
ST-2 Primate Japan ABI07969 Abe (2004) 
ST-3 Human Japan AB070988 Arisue et al. (2003) 
ST-4 Human Japan AY24462 Yoshikawa et al. (2003) 
ST-5 Pig Japan AB091249 Arisue et al. (2003) 
ST-6 Chicken Japan A B070994 Arisue et al. (2003) 
ST-7 Chicken Japan AB091246 Arisue et al. (2003) 
ST-8 Primate Japan ABI07970 Abe (2004) 
ST-9 Human Japan AF408426 Yoshikawa et al. (2004) 
ST-ll Elephant Austral ia GU256900 Parkar et al. (2010) 
ST-12 Giraffe Australia GU256902 Parkar et al. (2010) 
ST-13 Quokka Austral ia GU256935 Parkar et al. (2010) 
The flagellate Proteromonas lacertae was used as the outgroup based on earlier phylogenetic 
studies (Noel et al., 2003). The rooted neighbour-joining tree identified 17 lineages (Fig 5.1). 
The relationships among the STs already known those reported in the previous studies. Based 
on degree of divergence, there is a strong case for placing all our new sequences as separate 
novel lineages or STs, and we allocated them to ST14, ST15, ST16 and ST17 (Fig 5.1). 
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Fig. 5.1 Phylogenetic tree of the new Blastocystis sequences and reference SSU rRNA gene 
sequences from GenBank. This is based on 1100 aligned base pairs of the SSUrDNA and was rooted 
on Proteromonas lacertae. The values on the nodes are bootstrap support values based on 1000 
replicates for (A) Neighbour-joining (NJ) and 100 replicates for (B) Maximum likelihood (ML). 
To illustrate the differences in nucleotides between 17 ST of Blastocystis based on the SSU 
rRNA gene, the sequence of our four new STs was aligned with the other 13 known 
Blastocystis STs sequences (Fig 5.2) 
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TTCTCGGRTTTRTG6RRGRT6RRCRRRTGCGRRRGCRTTTRCCRRGGRTGTTTTCRTTRRTCRRGRRC&RRR6TTRGGGGATCGRR GRTTRGRTRC 
TTCTGGGRTTTRTGGRRGRT6RRCRRGT6C6RRRGCRTTTRCCRRGGRT6TTTTCRTTRRTCRRGRROGRRRGTTRGGGGATCGRR GRTTRGRTRC 
TTCTCGGRTTTRTGGRRGATGRRCTRGT6CGRRRGCRTTTRCCRRGGRTGTTTTCRTTRRTCRRGARCGRRRGTTRGGGGATCGRR RGGCTTRGRTR 
TTCTCGGRTTTRTGGRRGRTGRRCRRGTGCGRRA6CRTTTRCCRRG6RTGTTTTCATTRRTCRRGARCGRRA6TTAGGGGATCGARG-RGGRTTRGRTRC 
TTCTCGGRTTTRTG6RRGRTGRRCTRGTGCGRRR6CRTTTRCCRRGGRTGTTTTCRTTRRTCRRGRRCGRRR6CTAGGGGATCGRR GCTTRGATAC 
TTCTCGGRTTTRTG6RRGRT6RRCTRGTGCGRRRGCRTTTACCRRGGRTGTTTTCRTTRRTCRRGRRCGRRR6CTRGG6GATCGRRG-RGGCTTRGRTAC 
TTCTCGGRTTTRTG6RRGRT6RRCTRGT6C6RARGCRTTTRCCRRGGRTGTTTTCRTTRRTCRRGRRCGRRAGCTRGGGGATCGRR RGGCTTRGRTRC 
TTCTCGGRTTTRTGGRRGRTGRRCTRGT6CGRARGCRTTTRCCRRGGRTGTTTTCRTTRRTCRRGRACGRRAGCTRGGGGATCGAR GCTTRGRTAC 
TTCTCGGRTTTATGGRRGATGRRCRRRTGCGRRA6CRTTTACCRRGGRTGTTTTCRTTAATCRAGARCGRRAGCTAGGGGATCRRAG GCTTRGRTAC 
TTCTCGGRTTTRTGGRRGRTGRRCGRRTGCGRRR6CRTTTRCCRRGGRTGTTTTCRTTARTCRRGRACGRRAGCTRGGGGRTCRRA AGGCTTRGRTAC 
TTCTRTGRTTTRTGGRRGRTGRRCTRGTGCGRARGCRTTTRCCRRGGRTGTTTTCRTTRRTCRRGRRCGRRAGCTRGGGGRTCRRR GRTTRGRTRC 
TTCTCGGRTTTRTGGRRGRTGRRCTRGTGCGRRRGCRTTTRCCRRGGRTGTTTTCRTTARTCRRGRRCGRRRGTTRGGGGRTCGAA RGGCTTRGRTAC 
TTCTCGGRTTTRTGGRRGATGRRCTRRT6CGRARGCRTTTRCCRRGGRTGTTTTCRTTRRTCRAGRRCGRRAGTTRGGGGRTCGAA6 GATTAGATAC 
TTCTcGGRTTTRTGGRRGRTGRRCt RgTGCGRARGCRTTTRCCRRGGRTGTTTTCRTTARTCRRGRRCGRRAGcTRGGGGRTCgAAG RGGcTTRGRTAC 
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CCTCGTRGTCTTRGCTRTRARCGRTRCCGRCTR6GGGTTRGTAGAGGT----________ ---------------cAATG 
CCTCGTRGTCTTRGCTRTRRRCGRTRCCGRCTRGGGGTTRGTAGRGGT------_______ ------------------(TATG 
CCTCGTAGTCTTRRCTATAARCGATRCCGRCTAGGGGTTAGTGGRGGT-------____ ---------------CATTG 
CCTCGTRGTCTTRRCTRTRRRCGRTRCCGRCTRGGGGTTAGTRRTGGT-----------_-------------------cRTTG 
CCTCGTRGTCTTRRCTRTRRRCGRTRCCGRCTRGGGGTTRGTGGAGGT----------------------------------CATT-
CCTCGTAGTCTTRACTATRRACGRTRCCGACTAGRGGTTAGTGRAGGT-----------------------------------(ATTG 
CCTCGTRGTCTTRGCTRTRARCTRTRCCGRCTRGGGGTTRGTRGRAGT------------------------------CRTTG 
CCTCGTRGTCTTRGCTRTRAACGRTACCGRCTAGGGGTTRGTRGRRGT----------_-------------------CRTTG 
CCTCGTRGTCTTRGCTRTRRRCTRTRCC6RCTR6GGGTTRGTRGRRGT---------------------------------------CRTTG 
CCTCGTRGTCTTRGCTRTRRRCTRTRCCGRCTAGGGGTTRGTRGRRGT-------------------------------------CRTTG 
CCTCGTRGTCTTRGCTRTRRRCGRTRCCGRCTRGGGCTTRGTRGRTRT--------------------------------------CCAAT 
CCTCGTRGTCTTRGCTRTRRRCGRTACCGRCTAGGGCTTAGTRGATAT-----------------------------------(CRAT 
CCTCGTRGTCTTRGCTRTRRRCGRTRCCGRCTRGGRGTTRGTRGRTGRT-----------------------------------(CART 
CCTCGTRGTCTTRRCTRTRRRCGRTRCCGRCTRGGGCTTRGTRRRGTTCTTGGTRTTTTRGTRRTRTGRRTRCTTTTGTRTTTTTRTTRTTARTGCCTAT 
CCTCGTRGTCTTAACTRTAAACTATACCGRCTAGRGRTTGGTGGTATRCTC----------------TTTTARTCTTTTTTRAGRTTATAT AA 
CCTCGTRGTCTTRgCTRTRARCgRTRCCGRCTAGgGgTTRGTaga . gt... • •••••••••••••••• •••• Cattg 
1201 1210 1220 1230 1240 1250 1260 1270 1280 1290 1300 1--------+---------+---------+---------+---------+---------+------+---------+---------+------1 
TGTCTTTATTRGTRCCTTATGRGRARTCRARGTCTTTGGGTTCCGGGGGGRGTATGGTCGCRRGGCTGARRCTTRARGGRRTTGACGGRRG66CRCCACC 
TGTTTCTRTTRGTRCCTTRTGRGRRRTCRRRGTCTTTGGGTTCCGGGGGGAGTATGGTCGCRRGGCT6RRACTTRRAGGRRTTGACGGRRGGGCflCCACC 
TGTCTCTATTRGTACCTTRTGRGRRRTCRRRGTCTTTGGGTTCCGGGGGGAGTRTGGTCGCRRGGCTGRRRCTTRRRGGRATTGACGGRRGGGCRCCRCC 
TGTCTTTRTTRGTACCTTRTGRGRRRTCRRRGTCTTTGGGTTCCGGG6GGRGTATGGTCGCRRGGCTGRRRCTTRARGGRRTTGRCGGRRGGGCRCCRCC 
TGTCTCTRCTRGTACCTTATGRGRARTCRRRGTCTTTGGGTTCCGGGGGGAGTRTGGTCGCRRGGCTGRRACTTRRRGGRRTTGRCGGAAGGGCRCCRCC 
TGTGTTTRCTRGTRCCTTRTGRGRARTCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRRGGCTGRRACTTRRRGGRRTTGACGGRRGGGCRCCACC 
TGTCTCTACTAGTACCTTATGAGAAATCAAAGTCTTTGGGTTCCGGGGGGAGTATGGTCGCRRGGCTGRAACTTARAGGRATTGACGGRAGGGCACCACC 
TGTCTTGACTAGTATCTTRTGA6RARTCRRRGTCTTTGGGTTCCGGGG6GRGTAT6GTCGCRAGGCTGRRACTTARRGGRRTTGAC6GRRGGGCACCACC 
TGTTTCTRTTRGTRCCTTRTGAGRRRTCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRAGGCTGRRACTTRRRGGRRTTGACGGRRGGGCRCCACC 
C6TTTCTRTTRGTRCCTTATGRGARRTCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRRGGCTGRRRCTTRRRGGRATTGAC66RAGG6CRCCRCC 
TGTTTCTATTRGTRCCTTRTGRGRRRTCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRAGGCTGRRACTTRAAGGRATTGACGGARGGGCRCCRCC 
TGTTTCTATTRGTRCCTTRT6RGARRTCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRRGGCTGRRRCTTRRRGGRRTTGRCGGRAGGGCACCRCC 
GGTGTCTATTR6TACCTTGTGRGRRRCCRRRGTCTTTGGGTTCCGGGG6GRGTRTGGTCGCRRGGCTGRRRCTTRRRGGAATTGRCGGRRGGGCRCCACC 
GGTGTCTATTRGTRCCTTGTGRGRRATCRRAGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRRGGCTGRARCTTRRRGGRATTGACGGRRGGGCRCCACC 
GGTGTCTRTTRGTACCTTATGRGRRRTCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRRGGCTGRARCTTRARGGRRTTGACGGARGGGCRCCACC 
TGTCTTTRTTRGTACCTTRTGRGRRATCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRRGGCTGARRCTTRRAGGRATTGACGGARGGGCRCCACC 
RGTRTTCRTCRGCRTCTTRTGRGRRRTCRRRGTCTTTGGGTTCTGGGGGGRGTRTGGTCGCRRGGCTGRRRCTTRRRGGRATTGACGGRRGGGCRCCRCC 
t GT . TctRt TRGTRcCTTaTGRGRRRTCRRRGTCTTTGGGTTCCGGGGGGRGTRTGGTCGCRRGGCTGRRRCTTRRRGGRRTTGACGGRAGGGCRCCRCC 
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RGGRGTGGRGCCTGCGGCTTRRTTTGRCTCRRCRCGGGGRRRCTTRCCRGGTCCRGRCRTRGGRRGGATTGACRGRTTGATRGCTCTTTCTTGRTTCTAT 
RGGAGTGGRGCCTGCGGCTTARTTCGRCTCRACRCGGGGARRCTTACCRGGTCCRGRCATRGGRRGGRTTGACRGATTGRTRGCTCTTTCTCGATTCTAT 
RGGRGTGGRGCCTGCGGCTTRATTTGRCTCRACRCGGGGRRRCTTRCCRGGTCCRGRCRTAGGAAGGATTGACRGATTGATRGCTCTTTCTTGRTTCTRT 
RGGAGTGGRGCCTGCGGCTTRATTTGRCTCRACRCGGGGAAACTTRCCAGGTCCAGRCATAGGAAGGATTGACRGRTTGATAGCTCTTTCTTGRTTCTAT 
RGGAGTGGRGCCTGCGGCTTAATTTGRCTCRRCRCGGGRRAACTTRCCRGGTCCRGRCATRGGRRGGRTAGACAGRRCAA- RGCTCTTTCTTGRTTCTAT 
AGGRGTGGRGCCTGCGGCTTAATTTGRCTCAACRCGGGGRAACTTACCAGGTCCRGACATRGGRAGGATAGRCRGRACRA-AGCTCTTTCTTGRTTCTAT 
RGGAGTG6RGCCTGCGGCTTAATTTGRCTCRRCRCGGGGRAACTTACCAGGTCCRGRCATAGGRRGGRTAGRCRGRRCRA- AGCTCTTTCTTGRTTCTAT 
AGGRGTGGRGCCTGCGGCTTRRTTTGACTCARCRCGGGAARACTTACCRGGTCCAGACRTRGGRRGGATAGRCRGATTAA- AGCTCTTTCTT6ATTCTAT 
AGGRGTGGRGCCTGCGGCTTRATTTGACTCRRCACGGGGRAACTTACCAGGTCCAGRCRTAGGRRGGRTTGACAGRTTGATAGCTCTTTCTTGRTTCTAT 
AGGAGTGGRGCCTGCGGCTTRATTTGRCTCRRCRCGGGGAARCTTACCRGGTCCRGACATA6GRRGGRTTGACAGRTTGATAGCTCTTTCTTGRTTCTAT 
RGGRGTGGAGCCTGCGGCTTRATTTGACTCRACACGGGGAAACTTACCRGGTCCRGRCATRGGRRGGATTGRCRGATTGATAGCTCTTTCTTGRTTCTAT 
AGGRGTGGAGCCTGCGGCTTRATTTGRCTCAACACGGGGAAACTTACCAGGTCCRGRCATRGGRRGGATTGACAGRTTGATAGCTCTTTCTTGRTTCTAT 
RGGAGTGGAGCCTGC6GCTTAATTTGACTCRRCACGGGGAAACTTACCRGGTCCAGRCATAGGRAGGRTTGACAGRTTGATAGCTCTTTCTTGRTTCTAT 
AGGRGTGGA--CTGCGGCTTAATTTGACTCRRCRCGGGGRRRCTTRCCRGGTCCRGRCATRGGRRGGRTTGACRGRTTGRTAGCTCTTTCTT6ATTCTAT 
RGGRGTGGRGCCTGCGGCTTARTTTGRCTCRRCRC6GGGRRRCTTACCRGGTCCAGRCATRGGRAGGRTTGRCAGRTTGATRGCTCTTTCTT6ATTCTAT 
RGGRGTGGRGCCTGCGGCTTRRTTTGACTCRACRCGGGGAARCTTRCCAGGTCCRGRCATRGCRRGGATTGACRGGTTGATRGCTCTTTCTTGRTTCTAT 
AGGRGTGGAGCCTGCGGCTTRRTTTGRCTCAACRCGGGGARRCTTRCCRGGTCCRGRCRTAGTRR6GRTTGRCA6RTTGRTRGCTCTTTCTTGRTTCTRT 
RGGRGTGGAGCCTGCGGCTTRRTTTGRCTCRRCACGGGgARRCTTRCCRGGTCCAGRCATAGgRRGGRTt GACRGRttgAtRGCTCTTTCTTGRTTCTAT 
Fig 5.2 Aligmment ofnucleotides sequence from 17 STs. 
The region showed corresponds to 1101-1500 of the small subunit (SSU) rRNA 
gene of B las tocys tis sp. subtypes. 
128 
5.4 Discussion 
This is the first study to report Blastocystis isolated from Barbary sheep, gazelle, gundi and 
mouse deer which therefore should be considered as new hosts for this parasite. Also this is 
the first repOJ1 of four new Blastocystis subtypes from various animal hosts in both the UK 
and Libya. These are from gundi (ST14), camel (STI 5), cow and camel (ST16) and finally 
(STI7) from camel as well as from non-human primates (chimpanzee, gibbon, lemur and an 
unidentified monkey). 
Animals have been proposed to be a reservoir for human infection with Blastocystis since 
certain subtypes of this organism have been discovered in an extensive range of animals as 
well as humans (Yoshikawa et al., 2004a; Abe et al., 2003a; Arisue et al., 2003; Parkar et al., 
2007; Stensvold e/ al., 2009) and people with close animal contact were found to be at higher 
risk of Blastocystis infection (Salim et al., I999). In this study, ST8 appears to be a zoonotic 
subtype, being found in non-human primates as one of the most common subtypes (40%) 
while in zoo keepers it showed a prevalence of 13.8% but in UK human random population it 
represents less than 1 % of infections (Table 3.1). Although the number of zookeeper samples 
is small, the prevalence of ST8 in zookeepers (4129) was much higher than in the general 
population (41225). 
As was the case in earlier studies (Abe et al., 2002; Perez Cordon et al., 2008), the present 
study has shown that many primates in zoos and many domestic animals are infected with 
Blastocystis. Relatively few studies have screened non-primate zoo animals for Blastocystis 
(Abe et al., 2002, Lim et aI., 2008), but the recent paper by Parkar et al. (20 I 0) suggests that 
additional host-specific subtypes exist. 
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In Libya, even though ST5 and STIO were not found in humans, they were the most 
dominant subtypes in animals (50 % of samples) especially in camel and cow. This means 
that either those hosts do not contribute to human infections or these subtypes do not usually 
infect humans. Different authors have found ST5 in cattle and pigs (Abe et al., 2003; Arisue 
et al., 2003; Yan et a!., 2007; Yoshikawa et al., 2004a; Stensvold et al., 2009), while a few 
cases were detected in primates as in our study (Table 5.6). In Libya, none of the animal 
hosts carried ST2 (Table 5.5) but in humans this subtype was found in 8 % of infections 
(Table 3.1). Therefore this ST seems unlikely to be of zoonotic origin in Libya. STIO \Vas not 
detected in human samples either in our study or in any previous study (Table 6 chapter 3). 
However, it was detected in the most mammal hosts in Libya in this study (Table 5.5). 
Stensvold et al. (2009) detected STIO in cattle and nonhuman primates while Santin et al. 
(2011) also detected STIO in cattle. For the time being it appears that cattle are the most 
common host to carry STIO. In addition detecting STIO in Libyan, European and American 
mammals means that there is no geographical restriction to the distribution of this subtype. 
STI and ST3 are the most dominant subtypes in Libyan humans but are relatively rare in 
Libyan animals with 7 % and 9 % of samples respectively, mostly in camels. As people come 
in contact with camels on farms, animal markets or camel breeding places, it is possible that 
there is transmission of the parasite between the two hosts. As we do not know much 
information about the origin of the human Libyan samples, it might be that some infected 
people have been exposed to camels. It seems unlikely that camels would be the only source 
of infection, however. 
According to previous studies, ST6 and ST7 are found only in birds and sporadic cases of 
human infections. In this study ST6 was not detected in any samples in either the UK or 
Libya, whereas ST7 was identified in goat, chicken (Table 5.5) and in humans as well (Table 
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3.1). Therefore, this result suggests that human isolates of ST7 could be of zoonotic origin 
and may show evidence of animal-to-human transmission. However, there is no proof of this. 
Table 5.9 shows more information on the genetic diversity of Blastocystis in camels in Libya. 
Out of six camel farms, there were seven Blastocystis subtypes detected. However, STIO and 
ST17 were detected on one farm only whereas ST 1, ST3, ST5 and ST15 were found on more 
than one farm. ST5 had the highest frequency and was detected in most of the farms. 
Significant differences in ST distribution exist between camel farms even in the same region 
suggesting there is limited cross-infection occuring between farms. 
During my work four new subtypes were discovered and these subtypes were proposed 
based on comparing the sequence of the whole SSU rRNA gene to other sUbtypes. Some 
subtypes, like ST14 which was detected in a gundi, was very diverged compared with other 
subtypes and were clearly new. ST17 which was found in two hosts, monkey and camel also 
showed large differences from other subtypes. 
In contrast, some new STs were close to previously designed subtypes. Initially there were 
called ST5 variants. Whole SSU rRNA gene sequencing was carried out and a minimum 
divergence of 3% was used to distinguish between the potential new subtype and existing 
sUbtypes. In addition, I required that the 'new' subtype was separated from existing subtypes 
in phylogenetic trees with at least 99% bootstrap support. I recognise that future sampling 
may show that some of these new subtypes are not supported. As we get more sequences then 
new STs will either combine together with other STs to form one group or they will continue 
to be separate and confirmed as new. 
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The new Blastocystis ST17 that was detected on farm 2 is the same subtype as found in 
chimpanzee, gibbon, lemur and an unidentified primate in UK. Additionally, ST16 was found 
in two different hosts (two cows and one camel) (Table 5.5) that had been collected from 
different areas in Libya (Sebha, Garaboli and Zawia) (Table 5.2). These findings mean that 
there is no specific host or geographical distribution for these Blastocystis subtypes. 
Table 5.9 Blastocystis subtypes distribution in camels found in Libya 
5ubtype STl ST2 ST3 5T4 5T5 5T6 ST7 5T8 5T9 STlO 5TH 5T12 5T13 STl4 STl5 STl6 STl7 Mix5T /Total 
Farm 15ebha - - 1 (5%) - 15(75%) - - - - - - - - - 1 (5%) - - 3 (15%) 20 
Farm 25ebha - - - - - - - - - 6(60%) - - - - 1 (10%) - 1 (10%) 2 (20",",) 10 
Farm 3 5ebha 2 (50"10) - 2 (50%) - - - - - - - - - - - - - - - 4 
Farm 45ebha 1 (16.7%) - 2 (33.3%) - 1 (16.7%) - - - - - - - - - - - - 2 (33.3%) 6 
Farm 55ebha - - - - 1 (100%) - - - - - - - - - - - - - 1 
Farm 7 Zawia 2 (33.3%) - - - 3 (50%) - - - - - - - - - - 1 (16.7) - - 6 
Total 5 (10.6%) - 5 (10.6%) - 20 (42.6%) - - - - 6 (12.8%) - - - - 2 (4.2%) 1 (2.1%) 1 (2.1%) 7 (15%) 47 
Table 5.10 displays the STs of Blastocystis infecting 566 animals including the data from 
analysis of 168 isolates in the present study and identifiable ST data from all previously 
published studies. 
It is clear from Tables 5.5 and 5.6 that a number of animals in both the UK and Libya showed 
mixed subtype infections while in humans there were no mixed infections detected. In the 
UK the frequency of mixed infection in primates was 3.8% whereas in Libya it reaches up to 
20% of mammals. In previous studies of human populations overall mixed infection 
prevalence was only 3.3 % % (Table 3.2). Mixed infection in Libyan animals is higher 
compared with other groups and this could be due to animal husbandry practice in Libya 
where cow, camel, goat and sheep are often found in mixed groups feed is provided on 
ground where all the animals gather and eat in same place. The animals also defecate in the 
same place which gives more chance for animals to get infected with more than one ST. 
132 
In the UK, human and animal hosts shared the same range of STs except for ST13 (mouse 
deer) and ST 17 (non-human primates). Hence the genetic diversity of Blastocystis in both 
groups is not very different. In contrast, in Libya animals carried nine subtypes (Table 5.5) 
compared with only four subtypes in humans (Table 3.1). For example, both ST5 and STI 0 
are common in animals but ST5 in human is a rare and STI 0 is not found at all. In addition 
ST8 is rare in general population but more common in people who worked with non-human 
primate. It is possible that if we were to examine people who are in close contact with 
animals the range of subtypes in humans would increase, but at present it appears that the 
range of subtypes in animals (16) is much greater than in humans (9) and that some host 
specificity exists. 
Several Blastocystis STs reveal broad host ranges, although they may not all be of zoonotic 
significance. There are significant differences in prevalence among subtypes between hosts 
and between the UK and Libya. It is not yet clear how much of the variation is due to the 
surveyed hosts and how much to geographic origin. Wider sampling of cattle and other 
Artiodactyls in the UK would help to answer some of these questions. 
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Table 5.10 Blastocystis subtype classification in non-human primates, other mammals and birds (n=566) (continued on next page) 
Host 
Chimpanzee 
Gorilla 
Ora ng-uta n 
Gibbons 
Baboon 
Mandnll 
Macaques 
V~rvet Monkey 
r)0 [-$raz.z:a's Monkey 
L)tall~:l MC.Jnk0Y 
I (...:a.t Mc~nkE'y 
Jdpane<,.e Monkey 
VVoolty Monkey 
Con-lrnon Marmoset 
L<mwrs I - I - I - I - I - I - I - I ::- I - I I - I - I - I - I - I - I - I I~~~ ~. ~.-\~~ 
r---
;d:';;:,'.~':;'~-' Monkey I - I - I ~ I - I - I - I -:;- I - I - I - I - I - I - I - I 
~'dtd<> ~o"k"y :'. I ~ I I - I - I - I -:;- I - I - I - I - I - I - I 
_ >ta'-Yldn~~ -
I an()ur ~Ia('~ • ~t)VI.'k_·r Monkey 
<;()()ty Mdf)<)FttH-'Y 
I ~1y'_'~Munk"y 1 1 1 1 - 1 - 1 1 - 1 - 1 1 - 1 -I I~a ...... ~. 
I Irlldf'~nllflf''>.d prlnlates 1 5 
I 
134 
Table 5.10 (continued) 
Host 
Cattle 
Cattle total 
Camel 
Horse 
Roe d~er 
MOU5e deer 
Gazelle 
Sh"-~ep 
B.-lrb~ry shee 
Gr..>al 
O.!~r/rn0used~er/gazell""/h."lrbary sheep/goat Ihorse/carnel total 
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22 
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4 
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Reference 
Abe at al.(2003c 
Yoshikawa et 81.(2004a) 
Stensvold at al.(2009) 
Santin et al., 2011 
Present study 
Present study 
Thathais~ at al.(2003) 
Stensvold et al (2009) 
Present study 
Present study 
Stensvold et al.(2009) 
Present study 
P.-esent study 
Pari<.ar- at al.(2007 
E~lun at 01.(2010 
Abe at al.(2003c) 
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Navarro et 0.1.(2008 
Noel at 81.(2003) 
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Thathaisong at &1.(2003 
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Yoshik8W'8 at al.(1998 
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The objective 
To investigate associations between Blastocystis subtypes and specific hosts 
In Denmark, STI0 was detected in 22 samples from cattle as well as from a lemur. In the 
USA STI0 was also detected from cattle. In Libya STI 0 was found in various animals, six 
each from cow and camel and one each from goat and Barbary sheep. This shows that STI 0 
is present in different hosts and locations. In Libya most samples collected were from camel 
but only 47 of these samples were positive for seven Blastocystis STs (STl, ST3, ST5, STlO 
STl5, STl6 and ST17). In cattle, out of 15 samples three STs were detected (ST5, STl 0 and 
STl4); ifmore samples from cattle were investigated more STs might be detected. However, 
it seems that STl 0 is mostly restricted to artiodactyls. 
ST7 is normally found in birds and considered avian subtype but it was also recently detected 
in non-human primate (Colobus monkey) in UK and in a goat in Libya. This suggests that 
host specificity of ST7 is not as strong as origina.\ly thought. 
Another example is the rodent which is previously was found to carry ST4, the only 
nonhuman host for this ST until recently Stensvold et al. (2009) detected ST4 in a few 
monkeys as well. In this study a new ST was detected in a rodent called gundi that lives in 
North Africa, particularly in Libya. This was designed ST14 and is distant from other STs. 
This shows that rodents carry multiple STs. 
In order to study the link between Blastocystis and specific host we have to collect more 
samples from mUltiple locations in the same country and from different geographic regions as 
well as from different animal hosts. Only doing this can help us to make strong conclusions 
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about Blastocystis ST and host specificity. Previously, conclusions were being made based on 
too few samples from too few hosts from too few locations. 
To investigate the possibility that Blastocystis infection is a zoonosis 
In order to investigate the possibility that Blastocystis infection is a zoonosis we have to 
collect faecal samples from animals and from the people who work with these animals, like 
zookeepers, farmers or animal handlers. It is also important to have another group of people 
which can be considered true control group who do not come in close contact with animals. 
For example in Libya, there are people considered to be camel handlers and they care for 
their camels by feeding, milking, even helping the camel to deliver its baby, so there is very 
close contact with the camel on a daily basis. By taken faecal samples from these camel 
handlers and their camels as well and comparing them with other groups in the same region 
that do not have any close contact with either camels or the camel handlers, we can compare 
the distribution of Blastocystis STs in all groups. This will reveal whether the camel handler 
STs are more similar to other humans or to their camels. However, it is possible that not all 
STs infect humans so this needs to be considered. It is also possible that identifying strains 
within STs will be necessary to confirm zoonotic infection. As already discussed persuading 
asymptomatic individuals to provide faecal samples is often not easy so it may prove difficult 
to obtain the samples necessary to complete this investigation. 
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Chapter 6 
Development of Multilocus Sequence Typing 
(MLST) for Blastocystis STI 
138 
6.1 Introduction 
People have suggested zoonotic transmission of Blastocystis to humans occurs but we cannot 
prove a connection based on subtype alone. In addition, reports linking sUbtypes to symptoms 
are often contradicted by other studies. It is possible that strains within sUbtypes differ in 
ability to cause disease, or vary geographically. 
In order to make a link or distinguish between strains of the same Blastocystis subtype, we 
need a method that detects genetic variation in non-ribosomal genes. 
Sometimes a monkey carries the same Blastocystis subtype as found in zookeeper but it is not 
necessarily the same strain. For example, if a zookeeper has ST3 and a monkey they are 
looking after also has ST3 as well it does not mean that the ST3 in the monkey is the same 
strain as in zookeeper and therefore results from zoonotic transmission - ST3 is common in 
both hosts. So for us to prove that zoonotic transmission of Blastocystis of occurs we do need 
a tool to allow us to distinguish between strains within Blastocystis STs and MLST is one of 
the best molecular techniques to carry out this differentiation. 
Multilocus sequence typing (MLST) is a highly discriminatory and clear method of 
characterizing bacterial isolates that has now been successfully used in the characterisation of 
several eukaryotic species. MLST is based on the nucleotide sequences of internal fragments 
of housekeeping genes in which mutations are believed to be mainly neutral (Selander et al., 
1986). Different nucleotide sequences for each gene fragment are assigned allele numbers 
and the sequence type (SQT) of each isolate is defined by the combination of alleles present 
at each of up to seven distinct loci; the isolates that share the same SQT are believed to be 
members of the same clone (King et al., 2002). 
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The aim of this study was to develop a MLST scheme for Blastocystis STI in order to 
understand the epidemiology and zoonotic potential of this parasite. Normally. nuclear genes 
are used for MLST loci but no genome sequence was available for Blastocystis at the start of 
this work, so we used the mitochondrion-like organelle (MLO) genome instead. For the same 
reason other methods of detecting strain variation, like microsatellites, were also not an 
option. Even now the only genome available is for ST7, a rare subtype in humans and too 
diverged to be useful for designing primers for the common subtypes. We have investigated 
STI as initial investigation showed variation in its MLO genome sequence and also because 
the whole MLO genome sequence is available in GenBank. It is also a common ST in 
humans. The MLST scheme is based on nucleotide sequences of seven genome fragments 
and was used to evaluate 64 isolates from various hosts and geographical sources. This is the 
first report of an MLST scheme for Blastocystis. 
6.2 Material and Method 
6.2.1 Blastocystis isolates 
A total of 64 Blastocystis isolates that had previously been identified as STI by barcoding 
were collected from different hosts and geographical locations. Thiliy-nine of these isolates 
were eventually used in this study and their origins are shown in Table 6.1. The other 25 
isolates did not give complete results either because of problems with amplification or 
sequencing reactions for one or more loci. 
DNA samples from Denmark were provided by Dr Rune Stensvold (SSI, Copenhagen). 
These were extracted directly from faeces. 
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Table 6.1 Blastocystis STI isolates from different hosts and locations 
Host UK Denmark libya USA Total 
Unselected 14 4 3 1 22 
IBS 7 0 0 0 7 
NHP 7 0 0 0 7 
Zoo keepers 3 0 0 0 3 
Total 31 4 3 1 39 
6.2.2 Blastocystis culture and DNA extraction 
These methods were as described previously. See chapter 2, section 2.1-2.7 for details. 
6.2.3 Selection of gene fragments for MLST scheme 
The whole mitochondrion-like organelle (MLO) genome sequence for Blastocystis Nandli 
strain (STl) was available in GenBank (Accession number EF494740; Fig. 6.1). Initially, 17 
gene fragments were chosen for a pilot MLST study of 8 Blastocystis STI isolates. Loci that 
did not give reliable amplification or showed no variation or did not show good sequence 
results were eliminated as targets. Results from these pilot sequences were used to establish a 
final group of seven gene fragments that gave the highest discrimination for MLST analysis. 
Each region showed at least two polymorphic sites in the pilot study. Primers were designed 
to amplify gene fragments of 400-600 bp and are described in Table 6.2, with the 
corresponding genome location given. Two regions of the nad1 gene were used as were part 
ofnad7, nad5 and nad9. Two loci contain parts of more than one gene. Locus 2 contains part 
ofrps8 and rp16 while locus 7 contains part ofOrfl43 and rps12 and in between is a 
complete tRNA Trp gene. 
Perez-Brocal (unpublished) found that most protein-coding genes in the MLO genome of 
Blastocystis are under purifying selection. Purifying selection removes deleterious alleles 
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from the population and so this affects calculations of divergence times because it leads to an 
underestimation of the number of mutations that have occurred. The effect this will have on 
MLST is that the diversity is likely to be lower than if there was no purifying selection and 
there are likely to be fewer non-synonymous substitutions. However, even though most genes 
in the Blastocystis MLO are under purifying selection this has no impact on the usefulness of 
the MLST method that has been developed, because regions of a representative set of genes 
have been used (approximately 25% of the total number of protein-coding genes in the 
genome (27)) 
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Fig 6.1. The gene map of the MLO genome of Blastocystis Nand II (EF494740) and target loci used 
in the MLST study. Arrows indicate the location of the regions amplified. 
142 
6.2.4 Primer design 
Most of the primers sets used initially in this study were designed for the original MLO 
genome sequencing by Perez-Brocal and Clark (2008). AdditionaJlaltemative oligonucleotide 
primers for PCR at the seven MLST -determining loci were designed by eye, or using the 
Gene Runner software version 3.05, from the MLO genome sequence of Blastocystis Nand II. 
Table 6.2 Primers used for PCR amplification and sequencing of Blastocystis STI 
Locus Location of the locus in Nand II Primer name Sequence (5'-3') 
1 8711-9190 22BF 5' GTGAAA TIGTICAAAAAGCAG 3' 
23BR 5' GGGAATGnnTCTI AAATCC 3' 
2 15459-15842 NS14F 5' ACAAAATATGGTATAGCTCGTACTG 3' 
NL6R 5' AAAGTIAGTTTGAAATTTAATAATACC 3' 
3 19459-19733 
Nnad5F 5'TGCAAAGACTGTAGAATAATCAAC 3' 
56BR 5' AGGTICTITIAAATIATATIGGG 3' 
4 20797-21099 Nnad91-F 5' ATCAATIGCACACATATCGGAC 3' 
Snad9-R* 5' ATGGGAAATCTITICTWARMGG 3' 
5 25306-25621 
Nnad11F 5' ATIAGTATGTCTICTCAAATIATGTC 3' 
71BR 5' CCAGAAATAATAATACCATATATAGC 3' 
6 25898-26134 
72BF 5' CTIATGAACmCTATIGGTGC 3' 
Snad1R 5' CCTATICTCATIAATIGATCATAAC 3' 
78B2F 5' AAGTCAAGAAATTTATAATICATIGTIC 3' 
7 27394-27691 
5' GCTATATICCTGGTATIGGTCA 3' NRS12R 
*W=AIT, R=AIG, M=A/C 
6.2.5 Gene amplification and sequencing of MLST targets 
For each locus, primers were designed to have a similar melting temperature and loci were 
found to be successfully amplified by PCR. The details of seven primers sets used in peR 
and sequencing reactions are listed in Table 6.2. 
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The total reaction volume for DNA amplification was 20 )11. DNA amplification was 
performed using thermocycler G-storm Model GS-l (Gene Technologies Corp) with a 
programme consisting of a 2 minutes denaturation step at 94°C, followed by 30 cycles of 94 
°C for 30 seconds, 55 °C for 30 seconds, and 72 °C for 2 minutes , and ending with a final 
extension for 2 minutes at 72 °C. Another protocol was also tested (as some iso lates did not 
750bp 
500 bp 
lKb l ocus 1 lecu.' l 
Fig 6.2. peR result for MLST of seven loci 
lo,u,S 
Locus 1= 613 bp, locus 2 = 596 bp, locus 3= 397 bp, locus 4= 407 bp, locus 5 & 6 = 455 bp and 
locus 7 = 431 bp. DNA ladder 1 kb. 
lo~u, 7 
amplify with the previous programme) with an initial denaturation at 94°C for 2 minutes, 
followed by 10 cycles of touch-down PCR (denaturation at 94 °C for 30 seconds, annealing 
at 60 cC, decreasing by 0.5 °C per cycle, and extension at 68 °C for 4 minutes), then 20 
cycles with denaturation at 94 °C for 30 seconds, annealing at 56 °C for 30 seconds, and 
elongation at 68 °C for for 4 minutes (Fig 6.2). 
144 
The GeneJET PCR purification kit (Fermentas, York, UK) was used to purify the product. 
The procedure was carried out as in Chapter 2 except 20 III of sterile deionized water were 
used to elute the DNA instead of 50 III of elution buffer (resulting in more concentration of 
the DNA preparation). The PCR products were sequenced on both DNA strands. The same 
sequencing reaction protocol was used as in chapter 2; for each PCR amplified locus two 
sequencing reactions were carried out separately, one with the forward primer and one with 
the reverse primer. Primers used in MLST amplification were also used in sequencing 
reactions for each locus with 1: 1 0 dilution. 
6.2.6 MLST analysis 
The sequences of each of the seven selected 280-480 bp double stranded regions were 
obtained from a subset of 39 Blastocystis STI isolates. The edited sequences were saved into 
a text file for analysis. For each locus analysed, a multiple alignment was manually created 
in Multalin (Corpet, 1988) fronl all those isolates sequenced. The sequence file was later 
converted into different formats for analysis using the BioEdit and MEGA programmes. 
For each locus, different sequences were allocated distinct allele numbers. This resulted in a 
7-digit allelic profile for each isolate. Each unique allelic profile was manually assigned a 
sequence type (SQT) number. Isolates with the same allelic profile were assigned to the same 
SQT, and are considered to be members of a single clone. The construction of a dendrogram 
(based on concatenated DNA sequences of all loci) by the Neighbour-Joining method was 
also performed in MEGA 4.0; see Chapter 2 sections 2.8 for details. 
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Table 6.3 Allelic diversity among 39 Blastocystis STI isolates 
No of % of 
locus Amplicon Sized of sequenced No of polymorphic polymorphic Mean %G+C 
size (bp) region (bp) alleles sites sites content 
1 613 480 7 10 2.08% 25.57% 
2 596 388 12 17 4.38% 16.57% 
3 397 276 8 7 2.53% 25.04% 
4 407 303 10 9 2.97% 20.25% 
5 455 316 4 3 0.94% 27.15% 
6 455 280 10 10 3.57% 27.22% 
7 431 300 10 9 3% 20.76% 
6.3 Results 
For all 39 isolates, peR products of the expected size were obtained for the seven loci. 
Several new primers (23BF, 22BF, 56BF, 71BR, 72BF and 78B2F) were designed for use in 
this work as shown in Table 6.2. 
6.3.1 Allelic variation in Blastocystis STI 
The sequence diversity within the Blastocystis STI genes was low but was sufficient to 
distinguish 4-12 alleles for each selected locus (Table 6.3). The number of isolates with each 
allele for all seven loci is shown in Table 6.4. The locus with the most alleles was locus 2 (12 
alleles) while the locus with the fewest alleles was locus 5 (4 alleles) 
A total of 32 SQTs were recognised within the 39 Blastocystis isolates in this study (see 
Table 6.4). This gives a discriminatory index of 0.98. A discriminatory index of> 0.9 is 
required for a MLST scheme to be useful (Hunter and Fraser, 1989). The relationship 
between SQTs was displayed as a phylogenetic tree created from the concatenated sequences 
(Fig.6.3). 
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6.3.2 MLST analysis of Blastocystis STI 
The majority of SQTs (28) were represented by single isolates. Among SQTs shared by more 
than one isolate, the most frequently encountered were SQTl 0 (4 isolates), SQT2 (3 isolates), 
SQT15 and SQT16 (2 isolates each) (Table 6.4). 
The phylogenetic tree shows that STI can be divided into four clades (Fig 6.2). Clade 1 has 
most of the isolates with a variety of different hosts represented and a wide geographical 
distribution. Clade 2 has two non-human primates, both siamangs collected from the same 
zoo (Monkey World). Clade 3 has two isolates, one a primate keeper from the UK and the 
other an unselected individual from Denmark. Clade 4 consists mainly of unselected samples 
plus one each from an IBS patient and a zoo keeper; in this clade isolates came from four 
different geographical places (Libya, UK, Denmark and USA). 
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Table 6.4 Result of the MLST analysis of the isolates of Blastocystis subtype 1 
Isolates SQTs Allelic profile Geographic origin Host 
MA 1 2 3 4 5 6 7 
3 1 1 1 1 1 1 1 1 UK IBS 
4 2 1 2 1 1 1 2 2 UK Diana Monkey 
9 3 1 2 2 1 1 2 3 UK Unselected 
16 4 1 3 1 1 1 2 2 UK Mandrill 
27 5 1 4 1 1 1 2 4 Denmark Unselected 
29 6 1 2 2 1 1 2 5 Denmark Unselected 
39 7 1 2 2 2 1 2 2 UK Unselected 
48 8 1 5 1 3 2 1 2 UK Unselected 
53 9 2 6 3 4 1 3 2 UK Zoo keeper 
55 10 1 1 1 1 1 1 2 UK Unselected 
57 2 1 2 1 1 1 2 2 UK Zoo keeper 
70 11 3 7 3 5 1 3 6 Denmark Unselected 
71 12 4 8 4 4 3 3 7 UK Siamang 
73 13 5 9 5 4 2 3 6 Denmark Unselected 
76 14 5 9 1 4 2 3 8 UK Zoo keeper 
90 15 1 2 6 1 1 2 2 UK IBS 
95 15 1 2 6 1 1 2 2 UK IBS 
111 16 5 10 1 4 2 3 2 UK Unselected 
117 17 5 9 1 6 2 3 2 UK IBS 
138 10 1 1 1 1 1 1 2 UK IBS 
143 18 4 8 4 4 3 3 2 UK Siamang 
166 19 1 2 2 7 1 2 2 UK Unselected 
170 20 6 2 3 1 1 4 2 UK Unselected 
178 16 5 10 1 4 2 3 2 UK Unselected 
200 21 1 1 1 8 4 1 2 UK IBS 
206 22 5 9 7 4 2 3 6 UK Unselected 
225 23 1 1 3 4 1 1 2 UK IBS 
227 2 1 2 1 1 1 2 2 UK Unselected 
258 24 1 11 1 1 1 5 2 UK Diana Monkey 
260 25 1 2 8 1 1 6 4 UK Orangutan 
276 10 1 1 1 1 1 1 2 UK Mandrill 
289 26 1 11 1 1 1 2 9 UK Unselected 
298 27 5 12 1 4 2 3 2 UK Unselected 
402 28 1 11 1 9 1 7 2 UK Unselected 
409 10 1 1 1 1 1 1 2 UK Unselected 
LHR17 29 5 9 1 4 2 8 2 Libya Unselected 
LHR24 30 7 9 1 10 2 9 10 Libya Unselected 
LHR7 31 5 9 1 4 2 3 6 Libya Unselected 
Nandll 32 5 9 1 4 2 10 2 USA Unselected 
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Fig 6.3. Neighbor-joining phylogenetic tree of 39 isolates of Blastocystis STI based on the 
concatenated sequences of seven MLST loci . Numbers represent bootstrap support for the 
branch points. Bootstrap values of over 90% are shown in bold and a larger font size. 
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6.4 Discussion 
Although sequence analysis of complete genomes is the only way to distinguish all genetic 
variants, this approach is not feasible in most cases and is not necessary. Sequencing of a 
representative selection of regions distributed over the Blastocystis genome can also allow 
detailed genetic analysis of individual strains. 
This study was undertaken to develop MLST scheme for Blastocystis STI using 39 isolates 
of Blastocystis STI. We tried to develop a simplified PCR approach for this MLST scheme 
and were mostly successful. We used the same set of primers for both amplification and 
sequencing. We found that a single round of PCR was suitable to amplify seven products 
from all 39 isolates examined, including DNA extracted directly from faeces as well as from 
culture. 
The MLST results revealed four clades as I mentioned before. In clade 1 there are 3 groups of 
isolates which showed same SQT and they are from different hosts except isolates MA90 and 
95 which we discovered later are from the same person with IBS sampled at different times. 
This finding supports the idea that samples with the same SQT are likely to be related in 
some way. Two siamang samples in clade 2 have closely related SQTs and although this 
shows some evidence of host specificity of clades within a ST, the number of samples is too 
small to make a significant conclusion. 
It is clear from this that this MLST can allow us to make a strong link between infections as 
the discriminatory power is high enough to differentiate between most strains. MLST can be 
used as a tool to differentiate between Blastocystis STI strains within the same host species 
or to study the zoonotic transmission by making a link between the same Blastocystis ST in 
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different hosts. In the strains studies so far no clear evidence of zoonotic transmission or host 
specificity was found. Even though a zookeeper and a Diana monkey had the same SQT they 
are from different zoos. Yoshikawa et al. (2009) reported that the prevalence of ST2 In 
human and monkey isolates offered molecular evidence of the potential transmission of 
Blastocystis between these hosts. I think that without using a technique like MLST to 
distinguish between strains of Blastocystis within a subtype it is difficult to accept this 
conclusion. 
In summary, our data suggest strongly that the seven loci chosen are a suitable basis for a 
MLST scheme, as we could amplify and sequence from isolates obtained from a wide variety 
of sources and detect sufficient diversity to provide a high degree of resolution. In addition 
MLST gives high reproducibility and has the potential for sharing of data through the 
internet, as has been done for MLST schemes in bacteria. 
The objective 
To develop a MLST method that distinguishes strains within Blastocystis subtypes 
We have developed MLST for Blastocystis STI and the discriminatory power is more than 
0.9. With this method at least 4 clades were detected within STI and these clades did not 
show any link to pathogenicity, host specificity or geographical distribution. However, it can 
be a basis for study to determine the transmission of Blastocystis. Additional sampling is 
needed to determine whether the few clades detected cover the range of diversity within ST 1. 
It is also impOIiant to test whether these loci can be used to study, STI in non-primate hosts. 
Because of the divergence between Blastocystis STs it will be necessary to develop a separate 
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MLST for each one - the MLO genome available in genBank differ by almost 25%. 
However, the successful development ofMLST for STI shows that it should be possible. 
152 
Chapter 7 
Final discussion 
153 . 
When I started my study there were only nine STs of Blastocystis in birds and mammals but 
not many hosts been sampled. There was limited information on Blastocystis ST distribution. 
No clear evidence of zoonotic transmission and no clear link between pathogenicity and 
Blastocystis STs had been published. 
In this study a major finding was the discovery of four new Blastocystis STs from different 
hosts and also four new hosts for Blastocystis from UK and Libya (see Chapter 5). The more 
we do sampling we are likely to get many new ST and hosts as well. 
My survey showed that STI was the most common ST in Libya and this is quite different 
from most other parts of the world where ST3 is the most common ST. It will be very useful 
to collect samples from different regions of Libya to compare the distribution of Blastocystis 
STs with these results, to see whether it will show the same pattern or not. In Egypt two 
studies from different regions revealed different Blastocystis ST distribution. We need to 
investigate whether is it going to be the same situation with Libya. 
To investigate the link between ST and disease, we need a clear diagnosis of symptomatic 
individuals infected with Blastocystis by excluding all bacteria, virus, and other parasitic 
diseases as well as food allergy, ulcerative colitis and Crohn's disease to eliminate any bias in 
the results and make any conclusions stronger. Also important is having a good asymptomatic 
control group that matches the symptomatic group as closely as a possible. The fact I did not 
have such a group made interpretation of my results more difficult. 
To study the possible link of Blastocystis ST with IBS I think we need to be ceI1ain of the ST 
identification by following the same techniques so that we avoid any errors. For instance, 
Yakoob et al. (2010a) compared samples from IBS and an unselected control group using 
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sequence -tagged site (STS) analysis. He found high STI in IBS while ST3 was the second 
most common ST, but in the unselected group ST3 was the highest. In our study ST3 was 
high in both IBS and unselected group but ST4 was higher in IBS compared to unselected 
group. Comparing the Yakoob et al. (201 Oa) result with Blastocystis distribution from 
different countries (Table 3.2 chapter 3) only Iran and Libya showed high STl. Since 
different methods were used to identifY subtypes in this study and in Yakoob's study we need 
to be sure that they both give the same results with the same samples. 
Quite a number of animals in this study showed mixed ST infection compared to the 
frequency in human samples and to overcome this problem Stensvold et al. (2009) suggested 
using ST-specific primers which can be developed for PCR studies together with the genus-
specific primers that are already in use. The problem with this procedure is that it will lead to 
extra cost, as we now have 17 STs, and ST-specific primers will not have the ability to detect 
new STs. 
Development of MLST for the most common Blastocystis ST1-ST4 is needed to better 
understand zoonotic transmission, pathogenicity and geographical distribution of this 
parasite. Already, we can study zoonotic transmission using MLST for Blastocystis STI by 
collecting samples from animals and their keepers to investigate the link between strains 
within this subtype. However we do not know whether the same results will be obtained for 
all subtypes. The genetic distance between subtypes means that a separate MLST needs to be 
developed for each ST, which means the ST will have to be identified before MLST can 
performed. MLST can also be used to study geographical distribution of Blastocystis by 
comparing strains within a subtype in samples from different geographical areas. It is 
possible that the amount of diversity will vary between locations as well as different SQTs 
being found. 
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The objectives of this study were: 
To compare the Blastocystis subtype distribution between the UK and Libya 
Our result showed that there is a difference in Blastocystis ST distribution between the UK 
and Libya. ST3 was the most common ST in UK while STI was the most frequent ST found 
in Libya. No ST4 was detected in Libya but in the UK it is the second most common ST. 
To investigate Blastocystis sUbtypes in IBS patients 
This study showed that ST4 is more common in IBS compared to an unselected group and 
there is an indication that ST4 in UK is associated with IBS even though there was no 
significant difference. 
To investigate associations between Blastocystis subtypes and specific hosts. 
In our study different STs were detected in the same host but also different hosts showed the 
same ST. For example ST13 was detected in a quokka in Australia and I have detected the 
same ST in mouse deer. Some STs showed more host specificity than other STs like ST14 
and ST15 which were identified only in gundi and camel respectively. 
To investigate the possibility that Blastocystis infection is a zoonosis. 
Some STs may show some evidence of zoonotic transmission like ST1, which was detected 
in camel and identified in Libyan humans as well. Also ST7 was detected in humans in Libya 
and in a chicken. Similarly in UK ST8 was detected in zoo keepers and also showed a high 
frequency in non-human primates. However the most common STs in Libyan animals are not 
found in human population. 
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To develop a MLST method that distinguishes strains within Blastocystis sUbtypes. 
Concatenated sequences of seven MLST loci for 39 isolates of Blastocystis STI illustrated 
four clades in the phylogenetic tree and we were able to differentiate most strains within 
Blastocystis STl. Its usefulness was shown by two isolates that have an identical SQT, and 
were later found to be samples from the same person at different times. 
Overall, the original objective of this project have been met to varymg degrees, and I 
certainly believe I have contributed to the aim of increasing our understanding of genetic 
diversity of Blastocystis 
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Future work 
Human studies 
Distribution of Blastocystis STs in human: 
My results analysing Blastocystis ST distribution in Libya and the UK showed a significantly 
different prevalence even though the samples from Libya were low in number and collected 
from only one region, Sebha. Similarly the UK the samples were received from only one 
source (the Diagnostic Parasitology Laboratory, LSHTM) 
To confirm whether there is really variation in the distribution of Blastocystis STs between 
Libya and UK populations a more complete survey is needed. 
Libyan samples 
The samples used for our study were collected from the Central Medical Laboratory in Sebha 
and we do not know the clinical background of these patients. Many are likely to be samples 
submitted for routine screening but some samples might be from symptomatic patients as 
well. 
154 samples were used to identify Blastocystis in Sebha, 43 samples were positive by culture 
and in only 38 samples were Blastocystis STs identified. To improve our understanding, we 
should obtain the same number of samples from asymptomatic patients in both the Tripoli 
and Benghazi regions to obtain clear view of the overall Blastocystis ST distribution in the 
Libya popUlation. We have already contacted some clinics in both regions who agreed to 
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collect samples from asymptomatic patients visiting these clinics for reasons other than 
gastrointestinal symptoms, for example routine health checks. 
UK samples 
Previously, all UK samples have been received from the Diagnostic Parasitology Laboratory 
at LSHTM and the problem with these samples is that we do not have access to the clinical 
history of these patients. Because of this these samples could be from IBS patients or 
symptomatic patients with causes other than IBS. It is unlikely that many are from 
asymptomatic individuals, because samples are referred for diagnosis by GPs or IBS clinics. 
As asymptomatic patients may be infected with STs that are different from those with 
symptoms, asymptomatic patients should be clearly identified in both countries. Both gender 
and age information should be collected as well to give more information on the 
epidemiology of Blastocystis STs in these populations. 
By collecting samples randomly from Tripoli (North West of Libya) and from Benghazi 
(North East of Libya), which are different in climate from Sebha (South West of Libya), and 
joining them with the data which I already have from Sebha this will give a more complete 
picture of Blastocystis prevalence and STs in Libya as well as showing any influence of 
climate and geography. In the UK, samples still need to be collected randomly from different 
regions. All samples received from the Diagnostic Laboratory at LSHTM came from England 
and at the present no sources from other regions have been identified, but in the future this 
could be organized. 
Together these new samples will give the real prevalence and distribution of Blastocystis STs 
in Libya and UK populations. 
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Blastocystis STs and IBS 
Results showed the frequency of ST4 was much higher in IBS clinic patients than in 
unselected GP patients, although the difference was not statistically significant. Because 
unselected GP random samples received through the Diagnostic Laboratory at LSHTM may 
include patients with IBS and some samples from IBS clinics may have come from patients 
eventually found not to have IBS, to avoid any bias in the results in future we need to confirm 
the correct diagnosis (IBS, asymptomatic or symptomatic patients with intestinal symptoms 
other than IBS) in order to address any link between Blastocystis subtypes and IBS. This will 
require ethical approval and cooperation of doctors submitting the samples, but should be 
possible. The most difficult aspect is likely to be obtaining a good control group for 
comparison to the IBS patients. This will require further investigation. 
Animal studies 
Zoonotic transmission of Blastocystis infections 
Our results showed that STI and ST3 are the most common in humans and are found in some 
animals as well, including camels and goats. We do not know whether these STs are 
transmitted from animals to humans or the other way around, or in fact whether there is no 
cross-transmission. 
To investigate the possible zoonotic transmission of these Blastocystis STs we can use MLST 
to see if there is any link between the sequence types in human and livestock. Libyan people 
as a group have more contact with sheep than goats due to a religious event where a hundred 
thousand sheep are slaughter on one day every year. I propose to collect sheep samples from 
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different regions in Libya and from sheep handlers, as well from humans who do not have 
any contact with sheep, and hopefully sheep will be infected with STI and ST3. Sheep in 
other countries have been found to be infected with ST3. We can use the samples to 
investigate whether there is any cross transmission between sheep and human. A MLST 
scheme for STI already exist from my work and a MLST scheme for ST3 is being developed 
by Dr R.Stensvold (SSI, Copenhagen) so the tools will be available for this investigation. 
Blastocystis subtypes and specific hosts: 
By comparing tables 3.2 & 5.10, showing the distribution of both human and animal 
Blastocystis subtypes worldwide, we noted that ST5 and STIO are common in certain animals 
but very rarely found in humans. So whether these STs are specific to animals needs further 
investigation by screening more samples in cow, gazelle, sheep, gundi, goat and Barbary 
sheep and in a greater variety of animal hosts. For example the one gazelle sample available 
showed Blastocystis which was a mix of SUbtypes, therefore screening more samples from 
Gazelle is needed to identify the subtypes, or even new subtypes, that can be found in this 
host. As mentioned before cow, camel and goat can be infected with STI and ST3, which are 
also common in human, but whether these subtypes also found in other animals as well we do 
not know. Screening animal samples from different locations and including human samples 
from the same location as well is necessary. Screening individuals who work with the 
animals would be particularly informative, but may be difficult due to cultural issues with 
handling of faeces. I hope that by performing the additional studies described in this section 
that a clear picture of Blastocystis epidemiology will be obtained. 
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